oral
mucosa
human
may
manifest
local
system
diseas
derang
produc
therapeut
agent
signific
proport
therapyrel
oral
drug
reaction
appear
lichenoid
reaction
erythema
multiform
bullou
lesion
similar
idiosyncrat
immunemedi
skin
reaction
inflamm
oral
mucosa
oral
mucos
particular
side
effect
convent
anticanc
drug
treatment
also
featur
target
anticanc
therapi
monoclon
antibodi
small
molecul
system
disord
produc
anticoagul
anticanc
therapi
may
also
evid
bleed
ulcer
oral
caviti
buccal
ulcer
also
describ
part
gener
hypersensit
reaction
drug
excess
contact
therapeut
agent
aspirin
potassium
supplement
captopril
nicorandil
potassiumchannel
activ
corticosteroid
report
produc
local
ulcer
mouth
increas
use
mouthwash
last
year
also
result
number
report
advers
effect
buccal
mucosa
peopl
buccal
rout
offer
advantag
drug
deliveri
intestin
first
pass
hepat
metabol
avoid
limit
low
adsorpt
across
oral
mucosa
irrit
natur
mani
propos
permeat
enhanc
major
minor
salivari
gland
secret
also
repres
integr
part
protect
mechan
oral
caviti
derang
saliva
product
may
lead
loss
integr
oral
mucosa
see
mani
drug
enter
saliva
simpl
passiv
diffus
drug
effect
motor
coordin
give
rise
drool
disrupt
cricopharyng
coordin
druginduc
abnorm
tast
sensat
also
welldescrib
phenomena
occur
patient
inde
mani
alter
oral
mucosa
readili
detect
care
clinic
observ
peopl
rather
exhaust
histopatholog
examin
buccal
mucosa
laboratori
anim
histopatholog
preclin
toxic
studi
oral
irrit
studi
use
test
product
use
oral
caviti
mani
surgic
dental
hygien
purpos
therapeut
agent
also
develop
administr
sublingu
buccal
rout
rout
may
select
substanc
broken
stomach
show
rapid
first
pass
effect
technic
feasibl
perform
full
preclin
toxic
studi
sublingu
buccal
rout
convent
oral
parenter
rout
use
system
toxic
studi
compound
choic
best
rout
larg
extent
dictat
pharmacokinet
consider
howev
usual
deem
necessari
assess
local
irrit
potenti
oral
mucosa
use
laboratori
anim
model
test
speci
oral
irrit
studi
usual
rat
hamster
cheek
pouch
guinea
pig
dog
primat
use
gross
histopatholog
assess
similar
scheme
employ
histolog
assess
skin
irrit
appropri
inflamm
oral
caviti
stomat
may
involv
buccal
mucosa
gingiva
gingiv
tongu
glossiti
peridont
tissu
peridont
inflammatori
lesion
found
sporad
untreat
laboratori
rodent
dog
primat
gingiv
due
shigella
infect
report
macaqu
coloni
intestin
shigellosi
endem
acut
necrot
ulcer
gingiv
affect
interdent
papilla
occur
primat
coloni
strongli
suggest
endem
type
retroviru
infect
wbnkob
rat
made
sever
diabet
singl
dose
alloxan
shown
develop
increas
inflamm
oral
caviti
associ
mucos
hyperplasia
distribut
hard
palat
central
part
tongu
gingiva
caus
uncertain
although
alloxan
reduc
saliva
flow
may
increas
oral
commens
microorgan
stomat
induc
system
administr
high
dose
therapeut
agent
differ
class
anticanc
antimitot
agent
particularli
liabl
induc
stomat
experiment
anim
cancer
patient
notabl
exampl
bleomycin
capabl
produc
stomat
part
gener
effect
squamou
cell
number
cancer
chemotherapeut
agent
produc
mucos
involv
oral
caviti
includ
newer
target
anticanc
therapi
exampl
monoclon
antibodi
small
molecul
target
epiderm
growth
factor
receptor
report
produc
oral
inflammatori
alter
preclin
toxic
studi
patient
human
advers
effect
therapeut
ioniz
radiat
salivari
gland
ensu
reduct
secret
protect
saliva
may
also
give
rise
inflammatori
chang
oral
caviti
diuret
agent
capabl
produc
sever
electrolyt
disturb
uremia
high
dose
also
produc
stomat
administ
laboratori
anim
lesion
may
analog
welldescrib
associ
ulcer
stomat
uremia
human
laboratori
anim
dog
appear
sensit
ulcerogen
effect
uremia
oral
caviti
although
poor
correl
actual
level
blood
urea
stomat
factor
undoubtedli
involv
compound
alter
skin
pigment
produc
similar
chang
oral
mucosa
number
drug
includ
chlorpromazin
quinacrin
chloroquin
amodiaquin
pyrimethamin
associ
pigment
oral
mucosa
human
prolong
ingest
silver
salt
may
caus
slate
gray
pigment
skin
also
oral
mucosa
result
silver
deposit
around
basement
membran
patient
infect
human
immun
defici
viru
hiv
pigment
also
report
follow
therapi
clofazimim
zidovudin
ketoconazol
similar
effect
may
occur
laboratori
anim
chloroquin
pyrimethamin
shown
significantli
increas
number
activ
melanocyt
within
palat
mucosa
pigment
da
rat
treat
oral
week
melanocyt
treat
rat
shown
enlarg
pack
melanin
pigment
possess
extens
arbor
cell
process
squamou
cell
experiment
inhibitor
platelet
aggreg
produc
pigment
loss
dark
hair
longevan
rat
skin
beagl
dog
also
induc
pallor
normal
pigment
oral
mucou
membran
dog
apart
loss
pigment
histolog
mucou
membran
skin
normal
tongu
conveni
section
histolog
studi
although
relianc
often
place
care
visual
inspect
use
systemat
histolog
examin
tongu
preclin
safeti
studi
clearli
establish
lesion
occur
fairli
specif
tongu
amyloid
may
becom
deposit
muscular
connect
tissu
tongu
amyloidpron
speci
particularli
mice
mice
especi
dba
strain
liabl
develop
calcif
lingual
muscl
spontan
even
young
age
associ
myocardi
aortic
miner
calcifi
lesion
seen
longitudin
muscl
dorsolater
epithelium
central
part
tongu
sever
associ
inflamm
granul
tissu
polypoid
chang
hyperplasia
overli
squamou
epithelium
ulcer
histogenesi
lesion
uncertain
therapeut
agent
particularli
anticanc
drug
induc
inflammatori
lesion
tongu
exampl
provid
investig
anticanc
immunotoxin
mous
monoclon
antibodi
colorect
carcinoma
antigen
conjug
recombin
ricin
achain
administ
wistar
rat
agent
produc
myocyt
necrosi
inflamm
specif
locat
ventral
subepitheli
surfac
tongu
chang
differ
low
grade
myositi
seen
elsewher
treat
anim
author
specul
chang
tongu
may
relat
particular
receptor
profil
area
target
monoclon
antibodi
common
chang
induc
digest
tract
rat
cynomolgu
monkey
administr
recombin
human
epiderm
growth
factor
tongu
show
squamou
epitheli
hyperplasia
character
uniform
increas
thick
squamou
epithelium
speci
high
dose
squamou
epithelium
tongu
primat
twice
thick
control
mucosa
associ
elong
rete
peg
convers
interfer
growth
factor
activ
inhibit
tyrosin
kinas
associ
epiderm
growth
factor
receptor
appear
associ
mouth
inflamm
ulcer
patient
although
found
less
commonli
skin
chang
teeth
usual
inspect
nake
eye
convent
toxic
studi
appropri
assess
matur
dentit
howev
increas
awar
dental
lesion
toxic
studi
particularli
teeth
visual
maxilla
examin
histolog
inhal
studi
studi
rodent
dentit
inhal
studi
shown
spontan
lesion
dentit
quit
common
one
laboratori
malform
dental
dysplasia
maxillari
incisor
observ
femal
male
mice
femal
spraguedawley
rat
inhal
studi
respect
unlik
human
rodent
incisor
continu
grow
differenti
throughout
life
renew
everi
day
contrast
rodent
molar
grow
littl
root
develop
complet
although
dentin
product
continu
slower
rate
locat
center
tooth
vascular
pulp
surround
prolifer
ondotoblast
form
predentin
calcifi
becom
dentin
surround
ameloblast
induc
presenc
dentin
produc
overli
enamel
layer
activ
cellular
layer
modifi
damag
drug
vitamin
defici
calcium
phosphat
magnesium
defici
parathyroidectomi
hypophysectomi
hyperparathyroid
adren
insuffici
fluorosi
rat
ondontogen
cell
shown
immunocytochemistri
express
high
level
parathyroid
hormonerel
peptid
receptor
studi
genet
modifi
mice
shown
parathyroid
hormonerel
peptid
member
parathyroid
hormon
famili
import
normal
tooth
develop
well
cartilag
number
tissu
organ
although
human
matur
dentit
ceas
grow
children
dentit
growth
phase
start
utero
last
second
decad
increas
number
children
surviv
malign
diseas
damag
matur
dentit
occur
result
cytotox
therapi
childhood
clinic
studi
teeth
children
treat
malign
shown
increas
incid
dental
defect
enamel
hypoplasia
miss
teeth
histolog
examin
teeth
children
treat
vincristin
combin
chemotherapi
malign
diseas
demonstr
promin
increment
line
dentin
correl
number
time
intraven
cytotox
agent
administ
chang
reproduc
rodent
shown
vincristin
interfer
assembl
microtubul
reduc
secretori
activ
number
cell
includ
osteoblast
chondroblast
alter
dentin
format
rat
incisor
two
week
follow
singl
intraven
dose
vincristin
young
adult
rat
faint
increment
line
dentin
shown
occur
probabl
reflect
direct
effect
drug
dentinogen
tissu
time
inject
higher
dose
focal
nichelik
punchedout
defect
dentin
also
observ
express
sever
injuri
highli
sensit
dentinogen
popul
time
inject
precis
mechan
damag
fulli
understood
although
decreas
secret
dentin
matrix
odontoblast
demonstr
administr
alkyl
anticanc
agent
cyclophosphamid
singl
exposur
ioniz
radiat
also
produc
local
nichelik
punchedout
defect
rat
incisor
anticonvuls
drug
may
also
produc
chang
dentit
human
experiment
anim
children
report
alter
includ
tooth
root
resorpt
small
teeth
delay
shed
decidu
teeth
retard
erupt
perman
teeth
featur
similar
found
hypoparathyroid
pseudohypoparathyroid
condit
tooth
root
alter
also
report
studi
young
male
wistar
rat
treat
diphenylhyantoin
one
month
treat
rat
show
evid
molar
root
resorpt
lacuna
penetr
cementum
involv
dentin
lacuna
contain
dens
infiltr
cell
contigu
similar
cell
surround
periodont
ligament
chang
similar
occur
parathyroidectom
rat
rat
made
hypocalcem
calciumdefici
diet
therefor
suggest
chang
induc
diphenylhydantoin
rat
similar
pseudohypoparathyroid
resist
tooth
root
resorpt
reduc
high
circul
level
parathyroid
hormonerel
peptid
also
shown
disrupt
ondontoblast
cell
function
normal
tooth
growth
rat
numer
drug
report
produc
tooth
discolor
human
may
either
intrins
extrins
natur
extrins
discolor
occur
teeth
erupt
mouth
repres
superfici
discolor
remov
clean
offend
agent
includ
chlorhexidin
oral
administ
iron
salt
intrins
tooth
discolor
perman
chang
relat
interfer
odontogenesi
notabl
produc
fluorid
tetracyclin
doxycyclin
minocyclin
discolor
teeth
bone
welldescrib
side
effect
tetracyclin
administr
also
report
patient
treat
doxycyclin
semisynthet
deriv
minocyclin
ameloblast
epithelium
enamelform
tissu
grow
incisor
wistar
rat
treat
high
dose
human
recombin
epiderm
growth
factor
develop
hyperplasia
character
pseudostratif
increas
ratio
increas
cytoplasm
eosinophilia
find
consist
presenc
epiderm
growth
factor
receptor
cell
enamel
organ
administr
inhibitor
vascular
endotheli
growth
factor
receptor
fibroblast
growth
factor
receptor
also
shown
alter
tooth
format
rat
sever
week
administr
teeth
becom
whiten
fractur
histolog
teeth
show
reduc
dentin
format
degener
ondotoblast
presum
result
defect
vascular
manner
similar
seen
epiphys
growth
plate
see
chapter
ameloblast
odontoblast
degener
thicken
incisor
teeth
fractur
also
report
rat
given
high
dose
sitagliptin
phosphat
oral
activ
inhibitor
dipeptidyl
enzym
use
diabet
mellitu
although
causat
unclear
periodont
common
import
diseas
human
anim
although
overt
case
usual
seen
toxic
studi
howev
periodont
sever
enough
disrupt
chronic
rat
toxic
carcinogen
studi
periodont
character
eros
granulomat
caviti
adjac
molar
teeth
fistula
open
nasal
caviti
link
penetr
food
fiber
gingiv
sulcu
rat
studi
suggest
presenc
long
point
food
fiber
powder
diet
main
caus
occurr
periodont
rodent
also
result
effect
dental
patholog
fractur
malform
malposit
incisor
gingiv
overgrowth
hyperplasia
druginduc
overgrowth
gingiv
tissu
welldescrib
phenomenon
human
laboratori
anim
includ
dog
cat
rat
human
chang
associ
administr
diphenylhydantoin
phenytoin
nifedipin
calcium
channel
blocker
cyclosporin
valproic
acid
occasion
trexenam
acid
erythromycin
sodium
valproat
phenobarbiton
phenobarbit
vigabatrin
cyclosporin
diphenylhydantoin
calcium
channel
blocker
associ
similar
chang
laboratori
anim
instanc
swell
gingiva
firm
nodular
overgrowth
around
teeth
histolog
overgrowth
character
mark
acanthosi
squamou
epithelium
overli
connect
tissu
infiltr
larg
number
chronic
inflammatori
cell
rat
model
cyclosporin
ainduc
hyperplasia
epithelium
show
increas
prolif
activ
fibrovascular
prolifer
may
mark
patient
treat
cyclosporin
myxomat
degener
describ
associ
dens
infiltr
plasma
cell
lymphocyt
secondari
acut
inflamm
associ
food
debri
hair
shaft
describ
dog
treat
oxodipin
forc
behind
chang
unclear
studi
chang
induc
nifedipin
hydantoin
shown
increas
extracellular
ground
substanc
increas
number
fibroblast
contain
sulfat
acid
mucopolysaccharid
drug
may
alter
fibroblast
prolif
synthet
activ
possibl
select
subpopul
fibroblast
also
suggest
underli
mechan
phenytoininduc
gingiv
hyperplasia
involv
decreas
salivari
iga
develop
patient
studi
cyclosporin
ainduc
chang
suggest
impair
lymphocyt
function
may
permit
overgrowth
oral
bacteria
bacteri
product
may
influenc
fibroblast
function
spontan
form
gingiv
hyperplasia
describ
nonhuman
primat
macaca
mulata
character
enlarg
margin
alveolar
gingiva
connect
tissu
consist
rel
poorli
cellular
bundl
collagen
fiber
lesion
show
littl
inflammatori
alter
overli
squamou
epithelium
show
mild
hyperkeratosi
patholog
similar
hereditari
gingiv
fibromatosi
human
papilloma
carcinoma
oral
caviti
sessil
peduncul
squamou
papilloma
infiltr
squamou
carcinoma
occasion
found
oral
caviti
laboratori
anim
includ
rodent
rabbit
beagl
dog
monkey
oral
cancer
human
squamou
cell
carcinoma
afflict
individu
low
incom
commun
mainli
problem
older
men
expos
risk
factor
tobacco
without
alcohol
microscop
structur
neoplasm
rodent
resembl
occur
squamou
epithelium
site
squamou
carcinoma
gener
uncommon
spontan
lesion
laboratori
anim
howev
strain
rodent
develop
squamou
neoplasm
commonli
instanc
lifetim
studi
ad
libitum
fed
brown
norway
rat
male
femal
develop
oral
squamou
cell
carcinoma
although
foodrestrict
anim
respect
suggest
certain
pedigre
possess
genet
predisposit
neoplasm
number
mutagen
nonmutagen
industri
chemic
report
induc
squamou
carcinoma
oral
caviti
rat
carcinogen
studi
therapeut
agent
abl
show
signific
tumorigen
effect
oral
caviti
rodent
bioassay
howev
local
cytotox
irrit
effect
follow
oral
administr
high
dose
drug
long
period
may
produc
small
increas
number
tumor
predispos
rodent
strain
papilloma
occur
rabbit
dog
note
occur
quit
young
anim
appar
result
infect
virus
papilloma
group
viral
inclus
may
seen
histolog
section
implic
papilloma
virus
laboratori
speci
progress
viral
induc
papilloma
malign
squamou
carcinoma
potenti
nonvir
factor
includ
applic
xenobiot
rabbit
preval
oral
papilloma
vari
consider
quit
common
laboratori
strain
overlook
small
size
locat
ventral
surfac
tongu
microscop
typic
squamou
papilloma
compos
irregular
acanthot
squamou
epithelium
fibrovascular
stalk
variabl
size
squamou
cell
margin
papilloma
junction
normal
mucosa
often
show
larg
oval
nuclei
margin
chromatin
central
basophil
intranuclear
inclus
electron
microscop
examin
show
contain
viral
particl
oral
papilloma
dog
develop
multipl
growth
regress
spontan
month
also
caus
viru
papilloma
group
possess
high
degre
specif
mucosa
oral
caviti
adjac
skin
compos
prolifer
mass
epitheli
cell
keratin
surfac
rest
irregular
connect
tissu
stroma
pedicl
larg
vesicular
cell
basophil
intranuclear
inclus
also
found
granular
cell
layer
identifi
viru
array
electron
microscopi
malign
chang
describ
canin
lesion
occur
young
beagl
dog
although
mani
type
papilloma
virus
identifi
human
anim
common
antigen
determin
exist
virus
differ
speci
immunolog
crossreact
exploit
immunocytochem
local
papilloma
virus
epitheli
lesion
mani
anim
speci
papilloma
viru
antigen
demonstr
oral
papilloma
dog
rabbit
use
antisera
bovin
papilloma
viru
type
cell
posit
viru
viral
inclus
locat
upper
layer
epithelium
especi
within
cell
granular
layer
spontan
develop
odontogen
tumor
rare
rodent
induc
laboratori
anim
given
carcinogen
nitrosourea
expos
ioniz
radiat
rang
tumor
origin
dental
tissu
epitheli
mesenchym
mix
appear
report
rodent
classif
odontogen
tumor
complex
confus
rang
benign
anomali
cystic
structur
malign
neoplasm
ameloblastoma
compris
cord
nest
anastomos
strand
island
ondontogen
epitheli
cell
within
fibrou
stroma
tumor
cell
resembl
ameloblast
cord
spindleshap
cell
similar
stellat
epithelium
bound
peripher
layer
cuboid
columnar
cell
resembl
inner
enamel
epithelium
tumor
odontogen
epithelium
show
induct
mesenchym
element
develop
complet
sequenc
odontogen
epithelium
odontogen
mesenchym
dental
hard
tissu
includ
dentin
enamel
cementum
classifi
odontoma
character
presenc
dental
hard
tissu
odontogen
fibroma
compos
undifferenti
primit
mesenchym
cell
develop
dental
tissu
odontogen
tumor
develop
fischer
rat
treat
aflatoxin
locat
upper
jaw
associ
incisor
teeth
compos
prolifer
fibroblastlik
cell
within
ovoid
calcifi
bodi
resembl
cementum
seen
occasion
inclus
solid
epitheli
nest
also
seen
metastat
deposit
found
although
neoplasm
local
aggress
addit
squamou
tumor
neoplasm
mesenchym
origin
typic
organ
soft
tissu
found
region
although
salivari
gland
may
repres
vital
organ
sens
kidney
heart
sever
derang
secret
alter
qualiti
quantiti
saliva
autonom
nervou
system
play
import
role
releas
saliva
stimul
tend
produc
low
volum
saliva
high
viscos
stimul
low
volum
fluid
low
viscos
wherea
cholinerg
stimul
produc
saliva
high
volum
low
viscos
sever
oral
complic
irrevers
salivari
damag
dysfunct
occur
patient
head
neck
cancer
consequ
local
irradi
may
signific
impact
efficaci
therapi
qualiti
life
surviv
although
larg
number
drug
associ
dri
mouth
particularli
patient
treat
hypertens
mental
disord
seem
alway
correl
diminish
salivari
gland
function
drug
appear
associ
measur
glandular
hypofunct
anticholinerg
properti
drug
may
occasion
caus
painless
bilater
swell
salivari
gland
patient
protect
layer
mucu
viscoelast
materi
contain
high
molecular
weight
glycoprotein
produc
major
minor
salivari
gland
cover
stratifi
squamou
mucosa
oral
caviti
mucin
usual
contain
carbohydr
form
neutral
acid
oliosaccharid
chain
oglycosid
link
threonin
serin
mucin
possess
sever
role
includ
mechan
flush
oral
caviti
protect
lubric
soft
hard
tissu
modul
oral
microbi
flora
buffer
activ
regul
calciumphosph
equilibrium
digest
extracellular
posttransl
process
molecul
present
saliva
heterogen
salivari
glycoprotein
suggest
act
defens
pathogen
microorgan
compet
microbi
bind
site
similar
structur
surfac
cell
line
digest
tract
minor
salivari
gland
may
also
play
import
part
local
immunosurveil
oral
caviti
duct
anatom
close
associ
lymphoid
tissu
salivari
secret
also
possess
digest
enzym
activ
although
herbivor
carnivor
usual
low
contrast
high
digest
enzym
activ
omnivor
speci
phylogenet
associ
salivari
gland
thyroid
gland
evid
function
salivari
gland
capabl
concentr
iodid
secret
although
control
thyroidstimul
hormon
shown
thyroxin
acceler
differenti
granular
convolut
tubul
cell
appear
epiderm
growth
factor
submandibular
gland
neonat
mous
structur
salivari
gland
differ
among
laboratori
speci
differ
gland
speci
sex
usual
consid
three
major
salivari
gland
parotid
sublingu
submandibular
submaxillari
gland
minor
salivari
gland
scatter
locat
throughout
mouth
oropharynx
high
degre
structur
variabl
human
anterior
lingual
salivari
gland
precis
role
remain
uncertain
dog
carnivor
zygomat
infraorbit
gland
locat
zygomat
arch
buccal
molar
gland
also
often
refer
major
salivari
gland
microscop
salivari
gland
compos
secretori
gland
endpiec
attach
connect
system
intralobular
extralobular
secretori
duct
secretori
endpiec
may
acinar
tubuloacinar
natur
secretori
cell
subdivid
serou
mucou
seromuc
special
serou
type
controversi
remain
precis
natur
secretori
cell
found
variou
salivari
gland
differ
speci
make
critic
interspeci
comparison
difficult
duct
system
less
complex
compris
intercal
duct
lead
secretori
endpiec
striat
secretori
intralobular
duct
term
line
cell
striat
delic
eosinophil
cytoplasm
rod
striat
duct
converg
interlobular
duct
main
excretori
duct
system
rat
mice
hamster
overal
similar
gross
microscop
anatomi
variou
salivari
gland
exist
although
histochem
differ
salivari
gland
rodent
well
number
speci
show
morpholog
histochem
sexual
dimorph
sublingu
gland
rat
mice
hamster
compos
princip
mucou
acini
indistinct
serou
demilun
acini
open
fairli
long
intercal
duct
line
flat
cuboid
cell
devoid
granul
parotid
gland
compos
seroustyp
secretori
cell
contain
zymogen
granul
promin
hyperchromat
basal
cytoplasm
pole
submandibular
gland
anatom
complex
salivari
gland
rodent
secretori
endpiec
compos
small
moder
size
cell
foami
cytoplasm
basophil
basal
pole
strike
featur
presenc
addit
duct
segment
interpos
intercal
striat
duct
segment
line
cylindr
epithelium
basal
nuclei
eosinophil
cytoplasm
contain
secretori
granul
duct
segment
term
granular
duct
granular
convolut
tubul
granul
duct
cell
stain
particularli
well
chromotropeanilin
blue
stain
also
orang
g
pa
granular
cell
special
interest
contain
larg
number
heterolog
biolog
activ
peptid
includ
nerv
growth
factor
epiderm
growth
factor
renin
kallikrinin
epiderm
growth
factor
secret
saliva
believ
promot
wound
heal
howev
precis
physiolog
role
mani
peptid
salivari
tissu
remain
uncertain
epiderm
growth
factor
origin
isol
mous
salivari
gland
shown
produc
prematur
eyelid
open
incisor
erupt
inject
neonat
led
isol
epiderm
growth
factor
also
tyrosin
kinaseact
receptor
testosteron
thyroxin
growth
hormon
shown
regul
concentr
epiderm
growth
factor
rat
submandibular
gland
moreov
testosteron
respons
male
pattern
gland
notabl
larger
volum
secretori
tubul
cytoplasm
granul
castrat
caus
regress
androgen
hypertrophi
castrat
male
intact
femal
granular
cell
stain
antisera
epiderm
growth
factor
intracellular
distribut
epiderm
growth
factor
acini
duct
confirm
speci
includ
human
studi
mous
submandibular
gland
shown
epiderm
growth
factor
nerv
growth
factor
releas
saliva
follow
administr
phenylephrin
sympathomimet
amin
act
mainli
receptor
isoprenalin
isoproterenol
adrenerg
agent
immunohistochem
studi
also
demonstr
epiderm
growth
factor
becom
deplet
mous
salivari
tissu
follow
administr
phenylephrin
similar
agent
phenylephrin
shown
caus
mark
secretori
activ
accompani
loss
granul
granular
cell
well
loss
immun
reactiv
carbon
anhydras
enzym
particip
membran
transport
bicarbon
ion
saliva
glandular
secret
morpholog
studi
shown
acinar
granular
tubular
cell
particip
respons
adrenerg
agent
contrast
effect
pilocarpin
cholinerg
agent
elicit
secret
saliva
defici
serou
protein
littl
none
growth
factor
effect
limit
acinar
cell
abund
glycoprotein
secret
rodent
salivari
gland
stimul
histochem
studi
use
convent
mucin
histochem
techniqu
label
lectin
possess
affin
specif
sugar
sugar
sequenc
studi
rat
mous
digest
system
hamster
salivari
gland
use
batteri
label
lectin
shown
greater
heterogen
oligosaccharid
salivari
gland
seen
classic
histochem
techniqu
dog
salivari
gland
less
attent
paid
structur
cytochemistri
dog
salivari
gland
appear
rel
littl
variat
structur
mucin
histochemistri
salivari
tissu
beagl
strain
although
variat
age
report
dog
parotid
seromucin
type
secret
acid
neutral
mucosubst
contrast
neutral
mucosubst
secret
rodent
gland
salivari
gland
nonhuman
primat
similar
human
possess
parotid
gland
serou
seromuc
type
submandibular
gland
serou
mucou
acini
sublingu
gland
mainli
mucou
type
salivari
gland
nonhuman
primat
react
advers
stimuli
ioniz
radiat
similar
manner
human
salivari
tissu
nonneoplast
lesion
focal
chronic
inflamm
salivari
gland
occur
sporad
untreat
rat
mice
hamster
dog
primat
employ
toxicolog
although
sever
preval
variabl
acut
chronic
inflamm
may
also
develop
gland
affect
vascul
whether
spontan
natur
induc
xenobiot
sialoaden
result
sialodacryoaden
corona
viru
wellknown
fairli
ubiquit
condit
rat
first
describ
inn
stanton
condit
character
histolog
edema
congest
submandibular
parotid
salivari
gland
well
extraorbit
lachrym
harderian
gland
figur
accompani
inflamm
variabl
sever
chronic
glandular
connect
tissu
well
degener
necrosi
duct
epithelium
deplet
salivari
gland
epiderm
growth
factor
also
occur
infect
regen
hyperplasia
duct
epithelium
may
quit
intens
week
infect
chang
regress
two
week
gland
essenti
normal
three
four
week
may
delay
appear
inflammatori
cell
onset
repair
rat
treat
immunosuppress
drug
cyclophosphamid
suppur
infect
neck
region
rat
produc
klebsiella
aerogen
also
caus
acut
chronic
inflamm
salivari
gland
fibrosi
glandular
prolifer
salivari
tissu
sialaden
occur
spontan
autoimmunepron
strain
mice
nzbnzw
slni
strain
report
age
femal
male
mice
nonobes
diabet
mous
known
spontan
insulindepend
diabet
mellitu
also
develop
immunemedi
damag
submandibular
gland
age
femal
submandibular
gland
shown
involv
destruct
inflammatori
process
character
intens
infiltr
small
mediums
lymphocyt
associ
mild
inflamm
organ
parotid
sublingu
gland
pancrea
kidney
immunocytochemistri
show
lymphocyt
cell
helperinduc
subset
posit
less
suppressercytotox
posit
type
circul
antisalivari
duct
antibodi
igg
also
detect
afflict
mice
suggest
helperinduc
cell
play
key
role
product
chang
unlik
induc
autoimmun
sialoaden
cytotox
cell
subset
may
directli
destroy
glandular
tissu
suggest
process
age
femal
relat
declin
number
suppressercytotox
cell
mice
advanc
age
nonobes
diabet
strain
mous
deriv
jclicr
mice
periduct
chronic
inflammatori
infiltr
found
submandibular
gland
time
immunemedi
insul
mark
suggest
extens
autoimmun
process
salivari
tissu
probabl
helperinduc
cell
essenti
compon
infiltr
number
cytokin
receptor
interferon
induc
protein
rant
regul
upon
activ
normal
cell
express
secret
may
import
role
autoimmun
type
sialoaden
also
experiment
induc
certain
strain
mice
crj
mice
thymectom
three
day
time
point
suppress
lymphocyt
maxim
reduc
follow
immun
day
birth
homogen
salivari
gland
complet
freund
adjuv
develop
distinct
sialoaden
submandibular
extent
parotid
gland
sialoaden
character
degen
chang
salivari
glandular
tissu
associ
extens
intens
infiltr
small
mediums
lymphocyt
mostli
suppressorcytotox
lymphocyt
cell
appear
shortli
immun
increas
number
time
plasmacytoid
lymphocyt
contain
immunoglobulin
mainli
igg
class
appear
later
immun
balbc
mice
short
peptid
kda
ro
ssa
antigen
common
target
autoimmun
gren
syndrom
human
also
develop
similar
patholog
human
syndrom
chronic
autoimmun
disord
exocrin
gland
associ
lymphocyt
infiltr
salivari
gland
dryness
mouth
eye
result
function
disturb
salivari
lacrim
gland
affect
mice
show
lymphocyt
infiltr
salivari
tissu
consist
b
lymphocyt
reminisc
human
gren
syndrom
hamster
salivari
gland
interstiti
infiltr
lymphocyt
plasma
cell
quit
common
may
becom
mark
advanc
age
wherea
necrosi
parotid
gland
uncertain
etiolog
sometim
occur
dog
mild
focal
chronic
inflamm
quit
common
incident
find
canin
salivari
gland
report
normal
beagl
dog
inflammatori
cell
infiltr
submaxillari
parotid
salivari
gland
also
found
commonli
untreat
cynomolgu
monkey
although
inflamm
salivari
tissu
result
ioniz
radiat
indirectli
relev
drug
safeti
evalu
pertin
demonstr
speci
differ
sensit
serou
acinar
cell
human
rhesu
monkey
appear
least
resist
effect
ioniz
radiat
damag
character
widespread
degranul
degener
acini
infiltr
polymorphonuclear
cell
follow
lymphocyt
plasma
cell
subsequ
atrophi
fibrosi
xerostomia
dryness
mouth
due
salivari
gland
dysfunct
develop
cancer
patient
follow
local
ioniz
radiat
gland
chang
contrast
lesser
effect
ioniz
radiat
rodent
salivari
gland
littl
acut
inflammatori
respons
like
mani
glandular
organ
size
secretori
tissu
salivari
gland
respons
function
demand
subject
agerel
chang
human
gland
parenchyma
frequent
becom
atroph
replac
connect
tissu
fat
advanc
age
possibl
partli
relat
vascular
chang
age
rat
extent
height
granular
duct
content
matur
secretori
granul
also
shown
decreas
age
dietari
factor
influenc
salivari
gland
size
decreas
food
consumpt
protein
starvat
reduc
weight
salivari
gland
rat
shrink
mucou
serou
gland
loss
zymogen
granul
associ
decreas
rna
unchang
dna
content
attribut
reduc
requir
protein
synthesi
salivari
gland
function
respons
adrenerg
stimul
surpris
atrophi
occur
follow
adrenerg
blockad
weight
submandibular
gland
mice
shown
decreas
follow
administr
adrenerg
block
agent
propranolol
associ
reduct
stainabl
neutral
mucin
decreas
thick
acinar
cell
make
gland
lumen
appear
larger
normal
although
repeat
administr
phosphodiesteras
inhibitor
shown
increas
size
salivari
gland
rat
studi
rat
salivari
gland
singl
dose
phosphodiesteras
inhibitor
theophyllin
shown
preced
reduct
size
acini
drug
possess
adrenerg
block
effect
also
shown
result
reduct
salivari
flow
rate
patient
cytotox
agent
alloxan
known
primarili
specif
effect
pancreat
b
cell
also
shown
produc
weight
loss
rat
submandibular
gland
associ
lipid
inclus
acinar
cell
capillari
basement
membran
thicken
reduc
salivari
flow
possibl
result
cytotox
methotrex
folic
acid
antagonist
also
report
caus
vacuol
acinar
ductular
cell
reduct
secretori
granul
rat
salivari
gland
ligat
main
excretori
duct
frequent
use
experiment
model
studi
salivari
gland
atrophi
well
regener
follow
remov
ligatur
follow
ligatur
atrophi
cell
type
particularli
acinar
cell
process
apoptosi
although
overt
necrosi
report
follow
ligat
excretori
duct
appear
may
result
constrict
vasculatur
acinar
cell
rel
intoler
decreas
oxygen
nutrient
weight
increas
diffus
hypertrophi
hyperplasia
number
therapeut
agent
increas
salivari
gland
size
human
although
scarciti
biopsi
data
preclud
critic
assess
precis
patholog
mani
case
drug
report
produc
salivari
gland
enlarg
human
includ
iodidecontain
radiolog
contrast
media
isoprenalin
lithium
salt
phenytoin
antiinflammatori
drug
phenylbutazon
oxyphenbutazon
number
drug
also
link
treatmentrel
increas
salivari
gland
secret
patient
salivari
gland
enlarg
may
also
occur
endotrach
anesthesia
upper
gastrointestin
tract
endoscopi
human
agent
procedur
may
produc
spasm
larg
salivari
duct
retent
secret
high
circul
growth
hormon
level
also
associ
salivari
gland
enlarg
patient
correl
concomit
rais
serum
igfi
concentr
rodent
sever
pharmacolog
agent
particularli
sympathomimet
amin
shown
produc
increas
salivari
gland
size
follow
repeat
dose
intim
relationship
sympathomimet
amin
control
secretori
process
salivari
tissu
singl
inject
isoprenalin
isoproterenol
rang
mgkg
induc
discharg
preform
secretori
granul
follow
gradual
resynthesi
reconstitut
howev
repeat
inject
produc
increas
size
salivari
gland
enlarg
gland
compos
secretori
cell
increas
size
digest
system
contain
increas
amount
secretori
substanc
cytoplasm
accompani
dna
synthesi
differenti
chang
rna
transcript
histolog
featur
princip
diffus
cellular
hypertrophi
howev
increas
dna
content
radioact
thymidin
uptak
describ
salivari
tissu
follow
repeat
administr
isoprenalin
suggest
hyperplasia
also
occur
effect
depend
integr
autonom
nerv
occur
ablat
autonom
ganglia
appear
mediat
effect
adrenerg
receptor
effect
block
propranalol
receptor
antagonist
phenoxybenzamin
receptor
antagonist
theophyllin
caffein
also
elicit
salivari
gland
enlarg
rat
preced
initi
discharg
secret
role
cyclic
monophosph
camp
salivari
gland
enlarg
postul
howev
administr
receptor
antagonist
also
shown
diminish
respons
theophyllin
adrenerg
activ
may
also
play
role
effect
detail
studi
hypertrophi
protein
synthesi
intracellular
camp
activ
salivari
gland
rat
treat
ten
day
isoprenalin
isoproterenol
seri
adrenerg
receptor
agonist
phosphodiesteras
inhibitor
theophyllin
caffein
show
similar
effect
occur
agent
although
differ
degre
hypertrophi
natur
protein
glycoprotein
synthesi
golgi
membran
enzym
activ
record
parotid
gland
show
pronounc
hypertrophi
follow
submandibular
gland
sublingu
gland
appear
unaffect
treatment
degre
natur
chang
induc
variou
receptor
agonist
suggest
effect
mediat
receptor
present
greatest
number
parotid
salivari
cell
effect
adrenerg
agonist
salivari
gland
probabl
result
receptormedi
stimul
adenyl
cyclas
activ
caus
increas
level
intracellular
camp
mani
year
select
cardioact
phosphodiesteras
inhibitor
type
iii
iv
also
consist
shown
produc
submaxillari
hypertrophi
rat
subacut
toxic
studi
parotid
submaxillari
gland
affect
inotrop
phosphodiesteras
inhibitor
ici
agent
act
via
select
inhibit
cardiac
phosphodiesteras
requir
camp
substrat
gener
suggest
salivari
gland
hypertrophi
direct
result
phosphodiesteras
inhibit
class
drug
also
produc
salivari
gland
enlarg
rat
repeat
dose
studi
doxylamin
repres
wide
use
ethanolamin
group
antihistamin
report
produc
mark
cytomegali
fischer
rat
parotid
gland
enlarg
cell
character
basophil
coars
granular
vacuol
cytoplasm
mous
develop
chang
similar
treatment
schedul
view
presenc
consider
amount
epiderm
growth
factor
salivari
gland
interest
note
effect
administr
laboratori
anim
salivari
gland
weight
increas
rat
cynomolgu
monkey
infus
high
dose
recombin
human
epiderm
growth
factor
howev
histolog
featur
seen
primarili
ductular
epitheli
hyperplasia
see
hyperplasia
epitheli
cell
character
abund
granular
eosinophil
cytoplasm
result
accumul
mitochondria
often
refer
oncocyt
term
use
hamperl
describ
similar
cell
rthle
tumor
thyroid
gland
may
found
variou
focal
nodular
neoplast
state
salivari
gland
human
laboratori
anim
precis
signific
cell
uncertain
mitochondria
usual
appear
unremark
except
lack
dens
granul
suggest
mitochondri
chang
repres
adapt
phenomenon
compensatori
hyperplasia
human
salivari
tissu
preval
seem
increas
advanc
age
associ
hyperplast
lesion
neoplasm
oxyphil
adenoma
adenolymphoma
eosinophil
cell
also
occur
salivari
gland
certain
strain
age
rat
mice
experiment
induc
autoallerg
sialoaden
hypertroph
foci
foci
cellular
alter
basophil
foci
basophil
hypertroph
foci
giant
acini
welldefin
unencapsul
foci
enlarg
acinar
cell
occur
spontan
salivari
gland
particularli
parotid
rat
mice
hamster
although
incid
vari
laboratori
enlarg
cell
possess
greatli
expand
cytoplasm
volum
retain
vesicular
vacuol
foami
appear
possess
pale
eosinophil
granular
textur
basal
part
cell
usual
stain
intens
blue
hematoxylin
eosinstain
section
contain
larg
dens
irregular
hyperchromat
pyknot
nuclei
show
littl
evid
mitot
activ
although
littl
ultrastructur
studi
foci
cytoplasm
alter
appear
distinct
socal
oncocyt
character
granular
eosinophil
cytoplasm
pack
mitochondria
biolog
natur
foci
uncertain
lack
promin
mitot
activ
cell
prolifer
expans
growth
suggest
aptli
regard
hypertroph
lesion
rather
neoplast
preneoplast
number
basophil
foci
report
increas
uncertain
mechan
rat
mice
treat
two
year
exenatid
byetta
synthet
peptid
enhanc
glucosedepend
insulin
secret
pancreat
b
cell
use
treat
diabet
mellitu
hyperplasia
squamou
metaplasia
salivari
duct
common
featur
mani
inflammatori
reactiv
condit
salivari
gland
rodent
dog
monkey
human
associ
presenc
stone
calculi
duct
system
squamou
metaplasia
regen
chang
duct
occur
rat
afflict
sialodacryoaden
also
locat
duct
sublingu
gland
wistar
rat
absenc
obviou
sialodacryoaden
evid
specif
diseas
similar
regen
hyperplast
duct
chang
also
seen
necrot
inflammatori
condit
dog
salivari
gland
morpholog
examin
immunocytochem
studi
epiderm
cytokeratin
rat
salivari
gland
arteri
ligat
shown
acinar
unit
also
undergo
squamou
metaplasia
acinarintercal
duct
complex
appear
rapidli
reprogram
produc
epiderm
cytokeratin
filament
ischem
state
hyperplasia
ductular
epithelium
report
princip
result
administr
epiderm
growth
factor
rat
cynomolgu
monkey
rat
histolog
featur
primarili
ductular
epitheli
hyperplasia
without
evid
signific
acinar
hyperplasia
primat
chang
strike
interlobular
larg
intralobular
duct
epithelium
show
multilay
papilliform
project
howev
mitot
activ
evid
throughout
duct
epithelia
acinar
cell
also
show
hypertrophi
deplet
secretori
granul
presenc
larg
vesicular
nuclei
high
incid
ductal
hyperplasia
also
describ
submandibular
gland
rat
treat
week
synthet
steroid
possess
progestagen
estrogen
activ
lesion
character
microcyst
ductlik
cribriform
structur
line
singl
multilay
epithelium
surround
myoepitheli
cell
immunocytochemistri
show
nuclei
lesion
well
normal
gland
possess
abund
progesteron
receptor
devoid
estrogen
receptor
argu
repres
exagger
respons
intercal
duct
high
dose
particular
ratio
estrogen
progestagen
activ
primari
neoplasm
salivari
gland
uncommon
usual
strain
rat
mice
employ
carcinogen
bioassay
uncommonli
induc
system
administr
xenobiot
howev
acinar
tubular
adenoma
adenocarcinoma
well
squamou
carcinoma
report
rat
mice
hamster
subject
histopatholog
classif
squamou
glandular
carcinoma
origin
structur
head
neck
region
may
observ
infiltr
salivari
gland
occasion
salivari
gland
neoplasm
show
adenomyomat
differenti
mix
glandular
lymphoid
tissu
pattern
resembl
wartin
tumor
human
also
sometim
seen
neoplasm
soft
tissu
also
develop
around
major
salivari
gland
rodent
see
integumentari
system
chapter
human
esophagu
consid
common
site
druginduc
injuri
although
studi
suggest
medicationinduc
chang
preval
previous
suppos
although
one
hospit
seri
unselect
case
esophag
ulcer
gastrointestin
reflux
account
case
drug
induc
sever
damag
occur
follow
prolong
contact
mucosa
ingest
tablet
capsul
adher
produc
local
high
concentr
potenti
irrit
substanc
damag
result
local
contact
may
common
elderli
subject
amplitud
esophag
contract
decreas
age
capsul
liabl
lodg
lumen
esophagu
howev
patient
age
may
affect
women
injur
frequent
men
probabl
greater
likelihood
treat
potenti
injuri
drug
shape
surfac
coat
tablet
may
influenc
tendenc
adher
mucosa
lodg
esophagu
wide
varieti
drug
implic
unit
state
well
countri
mani
case
appear
caus
ingest
tetracyclin
doxacyclin
caus
agent
potassium
chlorid
aspirin
nonsteroid
antiinflammatori
drug
also
implic
ulcer
lower
gastrointestin
tract
recent
year
bisphosphon
alendron
common
caus
advers
effect
esophagu
sever
injuri
report
injuri
link
ingest
without
water
fail
remain
upright
swallow
medic
alendron
particularli
caustic
howev
risk
better
known
low
incid
esophag
damag
report
esophag
due
candida
albican
welldescrib
complic
antibiot
therapi
particularli
patient
treat
immunosuppress
drug
hivinfect
patient
number
agent
affect
neuromuscular
coordin
may
also
predispos
gastroesophag
regurgit
reflux
esophag
laboratori
rodent
spontan
lesion
esophagu
occasion
seen
esophag
impact
describ
untreat
srl
bhe
rat
character
massiv
dilat
esophagu
food
bed
muscl
fiber
wall
esophagu
show
vari
degre
degener
includ
swell
shrink
fiber
myofibrillar
fragment
cytoplasm
vacuol
miner
socal
megaesophagu
character
enlarg
esophagu
degener
muscl
fiber
ganglion
cell
myenter
plexu
also
describ
spontan
lesion
strain
rat
mice
megaesophagu
report
anim
human
result
congenit
acquir
motil
disturb
affect
esophagu
lesion
report
fischer
rat
age
esophag
hyperkeratosi
report
occur
commonli
rat
fed
proteinrestrict
calorieunrestrict
diet
rat
fed
ad
libitum
normal
diet
one
rat
studi
particularli
high
preval
esophag
hyperkeratosi
ascrib
acidif
drink
water
also
report
rat
made
sever
diabet
alloxan
anoth
patholog
find
rodent
perfor
esophagu
result
gavag
accid
circumst
variabl
inflammatori
purul
exud
local
around
perfor
spread
within
pleural
occasion
pericardi
caviti
esophagu
surround
tissu
need
care
examin
pathologist
alway
clear
clinic
find
esophag
damag
occur
spontan
esophag
lesion
uncommon
laboratori
beagl
even
though
emesi
vomit
frequent
respons
speci
follow
dose
toxic
studi
small
proport
laboratori
cynomolgu
monkey
report
show
foci
inflamm
esophagu
system
administr
drug
radiomimet
antimitot
activ
caus
hypoplast
chang
atrophi
hypoplasia
esophag
mucosa
addit
wellknown
patholog
chang
gastric
intestin
mucosa
hyperplasia
increas
keratin
report
esophagu
rat
follow
chronic
high
dose
administr
vehicl
alcohol
acanthosi
hyperkeratosi
parakeratosi
report
esophagu
stomach
rat
treat
month
mesuprin
hydrochlorid
adrenerg
receptor
stimul
part
gener
effect
gastrointestin
mucosa
esophagu
rat
primat
report
develop
uniform
hyperplasia
squamou
epithelium
follow
infus
recombin
epiderm
growth
factor
local
esophag
irrit
potenti
drug
assess
number
anim
model
notabl
cat
pig
dog
model
test
drug
place
upper
esophagu
use
endoscop
techniqu
standard
period
sever
hour
allow
dissolut
prepar
subsequ
anim
follow
day
histopatholog
assess
perform
esophagu
degre
inflamm
eros
mucosa
deep
ulcer
record
semiquantit
manner
degre
ulcerogen
activ
drug
model
seem
correl
report
ulcerogen
activ
human
esophagu
rat
mous
hamster
forestomach
occupi
twothird
proxim
area
stomach
line
cornifi
stratifi
squamou
epithelium
limit
ridg
distinct
elev
mucos
fold
junction
forestomach
mucosa
glandular
part
stomach
minipig
small
zone
cover
squamou
epithelium
adjac
cardia
human
lack
forestomach
relev
chang
produc
drug
chemic
rodent
forestomach
disput
studi
rat
forestomach
remov
suggest
forestomach
act
storag
organ
releas
rel
undigest
food
glandular
stomach
respons
energi
demand
henc
forestomach
mucosa
may
expos
xenobiot
mix
undigest
food
longer
period
elsewher
gastrointestin
tract
interpret
forestomach
chang
take
account
physiolog
factor
resid
time
exposur
differ
drug
rodent
forestomach
human
esophagu
howev
like
squamou
mucosa
line
esophagu
speci
without
forestomach
react
xenobiot
similar
way
forestomach
mucosa
rodent
equival
exposur
level
attain
inflamm
ulcer
forestomach
mucosa
commonest
spontan
gastrointestin
lesion
laboratori
rat
mice
hamster
preval
gastric
lesion
vari
speci
strain
laboratori
rodent
well
differ
laboratori
caus
forestomach
ulcer
often
remain
unclear
although
varieti
factor
associ
develop
includ
advanc
age
infect
parasit
diet
feed
regimen
stress
rat
conflictinduc
ulcer
occur
forestomach
agerel
suscept
older
rat
develop
ulcer
younger
rat
rat
mice
die
spontan
diseas
ulcer
forestomach
quit
frequent
observ
protein
restrict
starvat
also
shown
produc
forestomach
ulcer
rat
wbnkob
rat
made
diabet
singl
dose
alloxan
develop
increas
forestomach
inflamm
associ
increas
presenc
candida
albican
bacteria
eventu
prolif
lesion
see
shown
allevi
treatment
diabet
insulin
administr
antifung
drug
histolog
featur
ulcer
inflammatori
lesion
forestomach
similar
rat
mice
hamster
mild
case
scatter
acut
inflammatori
cell
seen
intact
squamou
mucosa
ulcer
singl
multipl
character
loss
squamou
epithelium
variabl
accumul
neutrophil
mononuclear
cell
cellular
debri
fibrin
hair
fragment
ulcer
crater
figur
inflammatori
process
may
extend
deepli
stomach
wall
associ
intramur
inflamm
edema
endarter
fibrosi
agent
appear
induc
primarili
submucos
intraepitheli
inflammatori
process
give
rise
pustul
format
suggest
effect
mediat
local
direct
irrit
hemosiderin
pigment
also
found
ulcer
margin
profus
hemorrhag
may
follow
eros
larg
blood
vessel
complet
perfor
stomach
wall
periton
involv
also
occur
longstand
case
ulcer
hyperplasia
adjoin
squamou
epithelium
occur
character
irregular
acanthosi
downgrowth
squamou
epithelium
submucosa
rodent
toxicolog
studi
ulcer
forestomach
often
sporad
distribut
among
anim
show
clear
relationship
dose
ulcer
limit
high
dose
group
may
result
nonspecif
toxic
howev
chemic
direct
local
effect
suffici
sever
caus
focal
damag
forestomach
mucosa
xenobiot
may
also
produc
inflammatori
chang
forestomach
mucosa
follow
initi
dose
subsequ
repair
adapt
occur
even
though
treatment
continu
exampl
phenomenon
illustr
butyl
hydroxyanisol
one
week
administr
agent
mixtur
diet
rat
vesicular
inflammatori
reaction
character
histolog
presenc
subepitheli
vesicl
contain
inflammatori
cell
exud
seen
treatment
hyperplasia
squamou
epithelium
evid
presum
adapt
respons
effect
continu
insult
hyperkeratosi
associ
hyperplasia
squamou
epithelium
seen
sporad
untreat
age
rodent
chang
may
local
margin
chronic
forestomach
ulcer
associ
diffus
inflamm
mucosa
occasion
forestomach
mucosa
untreat
age
rodent
exhibit
hyperkeratosi
hyperplasia
without
inflamm
chang
may
diffus
focal
often
local
zone
adjoin
glandular
stomach
mucosa
may
evid
basal
cell
prolifer
downgrowth
epithelium
underli
stroma
caus
chang
often
unclear
dietari
factor
shown
influenc
thick
forestomach
mucosa
vitamin
defici
link
squamou
metaplasia
glandular
tissu
may
produc
forestomach
hyperplasia
hyperkeratosi
rat
spf
fischer
rat
maintain
vitamin
defici
state
three
month
hyperplasia
hyperkeratosi
unlik
produc
carcinogen
report
diabet
rat
also
shown
develop
squamou
hyperplasia
promin
greater
lesser
curvatur
mark
near
limit
ridg
associ
inflamm
forestomach
presenc
candida
albican
may
signific
pathogenet
factor
administr
wide
rang
genotox
nongenotox
industri
chemic
therapeut
agent
may
produc
hyperkeratosi
hyperplasia
forestomach
epithelium
extens
use
antibiot
ampicillin
produc
inflamm
ulcer
acanthosi
hyperkeratosi
forestomach
mucosa
mice
rat
administ
two
year
sodium
saccharin
also
report
produc
hyperplasia
without
neoplasia
forestomach
fischer
rat
cytoprotect
prostaglandin
also
appear
capabl
induc
hyperkeratosi
hyperplasia
without
neoplasia
presum
mechan
relat
trophic
activ
occur
rat
treat
misprostol
synthet
prostaglandin
e
analog
gastric
antisecretori
antiulc
activ
synthet
analog
prostaglandin
e
e
type
among
wide
rang
pharmacolog
effect
gastrointestin
tract
forestomach
also
respond
recombin
epiderm
growth
factor
infus
rat
histolog
chang
character
hyperkeratosi
parakeratosi
vari
degre
acanthosi
papillomatosi
chang
florid
may
difficult
make
clear
distinct
sever
hyperplasia
neoplasia
nevertheless
shown
florid
hyperplasia
forestomach
epithelium
without
evid
cellular
atypia
complet
revers
follow
withdraw
incit
stimulu
ethyl
acryl
henc
import
featur
presenc
cellular
atypia
view
associ
agent
potent
genotox
carcinogen
activ
particularli
occur
rapidli
follow
initi
treatment
neoplasm
aris
forestomach
rodent
usual
squamou
cell
papilloma
carcinoma
basaloid
cellular
featur
occasion
seen
squamou
carcinoma
site
show
variabl
differenti
compos
prolifer
squamou
epithelium
moder
mark
cellular
atypia
pleomorph
mitot
activ
clear
evid
invas
musculari
although
rel
uncommon
spontan
lesion
age
rodent
induc
rodent
administr
nitroso
compound
well
number
genotox
nongenotox
chemic
human
relev
prolif
lesion
induc
drug
rodent
forestomach
larg
number
genotox
nongenotox
compound
report
produc
hyperplasia
carcinoma
forestomach
rat
mice
hamster
sixth
commonli
induc
neoplasm
nation
toxicolog
program
rodent
carcinogen
studi
proport
genotox
chemic
associ
rapid
develop
atyp
hyperplasia
neoplasia
forestomach
well
tumor
develop
site
contrast
nongenotox
chemic
induc
adapt
respons
chronic
cytotox
eventu
follow
neoplasia
long
period
addit
agent
appear
produc
hyperplasia
inher
trophic
activ
epitheli
cell
exampl
nongentox
agent
includ
butyl
hydroxyanisol
bha
import
food
antioxid
structur
relat
phenol
acid
ethyl
acryl
use
product
materi
dental
medic
devic
sk
f
experiment
histamin
h
receptor
antagonist
coenzym
hmgcoa
reductas
inhibitor
statin
aristoloch
acid
stand
alon
genotox
medicin
agent
induc
forestomach
tumor
although
longer
use
antiinflammatori
drug
data
larg
bodi
studi
perform
butyl
hydroxyanisol
instruct
illustr
variou
factor
influenc
develop
treatmentinduc
hyperplasia
neoplasia
rodent
forestomach
butyl
hydroxyanisol
possess
littl
mutagen
activ
vitro
administ
rat
two
year
mixtur
diet
shown
produc
inflamm
follow
squamou
hyperplasia
squamou
papilloma
squamou
carcinoma
forestomach
diet
butyl
hydroxyanisol
induc
hyperplasia
studi
butyl
hydroxyanisol
fed
diet
rat
shorter
period
shown
squamou
epitheli
hyperplasia
occur
one
week
treatment
mainli
lesser
curvatur
site
carcinoma
develop
twoyear
studi
week
treatment
mucos
hyperplasia
character
pronounc
hyperkeratosi
parakeratosi
acanthosi
pronounc
lesser
curvatur
present
rat
given
butyl
hydroxyanisol
diet
rat
given
mixtur
abund
mitos
found
basal
cell
layer
tritiatedthymidin
label
confirm
hyperplasia
accompani
high
rate
cell
prolifer
follow
cessat
administr
butyl
hydroxyanisol
week
tritiatedthymidin
label
index
rapidli
revert
control
level
within
one
week
although
hyperplasia
took
longer
regress
nearli
complet
regress
hyperplasia
occur
nine
week
normal
diet
distribut
squamou
hyperplasia
induc
rodent
stomach
butyl
hydroxyanisol
influenc
mode
administr
follow
feed
rat
butyl
hydroxyanisol
mix
diet
lesion
tend
locat
near
limit
ridg
wherea
gavag
corn
oil
produc
similar
chang
apex
forestomach
therefor
suggest
differ
due
incomplet
mix
butyl
hydroxyanisol
stomach
lumen
given
gavag
prolong
contact
gavag
mixtur
upper
segment
forestomach
moreov
shown
fischer
shr
lewi
spraguedawley
rat
differ
respons
hyperplast
carcinogen
effect
butyl
hydroxyanisol
pellet
diet
sensit
appear
shr
strain
follow
fischer
rat
differ
correl
cytotox
effect
butyl
hydroxyanisol
differ
strain
presenc
vascular
damag
stomach
shr
rat
might
contribut
respons
cytotox
subsequ
carcinogen
resid
time
administ
compound
forestomach
may
influenc
develop
lesion
although
demonstr
butyl
hydroxyanisol
produc
hyperplasia
esophagu
anim
speci
without
forestomach
high
dose
given
primat
capabl
produc
increas
mitot
activ
lower
end
esophagu
similar
occur
equival
exposur
level
rat
forestomach
implic
interspeci
differ
may
simpli
question
differ
exposur
squamou
mucosa
compound
underlin
fact
mechan
action
exposur
level
xenobiot
attain
gastrointestin
tract
rodent
nonrod
speci
well
human
need
assess
hyperplasia
neoplasia
induc
forestomach
mucosa
rodent
inform
clearli
help
facilit
decis
made
govern
regulatori
author
area
howev
case
butyl
hydroxyanisol
evid
suggest
tumor
develop
rodent
repres
epigenet
phenomenon
relat
larg
revers
cytotox
inflamm
increas
cell
prolifer
view
low
level
exposur
butyl
hydroxyanisol
occur
usual
use
agent
carcinogen
hazard
human
stomach
therefor
small
similar
phenomena
also
report
studi
phenol
acid
structur
relat
butyl
hydroxyanisol
agent
includ
nbutyl
acid
ester
propion
acid
howev
studi
suggest
certain
area
forestomach
epithelium
react
differ
structur
relat
chemic
possibl
due
variabl
level
activ
enzym
within
differ
zone
forestomach
epithelium
coadministr
acetylsalicyl
acid
shown
abrog
effect
suggest
prostaglandin
synthetas
may
involv
hyperplast
respons
number
coenzym
hmgcoa
reductas
inhibitor
statin
differ
chemic
structur
includ
market
product
lovastatin
simvastatin
fluvastatin
also
associ
develop
squamou
hyperplasia
rodent
forestomach
hypolipidem
agent
inhibit
oxidosqualen
also
report
produc
squamou
hyperplasia
forestomach
mice
hamster
hyperplasia
produc
hmgcoa
reductas
inhibitor
time
dose
depend
may
associ
edema
inflamm
submucosa
agent
also
capabl
produc
squamou
neoplasia
forestomach
mucosa
rat
mice
longterm
treatment
mechan
action
remain
unclear
although
effect
seem
correl
pharmacodynam
activ
detail
morpholog
studi
forestomach
rat
treat
lovastatin
suggest
relat
effect
assembl
cholesterol
lipid
lamella
bodi
intracellular
lipid
sheet
tumorigen
potenti
rodent
bioassay
seem
relat
degre
hyperplasia
shortterm
studi
moreov
develop
hyperplasia
depend
local
high
concentr
drug
administ
nonor
rout
hyperplasia
occur
drug
nonmutagen
find
presum
also
epigenet
origin
possess
rel
littl
risk
human
given
usual
therapeut
dose
import
inflamm
factor
develop
forestomach
tumor
illustr
studi
wbnkob
rat
made
diabet
singl
dose
alloxan
develop
increas
forestomach
inflamm
squamou
hyperplasia
promin
near
limit
ridg
invas
squamou
cell
carcinoma
anim
period
week
chang
link
presenc
candida
albican
gastric
bacteri
infect
prolif
chang
inflamm
shown
allevi
treatment
diabet
insulin
administr
antifung
drug
number
neoplasm
also
reduc
contrast
exampl
provid
aristoloch
acid
nitrophenanthren
deriv
ancient
medicin
plant
aristolochia
clemati
use
antiinflammatori
compon
number
medicin
prepar
germani
aristoloch
acid
found
aristolochia
asarum
speci
plant
aristolochiacea
famili
directact
mutagen
salmonella
typhimurium
fed
rat
dose
mgkgday
aristoloch
acid
produc
sever
papillomatosi
entir
forestomach
within
period
three
month
character
histolog
presenc
branch
squamou
papilloma
mm
high
focal
dysplast
featur
invas
squamou
carcinoma
metastas
found
subsequ
three
six
month
later
without
treatment
even
low
dose
mgkgday
papilloma
squamou
carcinoma
develop
nine
month
threemonth
period
treatment
find
preclud
safe
use
aristoloch
acid
therapeut
purpos
inde
use
aristoloch
acid
associ
develop
specif
nephropathi
urotheli
cancer
human
framework
assess
relev
human
cancer
risk
assess
develop
forestomach
neoplasm
propos
tumor
associ
chronic
irrit
particularli
induc
repeat
oral
gavag
dose
form
basi
carcinogen
classif
quantit
cancer
potenc
estim
human
contrast
genotox
chemic
produc
neoplasm
multipl
site
absenc
forestomach
irrit
consid
like
human
relev
rel
good
correl
druginduc
effect
stomach
well
intestin
rodent
nonrod
found
human
safeti
pharmacolog
studi
rodent
appear
reflect
gener
advers
effect
vomit
patient
studi
anticanc
drug
also
suggest
dog
particular
good
predictor
advers
gastrointestin
effect
human
unlik
mouth
esophagu
tablet
capsul
gavag
fluid
drugdiet
mixtur
pass
rel
rapidli
human
stomach
mucosa
remain
contact
high
local
concentr
administ
compound
much
longer
period
time
howev
gastric
mucosa
protect
number
defens
mechan
includ
mucusbicarbon
layer
epitheli
barrier
constant
state
renew
fast
state
cyclic
pattern
motil
consist
three
main
phase
first
quiescent
phase
follow
phase
irregular
contract
increas
amplitud
frequenc
reach
maximum
third
phase
feed
result
replac
cyclic
pattern
regular
tonic
contract
move
food
toward
antrum
mix
gastric
secret
pattern
well
studi
dog
human
appear
qualit
similar
two
speci
motil
pattern
may
impact
length
time
drug
remain
contact
stomach
mucosa
instanc
resid
time
larg
nondisintegr
capsul
tablet
administ
fast
state
depend
frequenc
power
phase
iii
contract
drug
given
fluid
mix
diet
dosag
form
releas
stomach
gastric
resid
time
influenc
drug
suppli
main
absorpt
surfac
small
intestin
turn
may
affect
drug
absorpt
gastric
acid
import
make
ingest
salt
solubl
although
presenc
food
stomach
stimulu
acid
product
ph
stomach
rat
highest
full
stomach
lowest
empti
presum
consequ
buffer
action
food
glandular
stomach
conveni
subdivid
fundu
character
mucos
fold
ruga
smoother
antrum
open
pyloru
duodenum
speci
devoid
forestomach
proxim
stomach
mucosa
cardia
also
line
glandular
mucosa
although
stomach
monkey
broadli
similar
human
stomach
detail
studi
cynomolgu
monkey
stomach
shown
unlik
human
fundu
lack
pariet
cell
glandular
mucosa
cover
surfac
epithelium
regular
columnar
cell
extend
downward
form
small
gastric
pit
foveola
gastric
gland
simpl
tubular
structur
usual
consid
compris
three
segment
base
deepest
part
neck
midregion
superfici
isthmu
continu
gastric
pit
upper
part
gastric
gland
contain
mucou
neck
cell
small
cuboid
chief
zymogen
cell
secret
pepsinogen
stain
blue
purpl
hematoxylin
eosin
section
locat
deeper
part
gland
eosinophilicstain
pariet
oxynt
cell
produc
hydrochlor
acid
distribut
randomli
throughout
gastric
gland
pariet
cell
also
visual
immunocytochem
stain
antibodi
direct
h
k
atpas
suggest
gastric
pariet
cell
may
endocrin
role
rat
shown
possess
aromatas
activ
abil
synthes
estrogen
gastric
gland
situat
near
limit
ridg
rodent
show
simplifi
structur
speci
endow
forestomach
mucosa
near
cardia
compos
simplifi
branch
gland
line
columnar
epithelium
antral
mucosa
cover
surfac
epithelium
gastric
pit
similar
fundu
mucou
secret
columnar
gland
line
gland
stomach
mucosa
richli
endow
endocrin
cell
well
character
rat
least
seven
endocrin
cell
type
demonstr
base
structur
histochem
featur
enterochromaffin
cell
quit
numer
basal
part
gastric
gland
fundu
particularli
rat
gener
argyrophil
stain
silver
techniqu
grimeliu
util
exogen
reduc
agent
cell
contain
histamin
histaminerel
enzym
histidin
decarboxylas
endocrin
cell
argentaffin
type
also
report
mucosa
fundu
speci
includ
human
appar
rat
cell
stain
silver
prepar
report
masson
presenc
endogen
reduc
substanc
includ
catecholamin
enterochromaffin
cell
character
ultrastructur
presenc
numer
round
oval
vesicular
electronluc
granul
frequent
contain
small
eccentr
electron
dens
core
gastric
enterochromaffin
cell
reliabl
stain
immunocytochem
techniqu
use
antisera
histamin
histidin
decarboxylas
well
nonspecif
enolas
chromogranin
enterochromaffin
cell
recogn
basal
zone
oxynt
mucosa
express
histidin
decarboxylas
histamin
immunocytochem
studi
show
varieti
peptid
cell
differ
area
glandular
stomach
includ
somatostatin
glucagon
gastrin
serotonin
reactiv
increas
gastric
acid
secret
initi
activ
central
vagal
effer
pathway
acid
secret
maintain
neural
endocrin
reflex
activ
presenc
food
stomach
gastrin
secret
g
cell
antrum
main
stimul
acid
secret
somatostatin
secret
antral
cell
lumin
ph
fall
act
paracrin
mechan
suppress
g
cell
function
thu
form
neg
feedback
loop
two
main
endocrin
cell
type
bodi
mucosa
integr
neurohumor
stimuli
rather
respond
lumin
chemic
although
gastrin
capabl
stimul
pariet
cell
directli
even
greater
effect
stimul
enterchromaffin
cell
releas
histamin
potent
paracrin
stimul
pariet
cell
gastrin
stimul
releas
histamin
enterochromaffin
cell
bodi
mucosa
increas
acid
secret
activ
pariet
cell
histamin
h
receptor
pariet
enterochromaffin
cell
inhibit
somatostatin
releas
cell
bodi
mucosa
respons
varieti
neurohumor
stimuli
norepinephrin
noradrenalin
vasoact
intestin
peptid
calcitonin
generel
peptid
cholecystokinin
gastrin
act
gastrincholecystokinin
b
receptor
express
gastric
epitheli
cell
well
neuron
central
nervou
system
gastrin
receptor
cholecystokinin
b
type
receptor
locat
stomach
cholecystokinin
receptor
cholecystokinin
high
affin
cholecystokinin
stimul
receptor
stomach
mediat
secret
pepsin
gastric
chief
cell
releas
somatostatin
cell
result
inhibit
acid
secret
gener
cell
gastric
mucosa
shown
uptak
tritiat
thymidin
distribut
princip
superfici
zone
gastric
gland
isthmu
trace
cell
use
thymidin
label
shown
cell
gener
zone
migrat
success
manner
mucos
surfac
form
columnar
epithelium
lifespan
surfac
epithelium
stomach
rat
mice
hamster
calcul
three
four
day
studi
cell
cycl
dna
synthesi
time
prolif
zone
stomach
suggest
gener
cell
isthmu
undergo
mitos
hour
interv
rodent
hour
interv
human
although
process
migrat
prolifer
cell
zone
isthmu
renew
surfac
epitheli
cell
rapidli
cell
migrat
lower
part
gastric
gland
much
slower
complex
detail
studi
shown
undifferenti
cell
region
isthmu
repres
common
sourc
surfac
mucou
cell
mucou
neck
cell
studi
transgen
mice
shown
matur
pariet
cell
influenc
fate
gastric
epitheli
cell
target
degener
pariet
cell
associ
loss
chief
cell
suggest
interact
cell
popul
determin
differenti
label
experi
hamster
stomach
shown
chief
pariet
cell
possess
similar
quit
long
lifespan
day
suggest
rel
distribut
chief
pariet
cell
gastric
gland
repres
express
differ
migrat
pattern
downward
prolif
zone
isthmu
type
migrat
pattern
cell
abl
overtak
term
stochast
flow
system
mucu
layer
repres
first
line
mucos
defens
layer
mucu
gel
along
bicarbon
hydrophob
phospholipid
maintain
near
neutral
ph
well
physic
barrier
much
knowledg
mucin
produc
epitheli
cell
line
gastrointestin
tract
obtain
use
histochem
techniqu
approach
help
understand
spontan
druginduc
gastrointestin
diseas
physiochem
properti
gastrointestin
mucin
depend
glycoprotein
constitu
glycoprotein
high
molecular
weight
compound
larg
number
sugar
chain
attach
polypeptid
backbon
oglycosid
linkag
nacetylgalactosamin
serin
threonin
princip
monosaccharid
present
fucos
galactos
nacetylgalactosamin
nacetylglucosamin
sialic
acid
due
extens
glycosyl
mucin
filament
conform
often
neg
charg
believ
import
form
protect
barrier
cell
howev
properti
twoedg
sword
oppos
cell
specif
receptor
mucin
adhes
may
becom
predomin
factor
consider
region
variat
glycoprotein
constitu
gastrointestin
tract
differ
probabl
relat
physiolog
function
factor
furthermor
synthesi
secret
glycoprotein
alter
chang
cell
differenti
alter
also
occur
mucin
variou
inflammatori
neoplast
diseas
state
well
follow
administr
drug
chemic
gastrointestin
mucin
usual
stain
use
pa
alcian
blue
well
high
iron
diamin
techniqu
sulfat
mucin
termin
sugar
sugar
sequenc
demonstr
histochem
use
label
lectin
mostli
plant
protein
combin
nonenzymat
particular
sugar
molecul
gastrointestin
mucin
studi
sever
speci
use
histochem
techniqu
uniform
condit
speci
differ
obviou
stomach
duodenum
neutral
mucin
gener
predomin
stomach
contrast
acid
mucin
small
intestin
sulfat
mucin
colon
stomach
neutral
mucin
stain
purpl
pasalcian
blue
stain
predomin
surfac
foveolar
mucosa
wherea
mucou
neck
cell
antral
gland
contain
acid
mucin
stain
blue
pasalcian
blue
procedur
sulfat
mucin
stain
black
high
iron
diamin
techniqu
also
found
deep
glandular
mucosa
antrum
rat
mice
human
extrem
heterolog
stain
pattern
seen
gastric
mucosa
label
lectin
lectin
stain
differ
cell
popul
nonneoplast
lesion
inflamm
eros
ulcer
gastric
glandular
mucosa
varieti
therapeut
agent
produc
gastric
damag
human
includ
potassium
chlorid
iron
salt
alendron
sodium
polystyren
sulfon
kayexal
cation
exchang
resin
nonsteroid
antiinflammatori
drug
low
dose
aspirin
use
elderli
patient
prevent
cerebr
myocardi
ischemia
also
associ
gastrointestin
damag
nonsteroid
antiinflammatori
drug
commonli
prescrib
drug
worldwid
peptic
gastric
upper
small
intestin
ulcer
one
wellknown
advers
effect
systemat
analysi
publish
data
suggest
onethird
patient
take
nonsteroid
antiinflammatori
drug
long
period
develop
upper
gastrointestin
tract
injuri
seriou
injuri
less
common
although
gastrointestin
bleed
follow
nonsteroid
antiinflammatori
therapi
signific
caus
seriou
sometim
fatal
advers
drug
reaction
one
prospect
studi
gastrointestin
bleed
caus
compound
account
hospit
admiss
due
advers
drug
reaction
predispos
factor
human
patient
peptic
ulcer
includ
helicobact
pylori
infect
antrum
cigarett
smoke
alcohol
use
pepticulc
diseas
shown
common
helicobact
pyloriinfect
patient
take
nonsteroid
antiinflammatori
drug
without
infect
suggest
possibl
interact
drug
use
infect
develop
peptic
ulcer
helicobact
pylori
microaerophil
gramneg
organ
possess
potent
ureas
activ
crucial
surviv
acid
ph
genom
sequenc
analysi
shown
helicobact
pylori
welldevelop
sequenc
motil
scaveng
iron
dna
restrict
modif
system
use
bacteria
degrad
foreign
dna
link
helicobact
pylori
infect
peptic
ulcer
relat
increas
gastrin
releas
perhap
bacteri
product
cytokin
releas
activ
lymphocyt
although
gastric
patholog
repres
signific
caus
morbid
mortal
human
follow
therapi
nonsteroid
inflammatori
agent
mechan
lead
injuri
fulli
understood
theori
gain
widespread
accept
ulcerogen
potenti
nonsteroid
antiinflammatori
drug
relat
pharmacolog
activ
john
vane
propos
ulcerogen
potenti
agent
larg
result
abil
inhibit
prostaglandin
synthetas
therebi
reduc
protect
effect
prostaglandin
inhibit
cyclooxygenas
agent
reduc
proinflammatori
cytokin
also
prostaglandin
synthesi
inde
good
correl
time
dose
depend
induc
suppress
gastrointestin
prostaglandin
synthesi
potenti
peptic
ulcer
lead
ulcer
less
clear
probabl
result
effect
sever
compon
mucos
defens
local
irrit
formul
may
import
may
alter
microcircul
impair
repair
chang
mucin
bicarbon
product
discoveri
two
differ
cyclooxygenas
led
develop
drug
preferenti
inhibit
cyclooxygenas
isoform
base
postul
constitut
express
cyclooxygenas
protect
gastric
mucosa
wherea
induc
isoform
respons
inflamm
pain
benefit
select
inhibitor
protect
gastrointestin
tract
gener
accept
situat
turn
far
complex
origin
envisag
mani
differ
mediat
shown
contribut
resist
gastrointestin
mucosa
injuri
inde
circumst
produc
highli
potent
gastroprotect
substanc
moreov
one
dramat
pharmaceut
event
recent
year
withdraw
marketplac
certain
select
inhibitor
eg
vioxxt
rofecoxib
bextrat
valdecoxib
concern
cardiovascular
safeti
skin
effect
shown
major
clinic
trial
laboratori
anim
spontan
chang
laboratori
anim
toxic
studi
inflammatori
chang
mucosa
well
gastric
eros
ulcer
glandular
mucosa
may
seen
eros
repres
mucos
break
superfici
musculari
mucosa
figur
ulcer
lesion
extend
musculari
mucosa
histopatholog
featur
gastric
eros
ulcer
rel
nonspecif
import
look
associ
patholog
stomach
mucu
deplet
epitheli
hyperplasia
dysplasia
intestin
metaplasia
vascular
lesion
see
gastric
mucosa
particularli
antrum
may
show
inflammatori
infiltr
along
presenc
lymphoid
follicl
dog
may
accompani
presenc
spiral
organ
helicobact
type
gastric
gland
monkey
may
also
show
varieti
spiral
organ
gastric
mucosa
associ
lymphocyt
gastriti
intestin
mucosa
atrophi
gastriti
promin
antrum
fundu
one
commonli
observ
patholog
laboratori
cynomolgu
monkey
also
often
found
associ
presenc
helicobact
organ
analog
condit
human
stomach
affect
anim
show
infiltr
mucosa
small
lymphocyt
plasma
cell
associ
reactiv
atroph
chang
presenc
small
curv
bacteria
gland
seen
best
warthinstarri
stain
although
helicobact
pylori
infect
rodent
may
develop
inflammatori
respons
seen
primat
except
appear
mongolian
gerbil
consid
model
choic
studi
gastriti
gastric
ulcer
metaplasia
respons
helicobact
pylori
infect
mice
strain
also
appear
develop
similar
alter
respons
helicobact
feli
minipig
may
also
show
scatter
foci
inflamm
microabscess
gastric
mucosa
gastric
ulcer
induc
experiment
stress
cold
restraint
particularli
wellstudi
phenomenon
rodent
differ
sensit
form
stress
among
laboratori
anim
exampl
spraguedawley
rat
appear
less
suscept
ulcerogen
effect
coldrestraint
stress
wistar
rat
gener
good
correl
druginduc
toxic
gastrointestin
tract
laboratori
anim
human
although
predict
precis
ulcerogen
potenti
drug
human
base
anim
model
cloud
lack
good
compar
data
patient
extens
differ
side
effect
report
proper
comparison
requir
equival
therapeut
dose
also
compar
dosag
form
moreov
quit
difficult
determin
whether
inflammatori
lesion
stomach
treat
anim
indic
real
ulcerogen
risk
test
compound
nonspecif
effect
relat
experiment
condit
usual
littl
histolog
specif
druginduc
ulcer
gastric
glandular
mucosa
although
morpholog
evid
crystal
fragment
drug
associ
featur
may
help
eros
ulcer
develop
laboratori
anim
follow
stress
reflux
intestin
content
bile
chang
acid
secret
hypoxia
may
develop
condit
occur
high
dose
toxic
studi
requir
give
test
compound
high
dose
may
also
dictat
need
administ
exceedingli
high
concentr
test
agent
may
simpli
damag
mucosa
result
local
irrit
manner
relev
therapeut
dose
use
clinic
practic
exampl
demonstr
oral
administr
hyperosmolar
solut
quit
innocu
substanc
glucos
sodium
chlorid
caus
gastric
inflamm
hemorrhag
eros
ulcer
rat
gastric
mucosa
hyperosmolar
solut
sodium
chlorid
also
shown
induc
increas
express
cytochrom
enzym
subtyp
surfac
foveolar
cell
gastric
mucosa
rat
could
also
modifi
express
xenobiot
activ
wellknown
associ
gastric
eros
hemorrhag
uremia
may
also
manifest
follow
administr
high
dose
drug
diuret
sever
derang
fluid
electrolyt
balanc
synerg
ulcerogen
action
drug
stress
also
welldescrib
phenomenon
protein
deplet
starvat
also
capabl
induc
gastric
ulcer
rat
laboratori
anim
varieti
differ
pattern
druginduc
gastric
damag
describ
studi
differ
antiinflammatori
drug
administ
fast
spraguedawley
rat
ident
condit
suggest
drug
could
divid
three
group
base
profil
gastrointestin
toxic
immunolog
drug
antiprolif
anticanc
agent
azathiaprin
cyclophosphamid
methotrex
dpenicillamin
produc
gastric
mucos
hemorrhag
wherea
aspirin
relat
agent
produc
gastric
mucos
hemorrhag
ulcer
power
nonsteroid
antiinflammatori
drug
indomethacin
phenybutazon
produc
gastric
mucos
eros
ulcer
well
small
intestin
damag
howev
novel
target
therapi
treatment
cancer
may
fall
simpl
categori
exampl
cyclindepend
kinas
inhibitor
produc
singl
cell
necrosi
intestin
treat
rat
also
produc
cell
damag
apoptosi
gastric
gland
fundu
pylor
region
markedli
basal
zone
isthmu
region
compar
singl
oral
dose
studi
sever
nonsteroid
antiinflammatori
agent
three
differ
dose
level
rat
use
histolog
evalu
measur
fecal
blood
loss
crlabel
blood
cell
also
shown
differ
pattern
ulcer
produc
differ
agent
administ
ident
condit
singl
oral
dose
nonsteroid
antiinflammatori
drug
includ
aspirin
produc
widespread
superfici
damag
desquam
gastric
epithelium
littl
inflamm
six
hour
follow
dose
complet
heal
two
week
later
damag
associ
transient
fecal
blood
loss
contrast
indomethacin
ibuprofen
produc
gastric
damag
circumscrib
penetr
ulcer
along
mesenter
border
jejunum
ileum
furthermor
ulcer
still
present
two
week
associ
prolong
biphas
blood
loss
pharmacokinet
factor
may
also
import
lipid
solubl
low
ph
environ
stomach
may
influenc
local
penetr
mucosa
addit
feed
condit
influenc
distribut
eros
ulcer
laboratori
anim
fast
rat
eros
due
indomethacin
treatment
found
bodi
stomach
convent
fed
rat
promin
small
intestin
one
detail
studi
show
rat
fed
one
hour
fast
given
singl
dose
indomethacin
within
two
hour
refeed
develop
eros
ulcer
antrum
primarili
along
lesser
curvatur
indomethacin
given
fast
rat
produc
eros
bodi
mucosa
factor
need
kept
mind
chronic
administr
ulcerogen
compound
may
produc
quit
differ
patholog
appear
found
follow
singl
dose
administr
administr
aspirin
rat
four
week
shown
stimul
epitheli
prolifer
gastric
bodi
antral
mucosa
possibl
effect
cyclic
adenosin
monophosph
cyclic
amp
though
increas
rate
epitheli
exfoli
respons
may
basi
increas
resist
gastric
mucosa
chronic
effect
agent
also
may
explain
tendenc
ulcer
occur
antrum
follow
chronic
administr
aspirinlik
drug
prolif
respons
presum
adapt
potenti
appear
less
part
gastric
mucosa
reactiv
prolif
chang
also
describ
human
treat
nonsteroid
inflammatori
drug
see
interspeci
variat
strain
differ
report
respons
ulcerogen
compound
extravas
red
blood
cell
greater
vascular
damag
observ
rat
treat
aspirin
benoxprofen
pig
given
similar
dose
anim
pharmacolog
model
notabl
use
rat
inhibitor
gener
appear
less
ulcerogen
convent
nonsteroid
antiinflammatori
agent
consist
report
effect
patient
howev
simpl
concept
inhibit
caus
gastrointestin
damag
select
inhibit
ulcerogen
cloud
number
experiment
observ
exampl
inhibit
delay
gastric
ulcer
heal
interfer
cell
prolifer
angiogenesi
matur
granul
tissu
moreov
high
dose
toxic
studi
reveal
inhibitor
caus
gastrointestin
ulcer
exampl
rat
dog
mice
develop
gastric
pylor
ulcer
treat
inhibitor
celecoxib
although
distal
small
intestin
seem
markedli
affect
shown
immunocytochemistri
distribut
express
interstiti
cell
monocyt
macrophag
fibroblast
endotheli
cell
lamina
propria
predomin
distal
ileum
led
suggest
might
factor
greater
sensit
ileum
stomach
ulcerogen
effect
inhibit
diuret
angiotensin
convert
enzym
ace
inhibitor
angiotensin
ii
antagonist
associ
develop
gastric
eros
ulcer
administ
high
dose
laboratori
anim
figur
howev
effect
appear
relat
sever
electrolyt
disturb
produc
excess
dose
drug
perhap
analog
wellknown
associ
gastrointestin
tract
eros
hemorrhag
uremia
dog
appear
predispos
microscop
examin
may
show
form
ulcer
associ
deposit
basophil
ground
substanc
miner
connect
tissu
blood
vessel
mucosa
vascular
damag
may
occur
laboratori
anim
treat
high
dose
cardioact
drug
phosphodiesteras
inhibitor
may
also
occur
intramucos
blood
vessel
stomach
inflammatori
process
spill
glandular
mucosa
infiltr
stomach
lymphocyt
rat
treat
human
recombin
interleukin
without
ulcer
report
part
multisystem
involv
induc
agent
decreas
gastric
mucu
secret
may
accompani
spontan
inflammatori
condit
druginduc
lesion
stomach
human
experiment
anim
mucu
deplet
character
histolog
presenc
intact
epitheli
layer
cell
show
loss
normal
clear
cytoplasm
replet
mucou
substanc
replac
basophil
cell
contain
littl
mucin
qualit
chang
mucu
composit
also
accompani
mucu
deplet
gastric
epithelium
human
show
decreas
sulfat
mucosubst
follow
stress
high
alcohol
consumpt
aspirin
nonsteroid
inflammatori
drug
administr
similar
chang
occur
laboratori
anim
subject
ulcerogen
regimen
stress
ulcer
rat
accompani
decreas
sulfat
gastric
glycoprotein
administr
aspirin
antiinflammatori
agent
includ
adrenocort
steroid
laboratori
anim
also
reduc
content
sulfomucin
gastric
mucosa
probabl
reduc
synthesi
also
suggest
agent
modifi
phospholipid
within
lumin
aspect
mucu
gel
layer
normal
provid
nonwett
properti
therebi
reduc
protect
hydrophob
barrier
properti
upper
gastrointestin
tract
administr
histamin
h
receptor
antagonist
proton
pump
inhibitor
reduc
gastric
acid
output
increas
gastrin
secret
also
associ
alter
gastric
mucu
administr
omeprazol
famotidin
rat
four
week
shown
inhibit
prostaglandin
pge
well
synthesi
total
sulfat
glycoprotein
along
histochem
evid
reduct
pa
stain
surfac
mucu
although
mechan
chang
unclear
reduct
mucu
particularli
sulfat
mucu
believ
particularli
resist
peptic
digest
may
implic
mucos
defens
intestin
metaplasia
stomach
character
presenc
differenti
epithelium
resembl
small
intestin
basi
light
microscop
ultrastructur
morpholog
mucin
pattern
enzym
histochemistri
develop
human
gastric
mucosa
alter
chronic
atroph
gastriti
signific
due
fact
intestin
metaplasia
associ
presenc
gastric
cancer
although
intestin
metaplasia
found
much
less
commonli
laboratori
anim
also
report
occur
associ
gastric
neoplasia
induc
polychlorin
biphenyl
view
associ
gastric
cancer
suggest
intestin
metaplasia
repres
preneoplast
lesion
howev
recent
year
prospect
clinic
studi
experiment
data
suggest
epiphenomenon
coexist
unrel
develop
cancer
human
sever
form
intestin
metaplasia
describ
variant
fall
two
main
group
socal
incomplet
type
complet
form
other
propos
best
regard
term
gastric
intestin
mix
phenotyp
complet
intestin
metaplasia
character
presenc
goblet
cell
paneth
cell
absorpt
cell
brush
border
variabl
develop
intestin
villi
incomplet
form
heterogen
character
goblet
mucou
columnar
cell
absorpt
cell
variabl
pattern
mucin
routin
alcian
blue
stain
perform
ph
period
acidschiff
stain
distinguish
intestin
acid
mucin
blue
neutral
mucin
gastric
type
howev
variabl
sialomucin
sulfomucin
stain
pattern
also
seen
intestin
metaplasia
human
stain
high
irondiaminealcian
blue
stain
perform
incomplet
form
intestin
metaplasia
show
mark
sulfomucin
secret
found
commonli
associ
gastric
cancer
peopl
howev
probabl
intestin
metaplasia
repres
adapt
respons
longstand
chronic
inflamm
reduc
acid
secret
also
suggest
repres
adapt
defens
respons
longstand
helicobact
pylori
infect
intestin
mucosa
resist
organ
immunocytochem
studi
shown
presenc
intestin
endocrin
cell
variou
form
intestin
metaplasia
appear
follow
phenotyp
particular
mucou
cell
differenti
fischer
rat
treat
polychlorin
biphenyl
aroclor
mix
diet
two
year
develop
foci
intestin
metaplasia
stomach
epithelium
associ
gastric
adenocarcinoma
lesion
character
abund
mucincontain
cell
alkalin
phosphatas
activ
typic
small
intestin
similar
diffus
intestin
metaplasia
report
stomach
primat
expos
polychlorin
biphenyl
although
associ
gastric
neoplasia
intestin
metaplasia
also
inconsist
report
stomach
laboratori
anim
treat
power
genotox
gastric
carcinogen
exampl
one
studi
rat
treat
nmethyln
nitronnitroguanidin
demonstr
hyperplasia
foci
atyp
chang
dysplasia
littl
intestin
metaplasia
wherea
anoth
shown
intestin
metaplasia
administr
agent
despit
link
carcinogen
administr
intestin
metaplasia
induc
rodent
varieti
differ
procedur
associ
develop
gastric
cancer
intestin
metaplasia
induc
glandular
stomach
rodent
fraction
local
ioniz
radiat
inject
xenogen
stomach
antigen
well
propanthelin
bromid
noncarcinogen
iodoacetamin
intestin
metaplasia
also
shown
occur
part
respons
helicobact
pylori
infect
small
anim
model
mongolian
gerbil
well
mice
infect
helicobact
feli
characterist
intestin
metaplasia
laboratori
rodent
similar
seen
human
earli
increas
intestin
enzym
activ
alkalin
phosphatas
lactas
trehalas
sucros
maltas
develop
goblet
cell
contain
neutral
sialo
sulfomucin
intestin
crypt
without
paneth
cell
fundu
antrum
show
chang
although
human
male
appear
prone
develop
intestin
metaplasia
femal
base
find
propos
intestin
metaplasia
precancer
condit
adapt
respons
chronic
elev
ph
gastric
secret
due
earli
loss
pariet
cell
mass
brought
variou
procedur
balanc
therefor
evid
suggest
although
intestin
metaplasia
associ
cancer
may
consequ
consid
help
morpholog
featur
evalu
human
gastric
biopsi
find
isol
intestin
metaplasia
safeti
studi
indic
preneoplast
state
form
metaplasia
hepatocyt
found
report
rare
incident
find
glandular
stomach
mice
sacrif
end
twoyear
carcinogen
bioassay
focal
accumul
welldifferenti
hepatocyt
found
submucosa
lamina
propria
adjac
limit
ridg
dilat
adjac
gastric
gland
show
epitheli
hyperplasia
miner
herniat
submucosa
foci
believ
relat
treatment
xenobiot
clear
whether
repres
metaplasia
congenit
ectopia
gastric
glandular
epithelium
predispos
deposit
calcium
possibl
site
mark
ion
exchang
normal
take
place
focal
aggreg
concret
dens
bluestain
miner
fairli
commonli
observ
hematoxylinstain
section
stomach
age
rat
associ
cystic
dilat
gastric
gland
mice
hamster
occasion
show
similar
chang
small
concret
also
observ
gastric
gland
beagl
dog
appear
repres
aggreg
calcium
around
mucoid
materi
gastric
miner
may
becom
mark
rodent
dog
disturb
miner
metabol
particularli
associ
renal
patholog
well
describ
rat
sever
renal
diseas
glomerulosclerosi
parathyroid
hyperplasia
well
vitamin
toxic
similar
phenomenon
describ
stomach
dog
urem
state
ident
chang
result
administr
drug
induc
prolong
azotemia
electrolyt
disturb
chang
character
diffus
deposit
miner
intestin
tissu
mucosa
gastric
bodi
usual
cardia
antrum
pyloru
miner
deposit
develop
around
basement
membran
surround
epithelium
blood
vessel
lamina
propria
becom
expand
edema
fibroplasia
interstitium
also
develop
gastric
gland
becom
distort
swell
degener
pariet
cell
atrophi
chief
cell
eros
glandular
epithelium
hemorrhag
occur
presum
result
ischemia
caus
diffus
vascular
injuri
alter
pariet
cell
function
miner
gastric
mucosa
fundu
musculari
submucos
arteri
also
report
rat
treat
select
inhibitor
fibroblast
growth
factor
tyrosin
kinas
appear
part
gener
effect
calcium
balanc
chang
bone
growth
plate
elev
serum
phosphoru
level
soft
tissu
miner
anoth
exampl
report
rat
follow
intraven
administr
gadolinium
chlorid
gadolinium
compound
wide
use
contrast
agent
magnet
reson
imag
treat
anim
develop
discret
band
interstiti
miner
fundic
glandular
mucosa
compos
calcium
phosphat
form
hydroxyapatit
littl
gadolinium
present
find
consist
form
metastat
miner
focal
atrophi
gastric
glandular
mucosa
sporad
occurr
laboratori
rodent
usual
result
previou
focal
gastric
inflamm
ulcer
miner
vascular
occlus
chang
character
microscop
focal
fibrosi
mucosa
gastric
glandular
dilat
atrophi
accompani
polymorphonuclear
cell
mast
cell
common
certain
strain
rat
two
year
age
wherea
diffus
mucos
atrophi
occur
follow
sever
inflammatori
insult
diffus
atrophi
stomach
glandular
mucosa
without
inflamm
result
surgic
druginduc
reduct
trophic
factor
necessari
mainten
normal
gastric
morpholog
function
observ
human
experiment
anim
follow
antrectomi
remov
peptideproduc
cell
antrum
rat
antrectomi
accompani
hypogastrinemia
reduc
weight
height
oxynt
mucosa
reduc
number
argyrophil
cell
contrast
procedur
antral
exclus
lead
hypergastrinemia
increas
thick
oxynt
mucosa
mice
genet
delet
gastrin
gene
also
show
reduct
thick
gastric
mucosa
cell
type
present
pronounc
decreas
number
pariet
enterochromaffin
cell
associ
increas
surfac
mucou
cell
chang
link
profound
decreas
acid
secret
becom
unrespons
histaminerg
cholinerg
gastrinerg
stimul
analog
atroph
chang
report
follow
pharmacolog
remov
trophic
stimuli
instanc
administr
cholecystokininbgastrin
receptor
antagonist
cynomolgu
monkey
period
week
associ
initi
phase
multifoc
degener
gastric
gland
primarili
fundu
follow
diffus
reduct
thick
glandular
mucosa
littl
qualit
chang
cell
popul
although
bilater
vagotomi
produc
profound
function
chang
stomach
notabl
reduct
gastric
acid
secret
morpholog
chang
fundal
mucosa
mark
either
experiment
anim
human
studi
rat
shown
diffus
atrophi
gastric
gland
character
decreas
number
size
pariet
chief
mucou
cell
occur
transient
follow
truncal
vagotomi
histolog
featur
return
normal
one
month
surgeri
contrast
unilater
vagotomi
rat
lead
mark
persist
atrophi
oxynt
zone
denerv
side
character
histolog
reduc
height
mucosa
reduc
number
stain
intens
argyrophil
cell
argu
unilater
atrophi
due
remov
trophic
action
vagu
lack
last
atrophi
bilater
unilater
vagotomi
explain
subsequ
rise
gastrin
occur
bilater
vagotomi
result
lack
acid
feedback
inhibit
gastrin
releas
remov
reduct
extragastr
trophic
factor
hormon
may
also
reduc
thick
gastric
mucosa
demonstr
rat
hypophysectomi
caus
reduct
thick
oxynt
antral
mucosa
compar
pairf
control
although
littl
chang
peptic
pariet
cell
ratio
signific
decreas
cell
volum
secretori
activ
gastric
glandular
cell
demonstr
suggest
widespread
disturb
synthesi
secretori
mechan
atroph
chang
chief
cell
observ
rat
treat
six
month
high
dose
omeprazol
inhibitor
acid
secret
find
consid
repres
disus
atrophi
secondari
inhibit
acid
secret
anoth
inhibitor
gastric
acid
secret
tricycl
agent
pirenzepin
also
produc
atrophi
fundic
mucosa
rat
follow
three
month
one
month
treatment
atrophi
character
reduct
pariet
cell
number
associ
lower
number
gastrincontain
cell
antrum
featur
unlik
follow
prolong
treatment
histamin
h
receptor
antagonist
increas
thick
gastric
mucosa
result
hypertrophi
hyperplasia
mucos
cell
occur
spontan
follow
administr
drug
chemic
view
differ
cell
popul
gastric
mucosa
varieti
morpholog
alter
occur
difficult
make
clear
distinct
hypertrophi
hyperplasia
without
morphometr
techniqu
techniqu
shown
hypertrophi
mucos
cell
coexist
hyperplasia
gastric
cell
popul
distinct
also
need
made
diffus
uniform
hyperplasia
involv
one
cell
popul
hyperplasia
associ
focal
prolif
adenomat
overgrowth
hyperplasia
evalu
atyp
cytolog
featur
dysplasia
link
develop
gastric
carcinoma
see
difficulti
make
distinct
exuber
reactiv
hyperplasia
dysplast
premalign
chang
issu
part
gastric
glandular
intestin
mucosa
particularli
presenc
chronic
inflamm
fibrosi
moreov
effect
compound
colchicin
taxol
arrest
mitosi
inhibit
tubulin
polymer
microtubul
may
mimic
gastrointestin
dysplasia
figur
like
mucosa
part
gastrointestin
tract
stimulu
high
concentr
bulki
irrit
substanc
caus
hyperplasia
stomach
mucosa
exampl
rat
mice
observ
follow
administr
high
dose
poorli
absorb
lanthanum
carbon
use
therapeut
phosphat
binder
patient
compromis
renal
function
high
dose
rat
mice
show
glandular
hyperplasia
stomach
mucosa
associ
submucos
chronic
inflamm
hyperplasia
squamou
mucosa
limit
ridg
cell
gastric
glandular
mucosa
also
undergo
increas
size
number
respons
effect
gastrointestin
trophic
hormon
synthet
analog
similar
chang
also
follow
administr
compound
inhibit
gastric
acid
secret
modifi
trophic
hormon
growth
factor
likewis
transgen
hypergastrinem
mice
also
develop
gastric
mucos
hyperplasia
shown
model
cyclooxygenas
within
interstiti
cell
contribut
gastric
hyperplasia
gastrin
synthet
analog
pentagastrin
administ
subcutan
rat
mice
sever
week
increas
number
size
pariet
cell
without
concomit
increas
zymogen
chief
cell
addit
diffus
hyperplasia
enterochromaffin
cell
also
occur
contrast
cholecystokinin
trophic
peptid
found
duodenum
share
ctermin
tetrapeptid
sequenc
gastrin
increas
number
chief
cell
pariet
cell
administ
mice
similar
condit
drug
inhibit
neutral
gastric
acid
secret
histamin
h
antagonist
proton
pump
inhibitor
antacid
also
induc
hypertrophi
hyperplasia
pariet
cell
popul
occur
laboratori
anim
treat
drug
also
human
agent
associ
rise
serum
gastrin
level
probabl
result
loss
feedback
inhibit
low
antral
ph
gastrinproduc
g
cell
histamin
h
antagonist
produc
ident
effect
cytolog
chang
report
famotidin
anoth
h
receptor
antagonist
agent
produc
doserel
increas
preval
degre
eosinophil
granular
chief
cell
stomach
toxic
studi
rat
dog
electron
microscopi
show
increas
electron
densiti
zymogen
granul
argu
effect
result
secondari
inhibit
pepsin
secret
turnov
due
inhibit
acid
secret
cytoprotect
agent
prostaglandin
type
produc
yet
differ
form
diffus
gastric
hyperplasia
rat
treat
prostaglandin
e
hourli
three
week
develop
forestomach
alter
see
also
thicken
bodi
antral
mucosa
bodi
mucosa
chang
result
proport
increas
total
mass
surfac
foveolar
mucou
cell
mucou
neck
cell
chief
cell
pariet
endocrin
cell
well
connect
tissu
larg
result
increas
cell
number
although
pariet
cell
also
increas
size
unlik
treatment
gastrin
gastrin
analog
increas
number
surfac
foveolar
mucou
cell
associ
increas
mucu
content
misprost
synthet
prostaglandin
e
methyl
ester
analog
also
produc
diffus
glandular
hyperplasia
character
lengthen
gastric
pit
increas
mucou
secret
preclin
safeti
studi
dog
rat
glandular
hyperplasia
affect
bodi
also
antral
mucos
studi
tritiat
thymidin
show
label
index
reduc
rat
treat
misprost
suggest
hyperplasia
follow
administr
prostanoid
result
increas
cell
surviv
decreas
cell
shed
rather
increas
cell
prolifer
prostaglandin
e
seri
also
shown
produc
uniform
hyperplasia
surfac
mucou
cell
increas
depth
foveola
bodi
antrum
stomach
dog
rodent
doserel
diffus
hyperplasia
gastric
glandular
mucosa
report
rat
cynomolgu
monkey
given
human
recombin
growth
factor
gastric
mucosa
thicken
increas
number
undifferenti
cell
particularli
neck
region
upper
part
gastric
gland
mitot
figur
also
numer
upper
reach
mucosa
lower
part
gastric
gland
gener
less
affect
larg
increas
number
undifferenti
cell
may
function
effect
gastric
acid
function
administr
recombin
growth
hormon
also
report
induc
thicken
gastric
glandular
mucosa
dog
along
typic
growth
hormoneinduc
chang
organ
bodi
weight
increas
insulinlik
growth
factor
pylor
fundic
mucosa
show
histolog
evid
hyperplasia
mucou
neck
cell
gastric
hyperplasia
prolif
adenomat
featur
adenomat
hyperplasia
giant
hypertroph
gastriti
hypertroph
gastropathi
adenomat
polyp
adenoma
thicken
gastric
glandular
mucosa
result
variou
form
irregular
polypoid
region
prolifer
cystic
dilat
gastric
gland
associ
inflamm
character
number
nonneoplast
condit
stomach
human
laboratori
anim
cystic
chang
chronic
inflamm
foveolar
hyperplasia
observ
biopsi
taken
edg
chronic
gastric
ulcer
human
hyperplast
cystictyp
benign
fundic
polyp
aris
patient
take
proton
pump
inhibitor
month
regress
cessat
therapi
diseas
polyadenom
en
napp
rare
condit
found
primarili
middleag
men
also
character
enlarg
gastric
fold
foveolar
hyperplasia
glandular
cystic
dilat
associ
decreas
acid
secret
hypoproteinemia
due
select
loss
serum
protein
across
gastric
mucosa
develop
gastric
cancer
although
pathogenesi
remain
elus
increas
express
transform
growth
factor
epiderm
growth
factor
receptor
describ
epitheli
cell
mitogen
inhibit
gastric
acid
secret
increas
gastric
mucin
transgen
mice
overexpress
gastric
mucosa
develop
similar
condit
see
suggest
might
import
role
condit
mutant
histamin
h
receptor
defici
mice
also
develop
similar
condit
associ
overexpress
one
sever
ligand
bind
epiderm
growth
factor
receptor
interest
note
treatment
patient
diseas
monoclon
antibodi
epiderm
growth
factor
receptor
amelior
condit
similar
chang
observ
anim
even
camel
sometim
associ
infest
gastrointestin
tract
parasit
laboratori
rodent
may
develop
similar
pattern
chang
spontan
advanc
age
although
caus
chang
remain
uncertain
rodent
distinct
form
exuber
adenomat
hyperplasia
adenoma
clear
cut
howev
customari
laboratori
anim
patholog
defin
adenoma
local
focal
prolif
lesion
wellord
glandular
pattern
clear
boundari
surround
normal
mucosa
usual
exophyt
polypoid
natur
mark
prolifer
gastric
glandular
mucosa
well
character
laboratori
mous
year
certain
strain
particular
tendenc
develop
condit
spontan
advanc
age
hyperplasia
occur
spontan
convent
laboratori
strain
employ
carcinogen
bioassay
preval
influenc
environment
factor
hous
food
restrict
administr
divers
xenobiot
notabl
histamin
h
receptor
blockad
agent
caus
hypergastrinemia
similar
gastric
chang
also
report
occur
mice
thymectom
shortli
birth
mice
overproduc
histamin
h
receptor
defici
mice
microscop
chang
mice
character
hyperplasia
foveolar
neck
region
bodi
mucosa
figur
advanc
case
accompani
elong
tortuou
dilat
gland
line
simpl
columnar
cuboid
epithelium
devoid
pariet
chief
cell
abnorm
cell
show
mild
cellular
pleomorph
mitot
activ
abnorm
gland
displac
normal
glandular
tissu
may
penetr
musculari
mucosa
reach
musculari
externa
serosa
step
section
demonstr
continu
glandular
element
total
absenc
metastat
spread
adjac
tissu
lymph
node
lamina
propria
also
show
increas
amount
smooth
muscl
collagen
accompani
variabl
number
lymphocyt
chronic
inflammatori
cell
edema
may
observ
blood
vessel
often
dilat
antral
mucosa
remain
rel
unaffect
histochemistri
shown
variabl
mucin
secret
alter
gland
gland
devoid
mucin
other
show
increas
sulfomucin
etiolog
spontan
condit
mous
remain
uncertain
suggest
featur
similar
diseas
human
might
similar
pathogenesi
occurr
similar
lesion
thymectom
mice
given
rise
suggest
autoimmun
damag
gastric
mucosa
may
digest
system
respons
presenc
circul
antipariet
antibodi
decreas
number
pariet
cell
thymectom
mice
suggest
autoimmun
damag
occur
pariet
cell
compensatori
chronic
stimul
prolifer
gener
zone
howev
evid
studi
femal
han
nmri
mice
suggest
prolif
condit
develop
mice
absenc
antipariet
antibodi
associ
increas
number
antral
gastrin
cell
rais
possibl
hormon
paracrin
mechan
similar
prolif
form
gastropathi
report
mice
overexpress
transform
growth
factor
potent
mitogen
member
epiderm
growth
factor
famili
peptid
possibl
key
mediat
develop
condit
act
bind
activ
tyrosin
kinas
epiderm
growth
factor
receptor
transgen
mice
overexpress
develop
sever
adenomat
cystic
hyperplasia
gastric
glandular
mucosa
start
two
month
age
along
loss
matur
pariet
cell
number
diminut
gastric
acid
product
degre
chang
shown
somewhat
depend
genet
background
mous
increas
preval
similar
chang
report
mice
treat
novel
histamin
h
receptor
antagonist
sk
f
month
although
treat
mice
develop
hyperplasia
gastric
neuroendocrin
cell
similar
observ
rodent
treat
antisecretori
agent
also
show
increas
sever
glandular
hyperplasia
like
spontan
condit
chang
character
thicken
mucosa
hyperplasia
foveolar
neck
region
downward
prolifer
glandular
element
gastric
gland
similar
glandular
hyperplasia
mous
stomach
alongsid
neuroendocrin
alter
associ
histamin
h
blockad
agent
ioxtidin
adenomat
polyp
also
report
pylor
antrum
mice
treat
week
synthet
progestin
cyproteron
acet
singl
peduncul
welldifferenti
lesion
show
littl
evid
dysplasia
mechan
induct
polyp
unclear
although
may
hormon
mediat
progesteron
estrogen
receptor
identifi
low
level
gastric
tissu
howev
similar
glandular
polyp
also
describ
male
femal
mice
follow
oral
administr
lanthanum
carbon
week
dose
time
maximum
recommend
daili
dose
renal
compromis
patient
bind
phosphat
howev
lanthanum
carbon
particularli
inert
poorli
solubl
well
absorb
suggest
polyp
may
also
develop
respons
local
mechan
factor
although
usual
less
preval
less
exuber
mice
age
rat
also
develop
prolif
gastric
glandular
chang
spontan
chang
character
hyperplasia
foveolar
mucinsecret
cell
bodi
mucosa
develop
cystic
gland
line
simpl
mucou
flatten
cell
accompani
chronic
inflammatori
cell
promin
blood
vessel
smooth
muscl
lamina
propria
antrum
remain
rel
unaffect
prolif
alter
induc
administr
varieti
xenobiot
well
follow
surgic
procedur
induc
chronic
reflux
normal
intestin
content
instanc
hyperplasia
gastric
mucosa
notabl
lesser
curvatur
describ
rat
follow
socal
bilroth
ii
gastrectomi
allow
reflux
intestin
biliari
secret
stomach
prolif
condit
gastric
mucosa
shown
develop
follow
longterm
treatment
rat
ulcerogen
regimen
aspirin
femal
spraguedawley
rat
given
mgkg
aspirin
methylcellulos
daili
oral
gavag
six
month
follow
period
month
without
treatment
develop
focal
prolif
chang
site
heal
ulcer
mainli
mucosa
antrum
antralbodi
junction
lesion
character
presenc
prolifer
gastric
gland
line
columnar
cuboid
flatten
epitheli
cell
mucosa
also
extend
musculari
mucosa
mucu
content
gland
variabl
present
princip
acid
type
shown
stain
alcian
blue
ph
lesion
accompani
increas
collagen
lamina
propria
endarter
infiltr
lymphocyt
plasma
cell
mast
cell
lesion
associ
develop
carcinoma
follow
month
observ
probabl
result
chronic
damag
repair
induc
aspirin
treatment
polychlorin
biphenyl
arochlor
produc
intestin
metaplasia
adenocarcinoma
stomach
rat
also
induc
prolif
alter
character
prolif
cystic
lesion
mucosa
associ
inflamm
fibrosi
chang
found
primarili
antrum
pylor
region
zone
predilect
develop
gastric
carcinoma
human
experiment
anim
import
distinguish
variou
hyperplast
adenomat
condit
found
gastric
glandular
mucosa
laboratori
anim
associ
neoplasia
preced
develop
carcinoma
distinct
complic
fact
prolif
chang
associ
develop
cancer
human
laboratori
anim
possess
featur
common
lesion
associ
neoplasia
probabl
overdiagnosi
gastric
neoplasia
laboratori
rodent
atyp
nonneoplast
gastric
gland
may
penetr
deep
musculari
inflammatori
condit
mirror
invas
cancer
howev
key
distinguish
featur
presenc
atyp
epithelium
dysplasia
dysplasia
consid
lesion
common
gastric
condit
human
atroph
gastriti
gastric
polyp
link
significantli
increas
risk
gastric
cancer
although
term
dysplasia
may
less
wide
employ
experiment
patholog
similar
dysplast
chang
occur
human
character
laboratori
anim
precancer
gastric
lesion
studi
therefor
repres
unifi
concept
assess
prolif
chang
gastric
glandular
mucosa
laboratori
anim
defin
intern
group
concern
diagnosi
preneoplast
condit
stomach
human
three
princip
featur
dysplasia
defin
cellular
atypia
abnorm
differenti
disorgan
mucos
architectur
cellular
atypia
character
nuclear
pleomorph
hyperchromasia
stratif
nuclei
increas
ratio
loss
cellular
nuclear
polar
abnorm
differenti
shown
reduct
alter
normal
secretori
product
mucosa
disorgan
mucos
architectur
shown
irregular
crypt
structur
backtoback
gland
bud
branch
crypt
intralumin
surfac
papillari
growth
import
assess
gastric
mucosa
care
featur
dysplasia
hyperplast
gastric
chang
found
treat
anim
rat
gastric
cancer
model
employ
carcinogen
nmethyln
nitronnitrosoguanidin
dysplast
chang
shown
start
prolifer
neck
region
hyperplast
zone
chang
character
histolog
irregular
growth
pattern
glandular
cell
show
reduc
mucin
secret
numer
mitos
enlarg
pleomorph
nuclei
atyp
gland
observ
extend
downward
eventu
replac
normal
gastric
gland
ultim
penetr
musculari
mucosa
form
infiltr
adenocarcinoma
variabl
differenti
antrum
develop
chang
earlier
bodi
mucosa
involv
antrum
quit
unlik
spontan
hyperplasia
rat
gastric
mucosa
consider
import
safeti
evalu
histamin
h
receptor
antagonist
tiotidin
ici
guanidinothiazol
deriv
also
produc
prolif
gastric
lesion
stomach
rat
carcinogen
studi
chang
found
mainli
pylor
region
character
histolog
superfici
eros
irregular
pylor
gland
line
cell
basophil
cytoplasm
enlarg
hyperchromat
nuclei
atyp
gland
penetr
musculari
mucosa
dysplast
lesion
situat
primarili
pylor
region
also
associ
develop
invas
carcinoma
rat
extens
histolog
section
stomach
rat
treat
tiotidin
six
month
also
reveal
evid
earli
prolif
chang
therefor
lesion
produc
tiotidin
possess
common
induc
power
carcinogen
nmethyln
nitronnitrosoguanidin
benign
speciesspecif
prolif
chang
littl
relev
human
safeti
interestingli
mice
treat
month
tiotidin
devoid
dysplast
chang
gastric
mucosa
certain
compound
may
produc
chang
mimic
gastrointestin
dysplasia
well
describ
human
gastric
biopsi
patient
treat
compound
colchicin
taxol
interfer
tubulin
inhibit
polymer
microtubul
effect
produc
mitot
arrest
character
promin
ring
mitos
associ
epitheli
pseudostratif
loss
polar
increas
apoptosi
featur
may
mimic
true
dysplasia
similar
featur
also
report
laboratori
anim
figur
hyperplasia
neoplasia
gastric
endocrin
cell
carcinoid
tumor
one
remark
exampl
druginduc
gastric
alter
report
rodent
bioassay
hyperplasia
enterochromaffin
cell
develop
carcinoidlik
neoplasm
stomach
rat
treat
omeprazol
omeprazol
substitut
benzimidazol
inhibit
gastric
acid
secret
block
enzym
atpas
proton
pump
pariet
cell
time
year
ago
much
concern
find
rat
potenti
implic
human
similar
find
report
drug
type
becom
regard
wide
class
effect
proton
pump
inhibitor
extens
use
safe
mani
year
mild
hypergastrinemia
gastric
biopsi
longterm
clinic
trial
human
suggest
increas
incid
enterochromaffin
hyperplasia
prolong
dose
howev
evid
enterochromaffin
hyperplasia
convinc
benign
fundic
glandular
polyp
convinc
relat
treatment
proton
pump
inhibitor
regress
cessat
therapi
carcinoid
tumor
dysplasia
gastric
carcinoma
rare
detect
even
hypergastrinemia
mark
prolong
patient
zollingerellison
syndrom
gastric
carcinoid
rare
thu
rodent
find
wide
understood
effect
exagger
pharmacodynam
activ
directli
relev
therapeut
use
drug
although
rat
increas
number
gastric
argyophil
cell
increas
age
rat
treat
omeprazol
week
show
mark
doserel
diffus
increas
argyophil
nonargentaffin
cell
basal
half
oxynt
fundal
mucosa
chang
mark
femal
male
rat
moreov
observ
bioassay
mice
treat
similar
dose
omeprazol
week
diffus
chang
rat
stomach
associ
focal
hyperplasia
argyrophil
cell
focal
lesion
also
associ
doserel
increas
larger
focal
nodular
lesion
argyrophil
cell
undoubtedli
local
infiltr
carcinoid
tumor
nodular
argyrophil
lesion
pose
usual
problem
differenti
diagnosi
endocrin
hyperplasia
neoplasia
see
endocrin
gland
chapter
precis
distinct
hyperplasia
neoplasia
unclear
histolog
nodular
lesion
compos
multifoc
anastomos
solid
pseudoacinar
cord
prolifer
regular
cell
uniform
nuclei
moder
abund
fine
granular
pale
cytoplasm
figur
nodul
show
littl
cellular
pleomorph
mitot
activ
clear
evid
submucos
infiltr
without
involv
musculari
externa
observ
case
overal
light
microscop
featur
similar
gastrointestin
carcinoid
tumor
report
human
incid
gastric
carcinoid
report
high
femal
high
dose
group
case
observ
similarli
treat
male
electron
microscopi
alter
argyophil
cell
confirm
presenc
electronluc
vesicular
granul
frequent
small
irregular
dens
core
characterist
enterochromaffin
cell
stomach
immunocytochem
studi
show
cell
contain
histidin
decarboxylas
normal
enzym
gastric
enterchromaffin
cell
produc
store
histamin
find
report
rat
treat
omeprazol
proport
increas
number
size
nonendocrin
cell
fundu
increas
number
immunostain
properti
antral
gastrincontain
g
cell
hypergastrinemia
function
morpholog
chang
follow
treatment
day
fulli
revers
day
drug
withdraw
result
treatmentrel
increas
normal
rare
gastric
carcinoid
rat
bioassay
omeprazol
clinic
trial
agent
suspend
agre
endocrin
alter
result
prolong
druginduc
achlorhydria
postul
omeprazol
caus
prolong
inhibit
acid
secret
rat
caus
activ
subsequ
hyperplasia
antral
gastrin
cell
mark
hypergastrinemia
hypergastrinemia
turn
stimul
enterochromaffin
cell
fundu
time
result
enterochromaffin
hyperplasia
argument
support
fact
similar
morpholog
find
report
chronic
atroph
gastriti
achlorhydr
site
human
antrectomi
rat
prevent
appear
enterochromaffin
hyperplasia
follow
treatment
omeprazol
although
mild
doserel
gastric
argyrophil
cell
hyperplasia
note
dog
treat
omeprazol
one
year
neoplasm
stomach
observ
time
period
mice
develop
neither
argyrophil
hyperplasia
gastric
carcinoid
similar
treatment
regimen
clear
mechan
action
omeprazol
similar
rat
dog
mous
howev
durat
action
omeprazol
shorter
mous
postul
sustain
inhibit
gastric
acid
secret
hour
necessari
activ
increas
gastrin
secret
antral
cell
also
suggest
mous
possess
fewer
gastric
enterochromaffin
cell
rat
show
much
lower
serum
gastrin
respons
omeprazol
treatment
nevertheless
gastric
neuroendocrin
tumor
occasion
report
develop
spontan
old
laboratori
mice
issu
carcinogen
studi
associ
rais
gastrin
level
durat
action
potenc
may
also
explan
lack
report
carcinoid
neoplasm
rat
follow
inhibit
gastric
acid
secret
histamin
h
receptor
blocker
cimetidin
ranitidin
neither
drug
complet
inhibit
gastric
acid
secret
rat
hour
howev
neoplasia
report
mild
gastric
neuroendocrin
hyperplasia
describ
cimetidinetr
rat
moreov
longact
h
receptor
antagonist
sk
f
produc
gastric
carcinoid
neoplasm
administ
high
dose
mgkg
rat
two
year
figur
although
dose
level
sk
f
entir
suppress
gastric
acid
secret
control
gastric
ph
hour
plasma
gastrin
level
remain
elev
three
four
time
control
valu
period
oral
carcinogen
studi
mice
dose
level
mgkg
diffus
neuroendocrin
cell
hyperplasia
multifoc
glandular
hyperplasia
neoplasia
also
observ
similarli
loxitidin
potent
noncompetit
insurmount
histamin
h
antagonist
digest
system
produc
hyperplasia
neuroendocrin
cell
carcinoid
tumor
gastric
fundu
rat
mice
two
year
treatment
diet
drink
water
respect
histamin
antagonist
ici
report
produc
neuroendocrin
neoplasm
stomach
rat
rat
mice
respect
drug
class
also
caus
hyperplasia
gastrincontain
cell
immunocytochem
studi
use
antigastrin
antibodi
reveal
increas
gastrin
cell
number
antral
mucosa
dog
given
high
dose
adrenocorticosteroid
four
week
chang
accompani
enhanc
serum
tissu
gastrin
level
result
suggest
corticosteroid
trophic
effect
gastrincontain
cell
confound
factor
drug
safeti
evalu
associ
gastric
cancer
human
laboratori
anim
nnitroso
compound
effect
stomach
carcinogen
laboratori
anim
prove
nnitroso
compound
particularli
sinc
sugimura
fujimura
induc
gastric
adenocarcinoma
rat
nmethyln
nitronnitrosoguanidin
dissolv
drink
water
furthermor
epidemiolog
evid
associ
nnitroso
compound
human
cancer
also
fairli
strong
stomach
past
consid
potenti
safeti
issu
new
drug
format
nnitroso
compound
theoret
possibl
number
compound
contain
amino
group
drug
widespread
clinic
use
shown
produc
nnitroso
product
acid
aqueou
media
although
extent
occur
actual
therapeut
use
unclear
evid
suggest
nitros
therapeut
agent
occur
clinic
practic
instanc
piperazin
cyclic
secondari
amin
wide
use
antihelminth
drug
shown
form
small
quantiti
nmononitrosopiperazin
human
stomach
measur
ga
chromatographytherm
energi
analysi
possibl
nitros
usual
taken
account
test
carcinogen
potenti
novel
drug
bioassay
usual
perform
parent
compound
howev
concern
nitros
arisen
subsequ
clinic
practic
exampl
propos
gastric
cancer
found
patient
treat
histamin
h
receptor
antagonist
cimetidin
result
treatment
seem
like
observ
cancer
associ
cimetidin
incident
howev
time
concern
increas
theoret
possibl
cimetidin
potenti
nitros
vivo
factor
concept
treatmentinduc
gastric
secretori
inhibit
subsequ
bacteri
colon
stomach
render
condit
conduc
gener
nnitroso
compound
normal
dietari
constitu
concern
appear
unfound
longterm
surveil
studi
cimetidin
shown
causal
link
clinic
usag
gastric
malign
addit
carcinogen
bioassay
perform
cimetidin
cimetidin
plu
nitrit
nitrosocimetidin
shown
tumorigen
effect
gastric
mucosa
sevenyear
studi
dog
multipl
gastric
biopsi
taken
interv
approxim
six
month
also
shown
indic
gastric
hyperplasia
dysplasia
intestin
metaplasia
neoplast
chang
although
complac
certainli
warrant
respect
nitros
therapeut
agent
vivo
risk
develop
gastric
malign
drug
administ
shortterm
basi
probabl
small
even
gastric
antisecretori
agent
administ
longer
period
time
balanc
view
would
also
permit
develop
novel
agent
provid
obvious
mutagen
carcinogen
usual
preclin
studi
particularli
liabl
undergo
rapid
nitros
carcinoma
glandular
mucosa
adenocarcinoma
whether
induc
potent
genotox
carcinogen
therapeut
agent
rang
welldifferenti
tubular
papillari
featur
poorli
differenti
form
trabecular
mucoid
signet
ring
featur
squamou
metaplasia
within
adenocarcinoma
also
observ
stroma
may
abund
pronounc
chronic
inflammatori
infiltr
hyalin
metaplast
cartilag
bone
also
describ
gastric
adenocarcinoma
induc
dog
nmethyln
nitronnitrosoguanidin
show
similar
histolog
featur
although
report
distribut
stomach
appear
variabl
rodent
histolog
criteria
diagnosi
invas
adenocarcinoma
experiment
anim
may
vari
individu
pathologist
retain
old
criteria
stewart
cowork
defin
invas
cancer
neoplast
growth
reach
serosa
consid
appropri
appli
criteria
use
human
diagnost
patholog
unequivoc
invas
submucosa
suffici
evid
invas
therefor
malign
process
howev
import
make
distinct
invas
adenocarcinoma
penetr
hyperplas
nonneoplast
gastric
gland
occur
quit
commonli
rodent
particularli
mice
hyperplast
lesion
show
dysplast
featur
gland
back
back
nuclei
stratifi
ratio
overli
increas
loss
cellular
nuclear
polar
small
intestin
major
import
drug
safeti
evalu
repres
primari
site
drug
absorpt
view
length
presenc
villi
possess
enorm
surfac
area
special
absorpt
epithelium
ingest
substanc
extend
resid
time
part
gastrointestin
tract
comfort
note
reason
correl
gastrointestin
find
preclin
studi
perform
rodent
nonrod
speci
gastrointestin
advers
effect
patient
dog
appear
better
predictor
advers
gastrointestin
drug
effect
patient
rodent
canin
model
one
popular
studi
drug
absorpt
dimens
canin
gastrointestin
tract
permit
administr
dosag
form
intend
clinic
use
human
reason
factor
influenc
drug
absorpt
better
studi
dog
human
mani
speci
resid
time
particular
import
drug
incomplet
absorb
differ
mucos
contact
time
expect
result
differ
fraction
absorb
dressman
shown
use
heidelberg
capsul
techniqu
small
intestin
transit
time
dog
vari
minut
wherea
human
equival
time
minut
result
suggest
absorpt
poorli
absorb
drug
like
quantit
less
although
variabl
dog
peopl
howev
differ
explain
poorli
lipophil
drug
chlorothiazin
acyclovir
phosphalin
acid
extens
absorb
dog
human
intestin
ph
consist
higher
dog
human
drug
half
maxim
absorpt
ph
rang
ph
may
also
expect
absorb
differ
rate
human
dog
physiolog
anatom
differ
small
intestin
test
speci
also
like
impact
drug
absorpt
although
mani
factor
still
poorli
understood
recent
studi
suggest
intestin
transit
time
intestin
ph
minipig
closer
human
laboratori
anim
speci
addit
small
intestin
act
absorpt
surfac
play
import
part
metabol
drug
although
monoxygenas
activ
rel
low
gut
compar
liver
conjug
mechan
effici
activ
udpglucuronosyltransferas
glutathionestransferas
high
even
higher
liver
addit
gastrointestin
microflora
possess
metabol
capac
also
influenc
turnov
rate
mucos
cell
subsequ
exfoli
releas
enzym
lumen
one
studi
untreat
rat
shown
concentr
total
cytochrom
small
intestin
microsom
found
liver
microsom
appear
differ
express
differ
subfamili
enzym
express
liver
intestin
well
signific
speci
differ
mice
appear
princip
subfamili
present
similar
human
small
intestin
likewis
beagl
dog
abund
express
small
intestin
predominantli
matur
epitheli
cell
upper
villu
mostli
duodenum
jejunum
less
termin
ileum
gene
express
data
rat
suggest
strong
express
speci
demonstr
rat
concentr
cytochrom
drug
metabol
enzym
activ
also
increas
intestin
epitheli
cell
move
crypt
villou
tip
liver
activ
cytochrom
induc
inhibit
drug
phenobarbitoneinduc
form
cytochrom
normal
repres
less
total
small
bowel
increas
total
cytochrom
small
intestin
cell
phenobarbiton
treatment
furthermor
shown
drug
metabol
activ
tip
villi
duodenum
greater
rat
fed
convent
diet
semisynthet
diet
activ
depend
critic
absorpt
iron
intestin
glutathion
also
present
throughout
entir
mucosa
rat
cell
tip
villi
contain
less
glutathion
cell
locat
basal
wherea
relat
enzym
transpeptidas
glutathionestransferas
show
highest
activ
villou
tip
region
fact
enzym
activ
highest
duodenum
lowest
termin
ileum
suggest
detoxif
system
exogen
compound
greater
proxim
small
intestin
small
intestin
mucosa
construct
act
absorpt
surfac
also
barrier
potenti
pathogen
substanc
microorgan
although
main
cell
popul
epithelium
compos
absorpt
cell
major
epitheli
cell
type
mucou
goblet
cell
paneth
cell
endocrin
cell
import
protect
function
addit
special
epitheli
cell
microfold
membran
cell
locat
epithelium
peyer
patch
cell
form
part
import
protect
system
intestin
gut
associ
lymphoid
tissu
galt
mucos
associ
lymphoid
tissu
malt
mucos
line
constant
state
renew
enter
epithelium
possess
fastest
rate
turnov
tissu
exceed
rapidli
grow
neoplasm
normal
circumst
constant
turnov
small
bowel
mucosa
maintain
equilibrium
cell
product
crypt
cell
loss
tip
villi
exogen
substanc
intralumin
secret
mechan
neural
factor
well
alter
blood
flow
possess
potenti
influenc
mucos
cell
kinet
main
epitheli
cell
type
believ
aris
undifferenti
columnar
cell
crypt
base
although
mucou
cell
may
also
aris
prolifer
partli
differenti
mucou
cell
crypt
cell
crypt
high
activ
enzym
thymidin
kinas
involv
nucleic
acid
synthesi
complet
cell
cycl
last
hour
rodent
least
hour
human
enter
epithelium
complet
replac
within
two
three
day
mice
rat
within
three
six
day
human
two
divis
crypt
cell
migrat
villu
lose
abil
incorpor
thymidin
differenti
matur
cell
equip
enzym
associ
nutrient
absorpt
cell
migrat
rat
complet
rapidli
ileum
jejunum
princip
result
lower
villou
height
ileum
migrat
termin
loss
cell
tip
villi
surround
crypt
sheath
fibroblast
cell
cell
also
undergo
synchron
divis
migrat
epitheli
cell
maintain
intim
relationship
epithelium
support
tissu
matur
absorpt
cell
import
activ
passiv
transport
nutrient
well
endocytosi
macromolecul
character
presenc
striat
brush
border
seen
hematoxylin
eosinstain
section
refract
bilaminar
band
inner
wider
lamina
correspond
microvil
region
associ
presenc
neutral
mucin
speci
outer
thinner
band
correspond
glycocalyx
compos
princip
acid
mucosubst
outer
band
brush
border
show
histochem
stain
predominantli
sulfomucin
speci
includ
mous
hamster
dog
rhesu
monkey
although
duodenum
rat
entir
human
small
bowel
sialomucin
predomin
layer
electron
microscopi
absorpt
cell
show
surfac
absorpt
cell
cover
tightli
pack
welldevelop
microvilli
approxim
long
wide
consid
first
site
entri
food
substanc
cell
import
aspect
absorpt
cell
membran
high
concentr
disaccharidas
sucras
maltas
lactas
relat
absorpt
sugar
alkalin
phosphatas
activ
also
abund
surfac
absorpt
cell
immunocytochem
demonstr
alkalin
phosphatas
use
tool
examin
effect
xenobiot
intrins
membran
glycoprotein
small
intestin
enterokinas
glycoprotein
enzym
initi
activ
pancreat
zymogen
convert
trypsinogen
trypsin
also
present
brush
border
glycocalyx
small
intestin
epithelium
human
anim
immunocytochem
studi
demonstr
human
enzym
locat
duodenum
proxim
jejunum
ileum
colon
stomach
goblet
cell
much
fewer
number
absorpt
cell
small
intestin
increas
number
duodenum
lower
ileum
import
product
mucu
remain
surfac
mucosa
viscou
layer
act
first
line
defens
intestin
pathogen
goblet
cell
character
presenc
abund
mucou
droplet
form
golgi
complex
accumul
apic
part
cell
cytoplasm
histochem
studi
show
neutral
mucin
present
goblet
cell
found
crypt
villi
entir
small
bowel
mucosa
speci
includ
human
interspeci
variat
popul
sialoand
sulfomucin
mous
sulfomucin
predomin
among
rat
consider
individu
variat
proport
sialoand
sulfomucin
report
hamster
sulfomucin
promin
proxim
sialomucin
distal
small
bowel
dog
sulfomucin
sialomucin
found
predomin
one
individu
anim
stain
acid
mucin
less
intens
goblet
cell
small
intestin
human
compar
nonhuman
primat
sialomucin
predomin
speci
paneth
cell
locat
near
crypt
base
throughout
small
intestin
rodent
human
typic
carnivor
dog
cat
character
presenc
numer
eosinophil
cytoplasm
secretori
granul
diamet
contain
variou
enzym
mucosubst
particular
care
need
fixat
stain
optim
demonstr
paneth
cell
rapidli
degranul
death
granul
destroy
acet
acid
fixat
formalin
mercur
fix
appear
appropri
method
permit
stain
methylen
blue
lendrum
phloxinetartrazin
masson
trichrom
apic
part
paneth
cell
show
carbon
anhydras
monoamin
oxidas
activ
shown
contain
lysozym
immunoglobulin
particularli
iga
paneth
cell
granul
also
contain
antimicrobi
peptid
secretori
phospholipid
defensin
also
call
cryptin
believ
possess
antimicrobiol
activ
also
import
regul
cell
volum
chemotaxi
mitogenesi
inhibit
natur
killer
cell
activ
studi
transgen
knockout
mice
support
pivot
role
paneth
cell
defensin
protect
oral
bacteri
pathogen
observ
suggest
paneth
cell
dysfunct
may
contribut
clinic
manifest
crohn
diseas
necrot
enterocol
human
endocrin
cell
also
scatter
throughout
small
intestin
mucosa
argentaffin
argyrophil
type
situat
predominantli
crypt
immunocytochem
studi
show
contain
varieti
differ
peptid
although
gastrin
secret
serotonincontain
cell
extens
studi
addit
barrier
form
mucu
epitheli
cell
lymphocyt
plasma
cell
macrophag
dendrit
cell
mast
cell
also
form
part
protect
function
small
intestin
lymphocyt
locat
within
epithelium
mostli
basal
lamina
epitheli
nuclei
lymphocyt
term
intraepitheli
lymphocyt
predominantli
suppressercytotox
type
human
laboratori
anim
lymphocyt
lamina
propria
also
cell
helper
posit
cell
outnumb
suppressercytotox
posit
phenotyp
mani
plasma
cell
present
lamina
propria
produc
iga
major
immunoglobulin
mucos
secret
repres
anoth
import
compon
mucos
barrier
morphometr
analysi
igacontain
immunocyt
rat
ileal
mucosa
use
immunocytochem
stain
shown
number
cell
vari
alter
microbiolog
statu
intestin
content
peyer
patch
promin
aggreg
lymphoid
tissu
gastrointestin
tract
constitut
import
site
antigen
gut
lumen
encount
immun
compet
cell
respons
initi
immun
respons
peyer
patch
locat
antemesenter
wall
small
bowel
consist
princip
collect
lymphoid
follicl
human
peyer
patch
common
ileum
mice
uniformli
distribut
rat
number
patch
common
distal
number
follicl
within
individu
patch
usual
vari
two
six
strain
differ
may
show
consider
variat
size
individu
anim
compar
studi
show
fischer
rat
smaller
wistar
rat
particular
care
select
orient
tissu
block
therefor
essenti
form
critic
assess
peyer
patch
peyer
patch
lymphoid
follicl
surround
corona
small
lymphocyt
princip
b
cell
type
interfollicular
area
contain
postcapillari
venul
lymphocyt
epithelium
overli
peyer
patch
follicl
dome
area
contain
special
epitheli
cell
call
microfold
membran
simpli
cell
cell
identifi
mani
speci
includ
rat
mice
hamster
dog
monkey
human
cell
differ
function
enterocyt
abil
transport
larg
molecul
ferritin
horseradish
peroxidas
particul
matter
lumen
underli
lymphoid
tissu
also
shown
site
penetr
reovirus
epithelium
transport
vibrio
cholera
organ
cell
therefor
form
point
intestin
wall
transport
intact
antigen
macromolecul
follicl
process
transport
lymph
node
consequ
iga
immun
respons
contrast
uptak
solubl
antigen
taken
ordinari
epitheli
cell
transport
circul
villi
ultim
trap
spleen
possibl
evok
igmigg
respons
understand
cellular
molecular
characterist
critic
design
mucos
vaccin
pathogen
exploit
pathway
mucos
mast
cell
also
appear
involv
immunolog
defens
gastrointestin
tract
respond
prolifer
migrat
discharg
granul
nematod
infest
shown
rat
mucos
mast
cell
gut
differ
sever
way
connect
tissu
mast
cell
differ
result
poor
preserv
mast
cell
gut
usual
metachromat
stain
techniqu
employ
demonstr
mast
cell
tissu
section
histochem
studi
suggest
mucos
mast
cell
differ
connect
tissu
mast
cell
lower
degre
sulfat
glycosaminoglycan
differ
spatial
relationship
protein
glycosaminoglycan
granul
crosslink
follow
formalin
fixat
prohibit
cation
dye
bind
prevent
histolog
stain
howev
stain
achiev
tissu
fix
formalin
prolong
incub
toluidin
blue
day
procedur
allow
adequ
penetr
toluidin
blue
molecul
optim
histopatholog
studi
small
intestin
complic
length
mucos
fragil
import
avoid
vigor
wash
procedur
form
excess
manipul
unfix
bowel
artifact
caus
wash
may
confound
interpret
chang
induc
xenobiot
combin
artifact
due
wash
autolysi
presenc
neutrophil
produc
histolog
appear
mimic
vivo
damag
although
care
visual
inspect
intestin
sampl
appropri
segment
histolog
examin
usual
suffici
routin
examin
variou
form
swiss
roll
techniqu
help
complet
studi
mucosa
also
detail
examin
associ
lymphoid
tissu
roll
unfix
open
rodent
intestin
around
wooden
stick
prior
freez
fixat
one
propos
method
although
method
risk
undu
manipul
unfix
tissu
anoth
versatil
techniqu
applic
rodent
larg
anim
human
intestin
perform
fixat
unfix
open
bowel
pin
flat
cork
board
fix
bath
formal
salin
fixat
full
thick
rodent
intestin
roll
transfix
pin
embed
paraffin
wax
likewis
mucosa
intestin
larg
anim
speci
human
roll
fixat
separ
musculari
externa
inflamm
ulcer
small
intestin
duoden
jejun
ileiti
inflamm
ulcer
mucosa
occur
result
stress
infect
bacteria
virus
infest
parasit
direct
result
effect
xenobiot
ioniz
radiat
eros
ulcer
strictur
associ
number
therapeut
agent
peopl
antimitot
radiomimet
agent
well
ioniz
radiat
liabl
advers
affect
rapidli
divid
cell
small
intestin
result
breakdown
mucos
barrier
newer
target
anticanc
drug
also
associ
intestin
damag
ulcerogen
activ
nonsteroid
antiinflammatori
drug
also
express
small
bowel
mucosa
commonli
distal
ileum
moreov
differ
agent
also
act
synergi
enhanc
damag
small
bowel
mucosa
import
exampl
drug
depress
immun
system
antimicrobi
agent
permit
develop
patholog
infect
microorgan
opportunist
type
small
intestin
vasoconstrict
may
also
result
intestin
ulcer
exampl
lifethreaten
gastrointestin
ulcer
report
result
cocain
abus
although
gastrointestin
complic
less
common
cardiac
damag
cocain
abus
may
induc
mesenter
ischemia
result
vasoconstrict
lead
gastric
intestin
ulcer
perfor
entir
wall
appear
abus
free
base
form
cocain
crack
liabl
produc
upper
gastrointestin
intestin
damag
oral
cocain
abus
tend
induc
distal
intestin
perfor
although
exact
mechan
lead
intestin
ischemia
certain
cocain
block
reuptak
norepinephrin
noradrenalin
believ
caus
mesenter
vasoconstrict
ischemia
histolog
featur
inflammatori
process
small
intestin
often
specif
particular
agent
import
search
evid
microbiolog
organ
viral
inclus
indic
caus
intestin
inflamm
ulcer
associ
featur
nonulcer
mucosa
morpholog
villi
accumul
abnorm
cell
presenc
drug
crystal
debri
chang
lymphoid
cell
blood
vessel
also
import
assess
chang
number
organ
includ
normal
resid
gastrointestin
tract
caus
inflammatori
chang
intestin
mucosa
laboratori
anim
notabl
except
nonhuman
primat
inflammatori
bowel
diseas
caus
microbiolog
organ
usual
evid
concern
toxic
carcinogen
studi
howev
anim
treat
antibiot
immunosuppress
agent
drug
alter
normal
intestin
flora
condit
may
favor
prolifer
potenti
pathogen
organ
suffici
quantiti
caus
overt
damag
mucosa
nonhuman
primat
coloni
gastrointestin
diseas
remain
one
import
health
problem
mani
indoorh
monkey
commonli
histolog
evid
intestin
inflamm
notabl
microabscess
eros
rather
overt
ulcer
although
major
potenti
pathogen
organ
affect
primat
colon
number
bacteria
protozoa
metazoan
occur
small
intestin
use
aid
identif
metazoa
histolog
section
remain
public
chitwood
lichtenfel
bacillu
piliformi
agent
respons
tyzzer
diseas
produc
intestin
inflamm
ulcer
rat
mice
hamster
suscept
differ
speci
strain
experiment
infect
bacillu
piliformi
variabl
instanc
balb
mice
fischer
rat
appear
resist
infect
outbr
syrian
hamster
lesion
variabl
sever
usual
occur
ileum
may
also
extend
cecum
colon
sever
infect
character
histolog
ulcer
mucosa
edema
acut
inflamm
submucosa
muscl
coat
muscl
may
also
show
focal
necrosi
nonulcer
mucosa
typic
infiltr
polymorphonuclear
cell
crypt
abscess
form
blunt
fusion
villi
reactiv
hyperplasia
mucin
deplet
overli
epithelium
mucos
lymphoid
tissu
may
also
show
reactiv
chang
hyperplasia
filament
bundl
bacillu
piliformi
usual
found
cytoplasm
epitheli
cell
smooth
muscl
cell
edg
necrot
zone
methylen
blue
giemsa
silver
impregn
techniqu
warthinstarri
levad
stain
best
stain
demonstr
organ
although
care
visual
hematoxylin
eosinstain
section
gram
neg
pa
posit
intestin
infect
due
salmonella
speci
rel
common
mous
also
occur
hamster
rat
salmonella
typhimurium
salmonella
enteritidi
regard
organ
typic
murin
salmonellosi
lesion
occur
ileum
may
extend
jejunum
cecum
character
presenc
ulcer
cover
fibrin
exud
associ
diffus
infiltr
adjac
mucosa
macrophag
neutrophil
lymphocyt
intact
crypt
epithelium
show
mucin
loss
reactiv
prolif
chang
characterist
featur
presenc
poorli
defin
granulomat
lesion
compos
macrophag
mainli
associ
lymphoid
tissu
peyer
patch
clostridia
speci
especi
clostridia
difficil
caus
pseudomembran
coliti
human
laboratori
anim
especi
hamster
may
also
produc
inflamm
ulcer
termin
ileum
histolog
featur
similar
found
colon
see
follow
prolif
ileiti
transmiss
ileal
hyperplasia
strike
lesion
hamster
affect
distal
segment
ileum
associ
intracellular
invas
intestin
mucosa
epithelium
bacteria
condit
repres
number
enter
condit
anim
refer
gener
head
prolif
enteropathi
definit
caus
agent
cultiv
diseas
associ
variou
organ
although
character
hyperplasia
ileal
mucosa
earli
stage
inflammatori
phase
interven
focal
necrosi
hemorrhag
mucosa
crypt
abscess
infiltr
lamina
propria
acut
inflammatori
cell
macrophag
histolog
featur
associ
hyperplasia
characterist
mucosa
cover
immatur
mucindeplet
pseudostratifi
hyperchromat
epithelium
mitos
extend
tip
villi
dens
basophil
intracytoplasm
inclus
helicobact
jejuni
campylobact
jejuni
common
caus
diarrhea
human
may
caus
agent
small
intestin
inflamm
laboratori
dog
primat
campylobact
speci
may
preval
beagl
dog
primat
commonli
appreci
import
recogn
anim
colon
agent
may
suscept
stressinduc
acut
onset
gastroenter
human
form
bacteri
diseas
character
histolog
mucin
deplet
flatten
reactiv
chang
small
bowel
epithelium
crypt
abscess
edema
infiltr
mucosa
neutrophil
lymphocyt
plasma
cell
similar
histolog
find
report
dog
infect
organ
organ
gramneg
curv
slender
rod
easili
visual
tissu
section
warthinstarri
stain
recogn
techniqu
spiral
bacteria
carbol
fuchsin
techniqu
gimenez
first
use
identif
ricketsia
yolk
sac
cultur
cresyl
fast
violet
techniqu
also
use
method
identif
campylobact
speci
paraffin
section
spironucleu
muri
hexam
muri
also
caus
inflamm
small
bowel
rat
mice
hamster
overt
infest
organ
seen
extracellularli
crypt
intervil
space
associ
blunt
intestin
villi
epitheli
degener
mucin
deplet
reactiv
epitheli
hyperplasia
edema
leukocyt
infiltr
giardia
speci
repres
margin
pathogen
flagel
found
upper
gastrointestin
tract
opportunist
agent
becom
import
anim
human
depress
immun
function
studi
mice
infect
experiment
giardia
muri
shown
earli
respons
increas
infiltr
epithelium
lymphocyt
predominantli
cell
depress
immun
respons
treatment
corticosteroid
shown
increas
parasit
number
murin
giardiasi
also
caus
recrudesc
occult
infect
giardia
muri
lamblia
muri
sometim
found
small
intestin
rat
mous
hamster
figur
trophozoit
appear
histolog
section
crescentshap
kitelik
structur
brush
border
intestin
mucosa
adjac
lumen
mucos
lesion
may
total
absent
may
blunt
villi
reactiv
epitheli
hyperplasia
typic
featur
increas
infiltr
epithelium
lamina
propria
mononuclear
cell
anoth
find
lactas
sucras
maltas
level
decreas
small
intestin
mice
infest
giardia
muri
giardia
lamblia
may
colon
small
intestin
monkey
human
produc
similar
morpholog
appear
found
infest
rodent
giardia
muri
flagel
tritrichomona
muri
also
found
small
intestin
mice
rat
hamster
coccidian
protozoan
parasit
cryptosporidium
repres
strike
exampl
close
relationship
human
anim
diseas
organ
first
recogn
gastric
gland
mice
tyzzer
sinc
confirm
caus
diarrhea
anim
human
pathogen
caus
mild
diarrhea
normal
subject
especi
children
young
adult
produc
sever
intestin
diseas
immunocompromis
individu
histolog
examin
small
intestin
laboratori
anim
infest
cryptosporidium
reveal
presenc
organ
attach
mucos
surfac
often
associ
human
parasit
infect
round
weakli
basophil
structur
diamet
hematoxylin
eosinstain
section
strongli
basophil
follow
romanowski
stain
transmiss
electron
microscopi
reveal
detail
intern
structur
cryptosporidium
attach
microvil
surfac
epitheli
cell
variou
stage
life
cycl
visual
light
electron
microscopi
infect
start
ingest
oocyst
contain
four
sporozoit
probabl
releas
action
digest
enzym
attach
intestin
mucosa
undertak
life
cycl
attach
epitheli
cell
organ
demonstr
laboratori
speci
includ
mice
hamster
rabbit
dog
monkey
hymenolepi
nana
dwarf
tapeworm
hymenolepi
diminuta
rat
tapeworm
describ
intestin
rat
mice
hamster
nonhuman
primat
human
varieti
metazoan
patient
found
small
intestin
nonhuman
primat
number
virus
produc
inflammatori
small
bowel
chang
mice
exampl
mous
hepat
viru
lethal
intestin
viru
infant
mice
caus
mucos
epitheli
necrosi
inflamm
characterist
compensatori
epitheli
hyperplasia
format
epitheli
syncytia
murin
rotaviru
epidem
diarrhea
infant
mice
produc
swollen
enterocyt
small
larg
bowel
fine
cytoplasm
vesicul
littl
inflamm
dilat
lymphat
vascular
congest
cytoplasm
acidophil
inclus
diamet
characterist
find
varieti
virus
isol
gastrointestin
tract
nonhuman
primat
includ
virus
human
although
overt
patholog
usual
seen
howev
goblet
cell
hyperplasia
villou
blunt
enter
report
gastrointestin
tract
monkey
infect
simian
type
retroviru
viral
antigen
also
demonstr
tissu
throughout
gastrointestin
tract
lesion
observ
absenc
detect
enter
pathogen
primari
pathogen
role
simian
type
retroviru
gastrointestin
tract
propos
mani
drug
associ
intestin
damag
human
particularli
nonsteroid
inflammatori
agent
anticanc
drug
also
produc
similar
effect
laboratori
anim
part
gastrointestin
tract
histopatholog
chang
usual
fairli
nonspecif
character
loss
mucosa
submucosa
acut
chronic
inflamm
variabl
fibroblast
respons
reactiv
respons
adjac
epitheli
cell
may
intens
case
may
even
mimic
preneoplast
alter
nonsteroid
antiinflammatori
agent
indomethacin
phenylbutazon
produc
gastric
ulcer
also
penetr
ulcer
small
bowel
patient
laboratori
anim
newer
inhibitor
cyclooxygenas
also
shown
tendenc
produc
penetr
ulcer
distal
small
intestin
rather
gastric
damag
toxic
studi
imag
studi
indiumlabel
leukocyt
human
also
suggest
subclin
intestin
inflamm
associ
longterm
therapi
nonsteroid
antiinflammatori
drug
postul
indomethacininduc
intestin
ulcer
rat
dog
may
produc
prostaglandinindepend
mechan
differ
manner
gastric
ulcer
induc
argu
damag
may
relat
concomit
effect
contact
irrit
drug
bile
rat
similar
mechan
may
respons
gastric
intestin
ulcer
dose
regimen
influenc
distribut
ulcer
good
tempor
correl
develop
intestin
ulcer
inhibit
prostaglandin
synthesi
demonstr
also
shown
potent
intestin
ulcerogen
indomethacin
inhibit
incorpor
radioact
sulfat
glycoprotein
stomach
upper
intestin
mucosa
rat
may
decreas
capac
mucu
intestin
act
buffer
hydrogen
ion
mechan
undoubtedli
complex
multifactori
may
includ
prostaglandin
suppress
local
irrit
also
effect
drug
disposit
singl
dose
studi
indomethacin
ibuprofen
rat
demonstr
differ
patholog
express
induc
damag
stomach
small
intestin
gastric
damag
superfici
occur
within
six
hour
fulli
repair
two
week
dose
ulcer
jejunum
ileum
reach
maximum
area
hour
dose
occur
mesenter
border
penetr
musculari
mucosa
accompani
inflamm
edema
ulcer
still
present
two
week
later
dog
indomethacin
given
oral
dose
mgkgday
one
day
also
shown
produc
deep
punchedout
ulcer
small
intestin
mani
situat
peyer
patch
ulcer
involv
whole
circumfer
small
intestin
wall
histolog
ulcer
associ
intens
inflammatori
respons
princip
mononuclear
cell
infiltr
bowel
wall
serosa
particularli
adjac
peyer
patch
suggest
distribut
ulcer
result
exagger
immun
respons
normal
intestin
antigen
follow
depress
prostaglandin
synthetas
indomethacin
special
dye
techniqu
scan
transmiss
electron
microscopi
also
shown
nonsteroid
antiinflammatori
drug
produc
gener
mild
morpholog
effect
small
intestin
mucosa
without
overt
eros
ulcer
evid
light
microscopi
follow
administr
aspirin
mice
sever
week
shorten
eros
microvilli
increas
number
goblet
cell
demonstr
duodenum
jejunum
scan
transmiss
electron
microscopi
morphometr
studi
intestin
mucosa
indomethacintr
mice
also
shown
widespread
alter
columnar
cell
goblet
cell
paneth
cell
suggest
gener
effect
mitot
activ
crypt
loss
although
nonsteroid
antiinflammatori
drug
bestknown
drug
advers
effect
gastrointestin
mucosa
small
intestin
inflamm
ulcer
also
produc
drug
differ
mechan
antimitot
anticanc
drug
high
dose
antivir
drug
depress
cell
prolifer
immunosuppress
agent
may
also
produc
intestin
mucos
apoptosi
necrosi
hemorrhag
inflamm
opportunist
gastrointestin
overgrowth
administ
dog
rodent
high
dose
figur
drug
includ
older
anticanc
drug
divers
structur
pharmacolog
type
well
new
antimitot
agent
socal
target
anticanc
therapi
act
vascular
endotheli
growth
factor
microtubul
acut
disrupt
upper
small
intestin
mucosa
consid
import
factor
develop
nausea
vomit
anticanc
therapi
chemotherapi
believ
induc
free
radic
format
lead
local
exocytot
releas
enterochromaffin
cell
interact
receptor
vagal
affer
termin
wall
bowel
link
dorsal
brain
stem
area
postrema
produc
nausea
vomit
particularli
well
studi
human
patient
laboratori
anim
effect
methotrex
small
intestin
mucosa
induc
loss
crypt
crypt
villu
atrophi
flatten
epitheli
cell
consequ
apoptosi
inhibit
cell
prolifer
howev
treatment
seem
spare
goblet
cell
paneth
cell
well
epithelium
associ
peyer
patch
colchicin
anticanc
drug
taxol
paclitaxel
interfer
tubulin
inhibit
polymer
microtubul
also
report
produc
intestin
damag
effect
produc
mitot
arrest
character
larg
pleomorph
nuclei
promin
ring
mitos
associ
epitheli
pseudostratif
loss
polar
increas
apoptosi
featur
may
mimic
true
premalign
chang
dysplasia
similar
featur
also
occur
laboratori
anim
figur
antivir
drug
may
also
show
radiomimet
effect
gastrointestin
mucosa
seen
dog
treat
high
dose
acyclovir
also
report
experiment
drug
therapeut
class
also
produc
intestin
damag
result
gener
antimitot
effect
small
intestin
radiosensit
chang
seen
patient
ioniz
radiat
therapi
termin
ileum
appear
sensit
virtu
fix
structur
part
intestin
three
stage
damag
describ
acut
phase
character
hyperemia
edema
inflamm
crypt
abscess
ulcer
subacut
phase
two
month
radiat
partial
tissu
repair
vari
degre
arteriolar
sclerosi
chronic
phase
progress
fibrosi
occur
wherea
acut
epitheli
alter
resembl
chang
follow
administr
antiprolif
anticanc
drug
ioniz
radiat
typic
associ
fibrou
thicken
blood
vessel
wall
normal
seen
drug
therapi
lymphoid
infiltr
without
tissu
damag
also
report
small
intestin
rat
treat
human
recombin
interleukin
part
multisystem
involv
agent
gener
toxicolog
interest
cysteamin
propionitril
structur
analog
well
mptp
capabl
produc
ulcer
chronic
type
duodenum
rat
mice
compound
vari
ulcerogen
capac
abl
produc
ulcer
chronic
type
crater
format
granul
tissu
reactiv
chang
adjac
mucosa
anterior
posterior
wall
proxim
segment
duodenum
rodent
although
differ
agent
influenc
gastric
acid
secret
differ
way
relationship
suggest
produc
duoden
dysmotil
decreas
bicarbon
product
reduc
deliveri
distal
proxim
duodenum
factor
decreas
neutral
gastric
acid
first
part
duodenum
may
contribut
develop
ulcer
furthermor
effect
attenu
prevent
dopamin
agonist
precursor
wherea
dopamin
antagonist
potenti
effect
suggest
dopaminemedi
action
agent
may
involv
pathogenesi
duoden
ulcer
fatti
chang
lipidosi
use
appropri
fixat
stain
procedur
fine
granular
lipid
droplet
visual
apic
part
epitheli
cell
cover
upper
third
normal
small
intestin
villi
administr
drug
chemic
may
produc
excess
accumul
lipid
specif
effect
lipid
metabol
part
gener
cellular
toxic
exampl
preclin
toxic
studi
sa
inhibitor
glucos
transport
intend
use
antiobes
drug
lipid
accumul
occur
lamina
propria
small
intestin
villi
spraguedawley
rat
guinea
pig
dog
primat
administr
agent
rat
progress
accumul
lipid
droplet
epitheli
cell
tip
duoden
villi
demonstr
osmium
tetroxid
stain
electron
microscop
examin
reveal
uniform
electronluc
droplet
within
profil
smooth
endoplasm
reticulum
golgi
apparatu
lipid
droplet
increas
time
accumul
form
larg
droplet
lamina
propria
larger
droplet
phagocytos
macrophag
lamina
propria
evid
epitheli
damag
necrosi
chang
pronounc
duodenum
also
note
lesser
extent
jejunum
ileum
colon
stomach
sequenti
studi
use
electron
microscopi
show
lipid
rapidli
accumul
within
sever
hour
profil
smooth
endoplasm
reticulum
golgi
apparatu
epitheli
cell
form
droplet
chylomicra
intercellular
space
absenc
subcellular
chang
evid
derang
protein
synthesi
suggest
sa
alter
pathway
lipid
resynthesi
transport
consist
distribut
lipid
upper
third
jejun
villou
epithelium
zone
report
activ
lipid
absorpt
resynthesi
transport
suggest
fatti
chang
might
taken
place
alter
sugar
moieti
chylomicra
brought
interfer
glucos
transport
lipid
droplet
stain
oilredo
formalinfix
frozen
section
show
uniform
electron
densiti
electron
microscop
characterist
neutral
lipid
also
observ
epitheli
cell
macrophag
lamina
propria
jejunum
duodenum
mesenter
lymph
node
rat
given
synthet
dodecyl
glutaramid
ester
erythromycin
unlik
erythromycin
base
rat
poorli
toler
ester
appear
ester
absorb
unhydrolyz
convert
chylomicronlik
droplet
accumul
macrophag
lamina
propria
local
mesenter
lymph
node
without
overt
damag
epitheli
cell
accumul
lipid
epitheli
cell
intestin
villi
observ
rat
follow
administr
puromycin
ethionin
agent
inhibitori
effect
protein
synthesi
detail
morpholog
studi
intestin
epitheli
cell
rat
treat
puromycin
shown
concomit
accumul
lipid
decreas
quantiti
rough
endoplasm
reticulum
golgi
membran
chang
keep
concept
lipid
accumul
result
inhibit
synthesi
membran
compon
golgi
rough
endoplasm
reticulum
thu
compromis
transport
lipid
addit
lipid
droplet
form
result
alter
lipid
metabol
may
form
epitheli
cell
intestin
mucos
result
direct
toxic
effect
ingest
drug
small
intestin
mucosa
instanc
atrophi
villi
degen
chang
epitheli
cell
typic
observ
see
follow
small
intestin
mucosa
also
one
mani
site
system
druginduc
accumul
polar
lipid
form
lamin
structur
myeloid
bodi
crystalloid
structur
within
lysosom
form
lipid
storag
disord
produc
divers
amphiphil
cation
drug
laboratori
anim
occasion
patient
usual
result
drug
interact
polar
lipid
render
difficult
digest
see
respiratori
tract
chapter
speci
differ
suscept
tissu
distribut
phospholipid
probabl
divers
origin
relat
physiochem
characterist
induc
drug
influenc
abil
permeat
select
biomembran
react
differ
lipid
also
local
tissu
concentr
drug
abil
particular
organ
metabol
parent
drug
less
amphiphil
product
gener
term
disord
character
membranebound
acid
phosphataseposit
cytoplasm
inclus
ultrastructur
studi
seen
lamellar
crystalloid
structur
lysosom
appear
characterist
revers
cessat
treatment
incit
agent
chloroquin
note
produc
accumul
foam
cell
stroma
small
intestin
villi
rat
treat
two
year
part
gener
phospholipid
accumul
back
anoth
exampl
phenomenon
occur
small
intestin
also
provid
iodin
amphiphil
drug
amiodaron
use
clinic
past
year
treatment
angina
recent
control
supraventricular
cardiac
arrhythmia
although
advers
effect
patient
link
accumul
drug
lysosom
particularli
liver
skin
eye
toxic
appear
direct
result
accumul
phospholipid
high
dose
amiodaron
administ
oral
rat
beagl
dog
multilamellar
lysosom
inclus
bodi
accumul
first
jejun
mucosa
mesenter
lymph
node
becom
wide
distribut
organ
particularli
lung
rat
dog
small
intestin
lesion
character
presenc
foami
macrophag
pale
fine
vacuol
cytoplasm
condens
eccentr
nuclei
within
lamina
propria
jejun
villi
mesenter
lymph
node
also
involv
earli
onset
treatment
dog
jejun
villi
somewhat
flatten
widen
show
variabl
degre
villou
atrophi
mark
proxim
middl
jejunum
electron
microscopi
confirm
presenc
lamellar
lysosom
bodi
distend
macrophag
earli
accumul
foam
cell
jejun
macrophag
probabl
reflect
disposit
drug
follow
oral
absorpt
although
similar
phospholipidosi
seen
mani
organ
follow
intraven
administr
dog
phospholipidosi
seen
jejunum
oral
dose
moreov
speci
differ
sensit
chang
baboon
rel
insensit
compar
dog
fischer
rat
sensit
chang
compar
spraguedawley
rat
wistar
rat
resist
phospholipidosi
induc
amiodaron
similar
condit
villou
shorten
stunt
result
prolif
activ
crypt
epithelium
reduc
crypt
cell
prolifer
insuffici
compens
increas
cell
loss
follow
mucos
cell
damag
decreas
cell
prolifer
seen
follow
decreas
food
intak
parenter
nutrit
hypophysectomi
thyroidectomi
bowl
segment
surgic
bypass
adrenerg
factor
import
control
small
intestin
epitheli
cell
divis
drug
alter
adrenoreceptor
activ
may
influenc
prolif
capac
epithelium
mice
increas
receptor
stimul
appropri
agonist
eg
phenylephrin
diminish
prolifer
crypt
cell
prolifer
increas
stimul
receptor
activ
yohimbin
antagonist
also
reduc
cell
prolifer
anim
model
effect
agent
may
mediat
chang
splanchnic
blood
flow
detail
morpholog
studi
small
intestin
mucosa
rat
follow
hypophysectomi
shown
reduct
height
small
intestin
villi
associ
reduct
mitos
crypt
epithelium
number
goblet
cell
shown
fall
particularli
jejunum
number
paneth
cell
increas
ileum
examin
ultrastructur
show
decreas
height
microvilli
absorpt
cell
lower
number
intracytoplasm
organel
ribosom
also
signific
decreas
brush
border
enzym
activ
alkalin
phosphatas
aminopeptidas
maltas
lactas
one
week
follow
hypophysectomi
substanc
reduc
mitot
activ
therefor
lower
regen
capac
intestin
epithelium
also
produc
shorten
stunt
small
intestin
villi
eventu
flatten
mucosa
wide
varieti
anticanc
agent
antivir
drug
radiomimet
properti
interfer
cell
divis
crypt
therebi
reduc
number
epitheli
cell
produc
histolog
effect
agent
character
blunt
shorten
complet
atrophi
villi
mitot
activ
reduc
crypt
crypt
becom
dilat
line
flatten
cell
overli
epithelium
lose
normal
regular
arrang
cell
show
pleomorph
nuclei
irregular
chromatin
pattern
increas
number
inflammatori
cell
may
infiltr
lamina
propria
epithelium
ulcer
hemorrhag
secondari
infect
gut
wall
ensu
overwhelm
cell
damag
comparison
gastrointestin
toxic
express
antimitot
anticanc
drug
differ
class
rodent
dog
monkey
human
suggest
higher
degre
correspond
effect
human
dog
human
speci
studi
antivir
agent
acyclovir
radiomimet
effect
note
gastrointestin
tract
dog
high
dose
rodent
anoth
exampl
villou
atrophi
describ
rat
follow
treatment
experiment
antibacteri
agent
ici
believ
aris
result
interfer
cell
divis
direct
effect
surfac
epitheli
cell
effect
ici
character
atrophi
villi
dilat
crypt
atyp
featur
crypt
epithelium
suggest
effect
mitot
activ
addit
vacuol
lipidladen
epitheli
cell
observ
tip
villi
accompani
reduct
number
goblet
cell
reduc
activ
acid
alkalin
phosphatas
esteras
adenosin
triphosphatas
succin
dehydrogenas
compat
direct
advers
effect
superfici
matur
epitheli
cell
varieti
factor
stimul
cell
prolifer
small
intestin
epithelium
includ
partial
enterectomi
increas
feed
stimul
autonom
nerv
administr
neurotransmitt
thyroxin
growth
hormon
corticosteroid
testosteron
gastrin
glucagon
glucagonlik
peptid
epiderm
growth
factor
key
determin
feedinginduc
intestin
adapt
appear
nonspecif
lumin
stimul
function
workload
induc
polymer
nutrient
stimul
pancreat
biliari
secret
well
divers
humor
mediat
induct
intestin
hyperemia
short
bowel
syndrom
occur
insuffici
length
small
intestin
maintain
adequ
nutrit
follow
surgic
resect
intestin
extent
adapt
depend
anatomi
resect
bowel
amount
bowel
remain
chang
also
shown
mediat
multipl
factor
includ
intralumin
parenter
nutrient
gastrointestin
secret
hormon
cytokin
growth
factor
understand
process
led
use
growth
hormon
glucagonlik
peptid
intestin
rehabilit
patient
mani
mechan
explor
laboratori
anim
sever
decad
rat
hypothalam
damag
hyperthyroid
tube
feed
diabet
mellitu
insulin
inject
shown
produc
intestin
hyperplasia
caus
greater
cell
product
lead
increas
villou
height
mucos
hyperplasia
although
intens
crypt
cell
prolifer
compensatori
regen
respons
associ
villou
atrophi
intestin
hyperplasia
seen
physiolog
process
allow
increas
capac
intestin
absorpt
numer
studi
rodent
well
speci
shown
small
intestin
mass
increas
lactat
mark
proxim
two
third
associ
histolog
evid
increas
villou
height
jejunum
ileum
gener
hypertrophi
hyperplasia
jejun
ileal
cecal
mucosa
compensatori
respons
surgic
resect
bypass
intestin
focu
detail
studi
cell
renew
small
intestin
partial
resect
rat
human
accompani
increas
villou
height
crypt
length
primarili
result
hyperplasia
shown
number
cell
per
unit
length
villu
remain
unchang
overal
increas
cell
popul
villu
crypt
dnarna
ratio
remain
larg
unalt
gross
chang
villou
shape
report
resect
total
number
crypt
remain
constant
although
increas
intestin
uptak
substanc
bowel
lumen
occur
hypertrophi
segment
per
unit
length
bowel
disaccharid
dipeptidas
activ
normal
even
decreas
resect
suggest
compar
immatur
cell
residu
mucosa
function
adapt
therefor
larg
achiev
larger
number
cell
individu
absorpt
capac
increas
increas
number
specif
goblet
cell
popul
also
seen
hyperfunct
state
follow
jejunoil
bypass
oper
rat
increas
number
pasposit
goblet
cell
develop
villi
crypt
hyperfunct
segment
duodenum
jejunum
ileum
mucin
histochemistri
shown
goblet
cell
hyperfunct
segment
contain
increas
sialomucin
villi
crypt
jejunum
ileum
duodenum
increas
sulfomucin
distal
ileal
segment
sialic
acid
convey
viscoelast
properti
mucin
suggest
goblet
cell
chang
follow
intestin
bypass
fulfil
protect
function
increas
flow
gastrointestin
content
interestingli
partial
hepatectomi
rat
also
shown
produc
persist
trophic
chang
proxim
jejunum
character
thicken
jejun
wall
villou
hypertrophi
number
nutrit
factor
particularli
dietari
fiber
shown
influenc
prolif
characterist
small
bowel
mucosa
care
control
studi
rat
given
differ
form
dietari
fiber
shown
prolif
characterist
small
intestin
modifi
quantiti
precis
natur
fiber
differ
effect
may
result
differ
solubl
gel
format
water
hold
capac
effect
transit
time
ion
exchang
activ
bile
acid
adsorpt
differ
fiber
howev
interact
dietari
constitu
complex
instanc
histolog
effect
rat
small
intestin
administr
dietari
cholestyramin
nonabsorb
ion
exchang
resin
shown
depend
interact
dietari
factor
administr
inhibitor
cholesterol
biosynthesi
rat
nine
day
also
shown
produc
enlarg
small
intestin
way
morpholog
similar
chang
found
follow
intestin
bypass
enlarg
mark
proxim
segment
small
intestin
progress
diminish
toward
ileocec
junction
spare
stomach
cecum
colon
histolog
examin
morphometr
analysi
reveal
increas
smooth
muscl
mass
lengthen
villi
well
increas
depth
cellular
prolifer
crypt
hn
without
evid
cell
damag
fatti
chang
like
chang
follow
jejun
bypass
procedur
also
increas
acid
mucosubst
goblet
cell
popul
overli
villou
mucosa
mechan
chang
rat
unclear
particularli
intestin
hyperplasia
seen
baboon
treat
long
period
howev
suggest
adapt
respons
possibl
relat
inhibit
cholesterol
metabol
cholesterol
absorpt
diet
laboratori
diet
employ
rat
studi
particularli
low
cholesterol
local
system
chang
hormon
variou
transmitt
substanc
also
influenc
number
cell
small
intestin
epithelium
morphometr
studi
small
intestin
mucosa
mice
follow
gastrin
administr
shown
increas
villou
area
associ
decreas
microvil
area
increas
number
goblet
cell
paneth
cell
studi
rat
treat
prolactin
inhibitor
ergocryptin
shown
total
number
mucou
cell
number
stain
alcian
blue
ph
increas
ileal
crypt
possibl
result
increas
synthesi
sulfat
mucosubst
administr
human
insulinlik
growth
factor
igfi
rat
five
day
also
report
produc
signific
increas
weight
small
intestin
along
mucos
hyperplasia
chronic
treatment
rauwolfia
neurolept
reserpin
deplet
adrenerg
nerv
norepinephrin
noradrenalin
caus
increas
sulfat
goblet
cell
mucin
small
intestin
demonstr
alcian
blue
stain
ph
high
iron
diamin
techniqu
without
chang
goblet
cell
number
agent
affect
activ
sympathet
nervou
system
also
alter
epitheli
cell
prolifer
small
larg
intestin
wherea
treatment
rat
epinephrin
adrenalin
isoprenalin
phenylephrin
phentolamin
yohimbin
result
decreas
mitot
activ
jejun
colon
crypt
cell
administr
metaraminol
clonidin
propranolol
prazosin
labetolol
well
simultan
inject
propranolol
epinephrin
adrenalin
result
increas
rate
crypt
cell
prolifer
result
suggest
agent
stimul
adrenerg
receptor
activ
antagonist
adrenerg
receptor
antagonist
increas
prolif
activ
rodent
intestin
mucosa
phosphodiesteras
inhibit
result
increas
intracellular
camp
may
also
produc
thicken
mucosa
small
intestin
rat
treat
period
six
month
high
dose
inotrop
vasodil
ici
phosphodiesteras
inhibitor
intend
treatment
congest
cardiac
failur
produc
salivari
gland
hypertrophi
also
mark
thicken
small
larg
intestin
mucosa
character
increas
villou
length
deepen
intestin
gland
rel
unchang
number
epitheli
cell
per
unit
length
gland
villu
although
prostaglandin
e
analog
produc
effect
stomach
increas
thick
small
intestin
character
longer
villi
deeper
crypt
increas
cell
size
report
rat
treat
agent
focal
hyperplasia
focal
avil
hyperplasia
focal
atyp
hyperplasia
duoden
plaqu
polypoid
hyperplasia
polyp
mous
irregular
atyp
singl
multipl
foci
glandular
hyperplasia
may
found
small
intestin
mucosa
sever
strain
age
untreat
mice
lesion
usual
locat
first
part
duodenum
form
discret
rais
plaqu
compos
elong
irregular
branch
gland
replac
normal
villou
structur
mucosa
gland
line
hyperchromat
columnar
cell
character
mark
pseudostratif
prolif
activ
paneth
cell
mucinsecret
goblet
cell
may
also
promin
gland
cystic
stroma
fibrou
infiltr
chronic
inflammatori
cell
lesion
becom
peduncul
polypoid
appear
show
fibrovascular
core
infiltr
inflammatori
cell
resembl
adenomat
polyp
describ
human
typic
show
sever
dysplast
featur
suggest
malign
premalign
lesion
see
neoplasia
caus
chang
mous
small
intestin
unknown
preval
alter
dietari
fiber
purifi
diet
particularli
defici
panthothen
acid
well
administr
drug
chemic
origin
studi
dba
mice
hare
stewart
consid
lesion
genuin
neoplasm
sinc
compos
mixtur
cell
type
normal
popul
mucosa
furthermor
suggest
presenc
inflammatori
compon
stroma
fact
preval
lesion
increas
mice
fed
high
roughag
diet
consist
concept
repres
inflammatori
adenomatoid
hyperplasia
panthothen
acid
defici
also
associ
inflamm
deep
penetr
chronic
ulcer
duodenum
affect
mice
compat
inflammatori
etiolog
lesion
increas
preval
duoden
chang
describ
mice
treat
synthet
prostaglandin
e
analog
misoprostol
month
suggest
find
pose
real
concern
safeti
patient
treat
misoprostol
ground
mous
uniqu
aspect
respons
misoprostol
particular
liabil
develop
chang
small
intestin
prolif
lesion
found
control
mice
studi
addit
also
argu
lesion
neither
neoplast
preneoplast
natur
similar
lesion
seen
rat
treat
misoprostol
two
year
lesion
character
intens
prolif
activ
may
difficult
distinguish
neoplast
lesion
inde
chronic
administr
hydrogen
peroxid
wide
use
antisept
dental
product
mice
drink
water
report
ito
colleagu
potenti
develop
similar
type
duoden
hyperplasia
also
produc
small
number
adenocarcinoma
period
two
year
nonmetastat
atyp
dyplast
flat
lesion
associ
eros
inflamm
argu
hydrogen
peroxid
unlik
reach
duodenum
intact
result
relat
interact
greatli
decreas
water
consumpt
result
abras
lumin
line
dri
pellet
rodent
feed
howev
may
simpli
anoth
exampl
neoplast
develop
follow
prolong
period
chronic
inflamm
gastrointestin
mucosa
dose
irrelev
usual
use
hydrogen
peroxid
human
see
neoplasia
compound
may
produc
prolif
reaction
mimic
intestin
dysplasia
well
describ
human
biopsi
patient
treat
compound
colchicin
taxol
interfer
tubulin
inhibit
polymer
microtubul
effect
produc
mitot
arrest
character
promin
ring
mitos
associ
epitheli
pseudostratif
loss
polar
increas
apoptosi
featur
may
mimic
dysplasia
similar
featur
may
occur
laboratori
anim
figur
human
monkey
larg
intestin
divid
anatom
cecum
appendix
ascend
colon
transvers
colon
sigmoid
colon
rectum
anal
canal
like
small
bowel
wall
colon
compris
mucosa
submucosa
musculari
mucosa
serosa
mucos
plica
found
rectum
although
plica
semilumari
form
fold
entir
thick
bowel
wall
found
colon
larg
intestin
dog
resembl
human
domest
speci
simplifi
tubular
structur
slightli
larger
diamet
small
intestin
colon
dog
divid
anatom
ascend
transvers
descend
part
welldefin
sigmoid
segment
cecum
dog
small
diverticulum
similar
found
carnivor
speci
commun
directli
colon
cecum
colon
larger
minipig
human
arrang
seri
coil
vascular
arcad
subserosa
rather
mesenteri
colon
rat
mous
shape
like
invert
v
divid
ascend
descend
segment
clearli
defin
transvers
colon
characterist
featur
rat
mous
presenc
curv
kidneyshap
cecum
size
intermedi
larg
anatom
complex
cecum
herbivor
rabbit
small
cecum
carnivor
speci
probabl
reflect
omnivor
natur
flexibl
rat
mous
dietari
habit
particularli
abil
break
cellulos
cecum
rat
mous
blind
pouch
colon
ileum
exit
close
proxim
antiperistalt
movement
occur
structur
presenc
bacteria
undoubtedli
contribut
abil
function
ferment
organ
breakdown
substanc
occur
control
milieu
anatom
studi
shown
mous
cecum
less
volumin
rat
cecum
ampulla
region
colon
cecum
also
narrow
mous
rat
cecum
site
absorpt
mani
substanc
includ
calcium
magnesium
water
electrolyt
vitamin
k
fatti
acid
speci
cecectomi
shown
decreas
digest
carbohydr
protein
increas
loss
fecal
water
speci
anatom
function
featur
rodent
cecum
peristalt
antiperistalt
movement
may
expos
segment
larg
bowel
potenti
irrit
oral
administ
xenobiot
prolong
period
activ
intestin
microflora
metabol
endogen
exogen
substanc
demonstr
rodent
cecum
usual
stock
diet
rodent
contain
abund
plant
fiber
provid
bulk
ferment
carbohydr
microbi
popul
cecum
rat
fed
stock
diet
shown
possess
high
level
reduct
hydrolyt
enzym
activ
eg
azoreductas
nitroreductas
nitrat
reductas
cecal
content
compar
rat
fed
purifi
fiberfre
diet
intestin
anim
reduc
microflora
thinner
lamina
propria
lower
cell
turnov
enlarg
cecum
alter
metabol
cholesterol
bilirubin
bile
salt
larger
amount
mucin
fece
compar
anim
possess
normal
gastrointestin
microflora
colon
cecum
human
laboratori
anim
line
fairli
uniform
mucosa
devoid
villi
columnar
cell
two
main
type
cover
surfac
epithelium
absorpt
mucou
cell
similar
found
small
intestin
intestin
gland
crypt
extend
downward
surfac
gener
simpl
unbranch
tubul
line
princip
mucou
cell
smaller
popul
absorpt
endocrin
undifferenti
cell
mucosa
human
laboratori
anim
show
slightli
corrug
uneven
pattern
vari
particular
site
within
colon
histolog
section
colon
human
corrug
pattern
seen
anthemionlik
structur
crypt
reminisc
greek
architectur
featur
also
seen
larger
laboratori
anim
speci
rat
mice
crypt
cecal
mucosa
wider
near
lumen
crypt
base
crypt
may
branch
featur
may
relat
absorpt
function
zone
prolif
zone
larg
bowel
normal
locat
lower
part
gland
small
bowel
multipot
undifferenti
stem
cell
situat
gland
base
give
rise
princip
cell
type
migrat
cell
surfac
subsequ
differenti
alter
enzym
activ
morpholog
featur
studi
mous
aggreg
chimaera
demonstr
entir
epithelium
adult
gland
descend
singl
progenitor
cell
singl
progenitor
may
give
rise
sever
stem
cell
respons
cell
renew
complet
crypt
absorpt
cell
found
commonli
surfac
epithelium
also
lesser
extent
glandular
epithelium
morpholog
similar
small
intestin
possess
apic
plasma
membran
uniform
microvilli
wellform
glycocalyx
speci
region
differ
glycoconjug
found
brush
border
larg
intestin
although
gener
contain
predominantli
acid
mucosubst
mous
rat
sialomucin
neutral
mucin
found
hamster
dog
nonhuman
primat
human
sulfomucin
sialomucin
may
seen
brush
border
compound
may
induc
qualit
quantit
chang
mucin
content
colon
mucosa
without
mark
morpholog
alter
exampl
phenomenon
describ
rat
treat
reserpin
seven
day
colon
mucosa
show
increas
sulfomucin
highiron
diamin
posit
contain
goblet
cell
surfac
epithelium
glycocalyx
import
protect
function
colon
mucosa
disrupt
agent
salicyl
shown
increas
absorpt
xenobiot
rat
rectal
mucosa
colon
like
mani
tissu
also
possess
drug
metabol
activ
although
much
less
liver
among
human
substanti
individu
variabl
lamina
propria
larg
bowel
arrang
similar
way
small
bowel
virtu
presenc
lymphocyt
plasma
cell
macrophag
dendrit
cell
well
scatter
small
lymphoid
aggreg
patch
form
integr
import
part
mucos
immun
defens
system
lymphocyt
lamina
propria
human
colon
mucosa
like
ileum
shown
cell
helper
cell
outnumb
suppress
phenotyp
contrast
intraepitheli
lymphocyt
human
colon
mucosa
also
cell
possess
characterist
suppressercytotox
phenotyp
helper
cell
distribut
lymphocyt
subset
rat
colon
also
show
presenc
lymphocyt
lamina
propria
helper
phenotyp
lymphocyt
lamina
propria
suppressercytotox
type
contrast
higher
proport
within
colon
epithelium
matur
small
b
lymphocyt
rel
uncommon
colon
lamina
propria
human
laboratori
anim
although
lamina
propria
contain
larg
number
plasma
cell
mainli
iga
subtyp
featur
colon
mucosa
presenc
lymphoid
aggreg
also
call
lymphoid
nodul
patch
complex
microbursa
similar
peyer
patch
small
intestin
compos
princip
lymphoid
cell
b
cell
seri
arrang
follicl
germin
center
interfollicular
perifollicular
zone
compos
cell
distribut
along
entir
length
colon
mucosa
although
gener
smaller
peyer
patch
spraguedawley
rat
lymphoid
aggreg
usual
mm
diamet
except
distal
colon
attain
size
mm
maximum
diamet
unlik
peyer
patch
characterist
associ
crypt
villi
colon
lymphoid
aggreg
frequent
contain
irregular
atyp
mucos
gland
may
enter
deepli
lymphoid
tissu
penetr
musculari
mucosa
human
laboratori
anim
glandular
structur
intim
associ
lymphoid
tissu
may
import
immun
protect
colon
mucosa
perhap
act
special
local
receptor
antigen
colon
carcinoma
induc
dimethylhydrazin
rat
also
appear
develop
commonli
lymphoid
aggreg
zone
inflamm
ulcer
coliti
proctiti
although
microorgan
import
caus
inflammatori
diseas
larg
intestin
human
anim
among
laboratori
anim
recent
year
signific
problem
nonhuman
primat
hamster
strain
rat
mice
beagl
dog
commonli
employ
drug
safeti
evalu
spontan
diseas
colon
result
infecti
agent
uncommon
form
chronic
coliti
character
submucos
round
cell
infiltr
shorten
irregular
crypt
crypt
abscess
mucin
deplet
reactiv
mucos
chang
report
occur
signific
number
cynomolgu
monkey
one
laboratori
specif
pathogen
usual
identifi
although
associ
clinic
evid
diarrhea
treatment
therapeut
agent
may
alter
normal
bacteri
flora
permit
overgrowth
pathogen
organ
disturb
normal
balanc
antigen
lumen
control
mechan
evok
inflamm
inflamm
induc
microorgan
may
also
confound
histolog
assess
druginduc
chang
colon
ulcer
inflamm
colon
direct
result
system
administr
potenti
therapeut
agent
report
human
although
less
commonli
small
intestin
suggest
studi
effect
anticanc
compound
neoplast
cell
colon
cell
possess
inher
protect
properti
form
acceler
efflux
pump
serv
protect
potenti
damag
agent
ulcer
inflamm
induc
local
applic
drug
vehicl
rectal
mucosa
assess
effect
appropri
anim
model
import
safeti
evalu
prepar
design
use
human
patient
rectal
suppositori
inflamm
larg
intestin
mucosa
usual
specif
histolog
featur
earli
mild
inflamm
surfac
glandular
mucosa
remain
intact
show
mucin
deplet
character
reduct
mucu
goblet
cell
increas
cytoplasm
basophilia
scatter
neutrophil
may
seen
epithelium
adjac
lamina
propria
sever
case
crypt
becom
fill
distend
acut
inflammatori
cell
crypt
abscess
lamina
propria
variabl
hyperem
congest
contain
increas
number
mononuclear
cell
sever
chang
character
attenu
frank
eros
epithelium
format
penetr
ulcer
fill
fibrin
exud
surround
intens
inflamm
granul
tissu
eventu
fibrosi
residu
gland
may
dilat
line
flatten
epithelium
show
reactiv
chang
mitot
activ
regen
hyperplasia
becom
florid
chronic
ulcer
condit
character
lengthen
irregular
cystic
dilat
gland
often
line
hyperplast
epitheli
cell
goblet
cell
distend
mucin
extrem
florid
reactiv
chang
may
appear
atyp
mimic
dysplast
preneoplast
chang
see
neoplasia
ulcer
damag
destroy
gland
support
stroma
regener
gland
may
occur
normal
regular
fashion
branch
crypt
may
evid
clostridium
difficil
may
caus
inflammatori
chang
colon
laboratori
anim
particularli
hamster
may
extend
distal
ileum
human
form
coliti
often
refer
pseudomembran
coliti
usual
associ
antibiot
therapi
human
origin
associ
lincomycin
clindamycin
therapi
antibiot
implic
clostridium
difficil
believ
respons
approxim
case
antibioticassoci
diarrhea
howev
precis
caus
much
antibioticassoci
diarrhea
human
less
well
defin
microorgan
also
implic
antibioticassoci
diarrhea
notabl
klebsiella
oxytoca
clostridium
perfringen
type
staphylococcu
aureu
candida
salmonella
speci
although
evid
less
strong
addit
alter
microflora
may
also
reduc
bile
acid
metabol
reduc
ferment
carbohydr
shown
human
hamster
clostridium
difficil
produc
toxin
induc
enter
human
condit
character
presenc
plaqu
pseudomembran
colon
mucos
surfac
pseudomembran
compos
mucu
fibrin
blood
cell
inflammatori
cell
cell
debri
appear
stream
underli
mucosa
mucosa
may
partli
necrot
mucos
gland
dilat
line
flatten
hyperplast
cell
ileal
mucosa
may
show
similar
chang
similar
featur
occur
antibiotictr
laboratori
anim
hamster
condit
character
eros
colon
epithelium
presenc
pseudomembran
plaqu
mucin
cell
debri
intact
affect
mucosa
thicken
reactiv
chang
accompani
mucin
loss
epithelium
infiltr
hyperem
edemat
lamina
propria
submucosa
polymorphonuclear
cell
although
instanc
form
clostridia
coliti
hamster
associ
antibacteri
therapi
also
report
untreat
hamster
treat
antineoplast
drug
similar
chang
report
antibiotictr
guinea
pig
rabbit
human
drug
believ
alter
intestin
flora
permit
overgrowth
clostridium
difficil
result
sever
sometim
fatal
enterocol
citrobact
freundii
gramneg
short
plump
rod
member
famili
enterobacteriacea
caus
agent
natur
occur
transmiss
colon
hyperplasia
mice
agent
usual
produc
mild
even
asymptomat
enter
suscept
mous
popul
although
caus
rectal
prolaps
mark
strain
differ
note
mice
infect
organ
nih
swiss
mice
show
sever
histolog
chang
mice
appear
least
affect
rat
hamster
seem
resist
microscop
chang
found
primarili
descend
colon
although
proxim
segment
colon
cecum
may
also
affect
import
morpholog
featur
epitheli
hyperplasia
occur
maxim
two
three
week
experiment
inocul
citrobact
freundii
colon
gland
elong
line
cell
show
mucin
deplet
loss
goblet
cell
consider
immatur
mitot
activ
surfac
epithelium
may
cover
numer
coccobacilli
visual
routin
hematoxylin
eosinstain
section
crypt
abscess
inflammatori
cell
lamina
propria
mucos
eros
ulcer
also
featur
regress
lesion
rebound
increas
goblet
cell
often
distend
mucin
colon
gland
may
branch
irregular
laboratori
anim
natur
resist
shigella
infect
case
nonhuman
primat
infect
shigella
colon
show
superfici
acut
inflammatori
reaction
compris
edema
congest
hemorrhag
infiltr
acut
inflammatori
cell
surfac
epithelium
show
mucin
loss
format
small
ulcer
total
destruct
epithelium
occur
ulcer
extend
lamina
propria
gener
term
inflammatori
process
remain
rel
superfici
organ
also
locat
predominantli
superfici
epithelium
anoth
bacteri
infect
gastrointestin
tract
affect
colon
primat
produc
nontubercul
mycobacteria
larg
intestin
lesion
character
massiv
accumul
epitheloid
macrophag
lamina
propria
may
extend
submucosa
muscular
layer
along
lymphat
involv
mesenter
lymph
node
small
intestin
lesion
may
also
occur
character
presenc
similar
larg
macrophag
lamina
propria
tip
villi
superfici
ulcer
may
occur
sever
affect
segment
intestin
acidfast
bacteria
typic
found
within
macrophag
organ
includ
spleen
liver
bone
marrow
lung
may
also
involv
focal
accumul
bacterialaden
macrophag
occasion
discret
granuloma
multinucl
giant
cell
new
world
monkey
chronic
idiopath
coliti
common
may
occur
part
marmoset
wast
syndrom
earli
featur
includ
neutrophil
infiltr
lamina
propria
crypt
abscess
eros
ulcer
regener
mononuclear
inflamm
microherni
gland
dysplasia
occasion
carcinoma
caus
uncertain
although
number
infect
agent
implic
numer
protozoa
metazoa
describ
inhabit
cecum
colon
nonhuman
primat
although
less
promin
current
coloni
laboratori
monkey
far
fewer
observ
usual
laboratori
rodent
beagl
dog
amoebiasi
caus
entamoeba
histolytica
widespread
diseas
among
nonhuman
primat
character
histolog
presenc
necrot
ulcer
reach
musculari
mucosa
form
typic
flaskshap
ulcer
contain
surround
trophozoit
extens
hemorrhag
may
seen
well
inflammatori
infiltr
compos
neutrophil
mononuclear
cell
ciliat
balantidium
coli
also
caus
ulcer
process
colon
primat
character
ulcer
extend
musculari
mucosa
accompani
lymphocyt
infiltr
balantidium
coli
trophozoit
greatest
diamet
varieti
metazoan
parasit
observ
primat
colon
usual
reason
well
identifi
tissu
section
nematod
speci
strongyloid
import
parasit
may
observ
intestin
mucosa
primat
oxyurid
commonli
known
pinworm
essenti
innocu
parasit
seen
human
monkey
rodent
enterobiu
vermiculari
found
larg
intestin
appendix
human
nonhuman
primat
syphacia
muri
syphacia
obvelata
rodent
oesophagostomum
speci
nodular
worm
especi
common
nematod
parasit
nonhuman
primat
form
characterist
nodul
mm
diamet
frequent
seros
surfac
larg
intestin
cecum
adjoin
mesenteri
well
site
periton
caviti
also
parasit
rumin
pig
found
human
part
africa
histolog
nodul
compos
parasit
cell
debri
surround
fibrou
tissu
variabl
mantl
chronic
inflammatori
cell
occasion
foreignbodi
giant
cell
frequent
found
close
proxim
small
arteri
arteriol
submucosa
subserosa
colon
may
associ
local
granulomat
arter
inflammatori
process
may
spread
surround
drain
tissu
particularli
nodul
ruptur
mild
periport
hepat
chronic
inflamm
sometim
associ
presenc
parasit
mesenteri
may
confound
interpret
druginduc
hepat
chang
monkey
divers
rang
xenobiot
report
damag
colon
mucosa
human
although
comparison
stomach
small
intestin
colon
appear
remark
resist
druginduc
damag
although
longterm
use
nonsteroid
antiinflammatori
drug
associ
benefici
effect
decreas
colorect
cancer
incid
regress
adenomat
polyp
drug
occasion
caus
mucos
inflamm
ulcer
follow
focal
scar
submucosa
constrict
format
mucos
diaphragm
damag
occur
mainli
right
side
colon
believ
relat
inhibit
prostaglandin
rather
contact
damag
potassium
chlorid
therapi
may
also
produc
colon
damag
character
segment
full
thick
scar
constrict
anoth
form
induc
colon
damag
report
children
cystic
fibrosi
mani
take
high
strength
pancreaticenzym
supplement
control
malabsorpt
patient
fusiform
stenosi
long
segment
ascend
colon
primarili
result
submucos
thicken
matur
collagen
mucosa
appear
rel
spare
may
show
ulcer
repar
chang
although
suggest
chang
may
due
methyacryl
copolym
use
enter
coat
high
strength
prepar
studi
show
strong
relat
high
daili
dose
enzym
supplement
accentu
avail
high
dose
form
view
usag
year
preclin
data
materi
scarc
cellular
degener
loss
mitot
activ
mucin
deplet
also
occur
colon
follow
treatment
antimitot
drug
cocain
abus
also
lead
ischem
form
coliti
although
exact
pathophysiolog
form
ischemia
certain
cocain
block
reuptak
norepinephrin
noradrenalin
lead
mesenter
vasoconstrict
tissu
ischemia
like
caus
perfor
digoxin
diuret
also
link
ischem
coliti
individu
predispos
low
mesenter
blood
flow
occur
heart
failur
form
coliti
character
superfici
epitheli
loss
spare
crypt
base
along
hemorrhag
hyalin
lamina
propria
rectal
administr
therapeut
agent
surfact
may
also
induc
ulcer
inflammatori
chang
chemic
coliti
resembl
pseudomembran
coliti
report
human
result
chemic
clean
agent
accident
induc
endoscop
examin
laboratori
anim
colon
damag
induc
experiment
administr
therapeut
agent
dog
administ
mgkg
nonsteroid
antiinflammatori
drug
indomethecin
oral
day
period
day
develop
gastric
small
intestin
ulcer
also
scatter
hemorrhag
eros
colon
rectum
microscop
lesion
character
loss
superfici
epitheli
cell
mucu
deplet
glandular
epithelium
crypt
abscess
frequent
acut
inflamm
adjac
lymphoid
aggreg
submucosa
anoth
exampl
chemic
induc
coliti
relev
patholog
drug
safeti
assess
induc
degrad
carrageenan
synthet
sulfat
dextran
carrageenan
heterogen
group
sulfat
polysaccharid
compos
mainli
long
chain
dgalactos
subunit
dgalactan
deriv
red
seawe
speci
wide
use
food
emulsifi
stabil
thicken
gell
agent
carrageenan
degrad
acid
hydrolysi
smaller
molecular
weight
fragment
kda
administ
oral
high
dose
eg
diet
rat
mice
guinea
pig
rabbit
rhesu
monkey
coliti
result
similarli
coliti
induc
rat
follow
administr
dietari
admixtur
dextran
sulfat
sodium
sulfat
polym
glucos
molecular
weight
kda
high
molecular
weight
dglucan
amylopectin
sulfat
although
histolog
featur
form
induc
coliti
vari
studi
speci
strain
coliti
rodent
gener
character
mucos
ulcer
mainli
cecum
also
distal
ileum
distal
colon
rectum
mucu
deplet
variabl
acut
inflammatori
infiltr
intact
epithelium
increas
cell
prolifer
crypt
abscess
inflammatori
infiltr
lamina
propria
edema
hyperemia
even
vascular
thrombosi
submucosa
cecum
rat
ulcer
linear
often
circul
entir
circumfer
intestin
wall
subsequ
scar
strictur
format
ulcer
lesion
rectum
anal
margin
associ
squamou
metaplasia
squamou
metaplasia
regen
hyperplasia
columnar
epithelium
shown
progress
even
cessat
treatment
foami
macrophag
contain
metachromat
materi
presum
polysaccharid
also
seen
lamina
propria
submucosa
region
lymph
node
liver
spleen
precis
mechan
involv
develop
coliti
unclear
low
dose
level
may
expect
mimic
human
exposur
produc
coliti
dextran
carrageenan
polysaccharid
molecular
weight
outsid
rang
kda
tend
incit
coliti
except
agent
amylopectin
sulfat
far
higher
molecular
weight
howev
amylopectin
compos
polysaccharid
chain
degrad
amylas
therefor
smaller
molecular
weight
fragment
may
form
vivo
suggest
colon
diseas
produc
agent
may
link
induc
chang
intestin
microflora
result
increas
intestin
permeabl
antigen
inflammatori
substanc
normal
resid
larg
intestin
longterm
administr
high
dose
agent
rat
lead
develop
colorect
cancer
despit
devoid
mutagen
activ
see
obviou
patholog
colon
chang
associ
administr
nongenotox
agent
chronic
inflamm
increas
prolif
activ
lymphoid
infiltr
without
tissu
damag
report
larg
bowel
rat
treat
human
recombin
interleukin
melanosi
coli
repres
welldescrib
phenomenon
human
associ
chronic
ingest
anthraquinon
purg
also
bisacodyl
diphenylmethan
stimul
lax
act
contact
mucosa
larg
bowel
increas
peristalt
activ
melanosi
coli
due
excess
accumul
lipofuscinlik
pigment
macrophag
colon
lamina
propria
pigment
probabl
origin
organel
epitheli
cell
macrophag
damag
treatment
basi
studi
melanosi
coli
induc
guinea
pig
anthraquinon
suggest
primari
process
treatmentinduc
increas
apoptot
bodi
surfac
colon
epithelium
phagocytos
intraepitheli
macrophag
transport
lamina
propria
pigment
deposit
induc
guinea
pig
seem
occur
rat
mice
dog
oral
rat
toxic
carcinogen
studi
wide
use
lax
senna
shown
colon
epitheli
hyperplasia
evid
carcinogen
consist
benign
natur
melanosi
coli
lack
risk
cancer
human
patient
lipofuscin
iron
pigment
occasion
observ
lamina
propria
untreat
rodent
presum
result
age
previou
inflammatori
process
hemorrhag
glandular
epitheli
tissu
hyperplasia
may
focal
diffus
without
atyp
cellular
featur
term
usual
use
hyperplasia
atyp
cytolog
featur
atyp
hyperplasia
although
use
term
dysplasia
thu
pathologist
must
make
distinct
hyperplasia
repres
simpl
adapt
respons
show
suffici
atyp
featur
suggest
premalign
state
like
small
intestin
cell
prolifer
larg
intestin
mucosa
stimul
varieti
differ
factor
although
function
adapt
respons
less
well
studi
physic
stimul
distens
increas
dietari
bulk
long
known
suffici
initi
hyperplasia
includ
thicken
muscl
coat
one
clearli
document
form
compensatori
hyperplasia
occur
respons
surgic
resect
bypass
segment
colon
follow
resect
segment
colon
rat
shown
remain
proxim
segment
right
side
colon
develop
increas
thick
mucosa
musculari
externa
well
enlarg
lymphoid
aggreg
microscop
mucosa
right
side
colon
appear
uniformli
thicken
accentu
fold
elong
mucos
gland
increas
height
surfac
columnar
cell
chang
mark
day
follow
surgeri
less
pronounc
day
shown
signific
increas
mitot
index
proxim
segment
occur
seven
day
day
mitot
index
return
normal
distal
downstream
segment
show
littl
morpholog
chang
rather
longliv
increas
mitot
activ
suggest
differ
relat
differ
embryolog
origin
segment
similar
form
uniform
colon
hyperplasia
affect
princip
cecal
rightsid
colon
mucosa
also
occur
rat
follow
oral
administr
sulfat
dextran
molecular
weight
approxim
kda
figur
oral
administr
larg
volum
wide
rang
poorli
absorb
carbohydr
osmot
activ
agent
produc
similar
chang
dose
rodent
larg
amount
compound
raw
chemic
modifi
starch
variou
dietari
fiber
caramel
sugar
alcohol
lactitol
sorbitol
mannitol
xylilol
lactos
synthet
polydextros
cyclodextrin
polyethylen
glycol
magnesium
sulfat
also
link
increas
cecal
size
colon
mucos
hyperplasia
characterist
histolog
appear
colon
mucosa
follow
administr
agent
lengthen
mucos
gland
line
epithelium
compos
increas
number
enlarg
epitheli
cell
includ
goblet
cell
ie
hypertrophi
hyperplasia
show
increas
prolif
activ
rapid
incorpor
tritiat
thymidin
note
morphometr
studi
rat
given
pectin
cellulos
shown
precis
natur
administ
substanc
influenc
degre
distribut
mucos
hyperplasia
associ
smooth
muscl
hypertrophi
moreov
agent
may
produc
addit
chang
mucos
submucos
edema
report
associ
administr
lactos
increas
mucos
lymphoid
aggreg
follow
lactos
xylitol
feed
may
also
interact
dietari
fiber
content
colon
microflora
influenc
mucos
growth
although
mechan
unclear
gener
argu
increas
cecal
size
mucos
hypertrophi
appear
relat
osmot
activ
cecal
content
rodent
treat
larg
dose
agent
therefor
relev
human
expos
low
dose
thu
chang
repres
physiolog
adapt
increas
osmot
forc
high
dose
given
irrespect
contribut
compound
administr
high
dose
lax
also
report
produc
mild
colon
hyperplasia
laboratori
rat
consid
exagger
pharmacodynam
effect
treatment
rodent
antibiot
also
caus
cecal
enlarg
dilat
without
signific
histopatholog
chang
probabl
result
chang
cecal
microflora
suggest
enlarg
relat
accumul
urea
result
inhibit
bacteri
ureas
howev
histochem
studi
intestin
mucosa
rat
treat
neomycin
also
shown
treatmentrel
reduct
activ
nad
tetrazolium
reductas
succin
dehydrogenas
esteras
alkalin
acid
phosphatas
distal
ileum
suggest
antibiot
also
possess
potenti
directli
influenc
absorpt
metabol
function
mucos
cell
longterm
administr
prostaglandin
e
prostaglandin
e
analog
rat
also
produc
thicken
proxim
colon
mucosa
although
less
mark
stomach
duodenum
small
intestin
administr
epiderm
growth
factor
rat
cynomolgu
monkey
induc
hyperplasia
colon
mucosa
character
histolog
hyperplasia
increas
mitot
activ
crypt
cell
reduct
goblet
cell
number
increas
crypt
depth
slight
increas
number
infiltr
neutrophil
atyp
hyperplasia
common
epitheli
surfac
atyp
hyperplasia
associ
develop
colon
cancer
human
laboratori
anim
earli
alter
observ
rat
treat
colon
carcinogen
similar
found
immedi
vicin
human
colorect
carcinoma
chang
character
lengthen
dilat
branch
gland
epithelium
line
gland
show
mucou
cell
hyperplasia
goblet
cell
hyperplasia
goblet
cell
contain
predominantli
sialomucin
instead
normal
sulfomucin
lesion
becom
atyp
dilat
branch
gland
becom
complex
line
epithelium
show
increas
pseudostratif
vesicular
cell
nuclei
rat
treat
carcinogen
azoxymethan
crypt
show
diminut
mucu
secret
increas
cytoplasm
basophilia
promin
round
enlarg
nuclei
show
variabl
degre
pseudostratif
eventu
develop
frankli
invas
gland
similar
alter
occur
rat
treat
azoxymethan
studi
anim
model
human
colorect
cancer
preneoplast
chang
use
rat
mice
given
chemic
pertin
assess
drug
safeti
fact
atyp
hyperplasia
eventu
neoplasia
induc
nongenotox
agent
dextran
sodium
sulfat
produc
prolong
chronic
colon
inflamm
potenti
therapeut
agent
design
poorli
absorb
may
produc
similar
alter
rodent
colon
administ
high
dose
dose
dextran
sodium
sulfat
rodent
use
model
human
chronic
inflammatori
diseas
ulcer
coliti
crohn
coliti
associ
increas
risk
develop
colorect
cancer
see
neoplasia
approach
histolog
examin
form
hyperplasia
take
account
fact
inflammatori
model
progress
atyp
featur
dysplasia
polypoid
flat
infiltr
carcinoma
grade
degre
atyp
featur
perform
human
case
coliti
appear
best
approach
adenoma
adenocarcinoma
small
larg
intestin
infrequ
spontan
neoplasm
laboratori
anim
compar
human
colorect
carcinoma
one
preval
neoplasm
western
world
adenoma
adenocarcinoma
probabl
occur
spontan
older
dog
anim
speci
human
locat
frequent
distal
colon
rectum
nonhuman
primat
glandular
neoplasm
intestin
occur
increas
age
ileum
colon
predilect
zone
near
ileocec
valv
one
rhesu
coloni
incid
colon
cancer
report
anim
convent
rat
mice
spontan
intestin
neoplasm
uncommon
although
adenocarcinoma
occasion
observ
ileum
colon
chronic
toxic
studi
carcinogen
bioassay
origin
distal
part
small
intestin
cecum
right
side
colon
may
produc
metastas
mostli
liver
lung
one
seri
spontan
adenocarcinoma
develop
period
wistar
rat
appear
intim
relationship
campylobacterlik
organ
togeth
diverticula
chronic
inflamm
suggest
associ
inflamm
involv
pathogenesi
cancer
adenoma
adenocarcinoma
report
occur
colon
rectum
male
femal
control
fischer
rat
cecum
male
femal
control
mice
nation
toxicolog
program
hamster
coloni
inflammatori
bowel
diseas
also
high
incid
small
larg
intestin
polyp
adenoma
adenocarcinoma
poorli
differenti
carcinoma
may
infiltr
local
lymph
node
may
difficult
locat
primari
neoplasm
polyp
predominantli
adenomat
natur
although
inflammatori
regen
polyp
observ
chemic
induc
colon
carcinoma
rel
uncommonli
rodent
carcinogen
studi
nation
toxicolog
program
databas
rodent
tumorigen
target
intestin
compar
produc
tumor
forestomach
liver
therapeut
agent
seldom
induc
intestin
neoplasm
rodent
carcinogen
studi
one
case
report
itraconazol
formul
cyclodextrin
vehicl
produc
cecal
colon
hypertrophi
small
increas
colon
carcinoma
rat
given
high
oral
dose
two
year
seen
adapt
high
dose
effect
relev
intraven
use
vehicl
antifung
drug
adenocarcinoma
induc
experiment
rodent
intestin
carcinogen
azoxymethan
histogenesi
induc
carcinoma
extens
studi
gener
accept
resembl
human
colorect
cancer
view
import
colon
cancer
human
number
new
genet
mous
model
predispos
colon
cancer
develop
recent
year
one
wide
use
chemoprevent
assay
apc
min
mous
heterozyg
multipl
intestin
neoplasia
allel
produc
intestin
polyp
mostli
small
intestin
rather
colon
howev
infect
citrobact
rodentium
shown
promot
colon
tumor
format
mice
reflect
complex
interact
involv
colon
tumorigenesi
studi
compar
use
differ
rodent
model
predict
efficaci
colon
tumor
prevent
human
volunt
suggest
model
reason
predict
abil
carcinogeninduc
rat
model
perform
least
well
apc
min
mous
model
pertin
evalu
drug
chemic
rodent
close
link
chronic
inflamm
develop
neoplasm
particularli
larg
intestin
recent
year
epidemiolog
studi
patient
genet
evid
anim
model
serv
confirm
close
link
chronic
inflamm
cancer
moreov
shown
treatment
nonsteroid
inflammatori
drug
decreas
incid
mortal
number
cancer
two
key
gene
inflammatori
process
cyclooxygenas
nuclear
factor
b
also
provid
plausibl
mechanist
link
inflamm
cancer
human
chronic
inflammatori
bowel
diseas
long
associ
increas
risk
colon
cancer
sever
anim
model
use
predomin
oral
administr
dextran
sodium
sulfat
recapitul
find
neoplasm
occur
rat
colon
follow
administr
high
dose
sulfat
dextran
degrad
carrageenan
usual
occur
distal
colon
rectum
well
cecum
proxim
colon
may
flat
polypoid
adenoma
adenocarcinoma
distribut
close
link
area
chronic
inflamm
pathogenesi
neoplasm
induc
carrageenan
dextran
remain
unexplain
although
presenc
inflamm
essenti
like
provid
microenviron
aid
prolifer
surviv
malign
cell
promot
angiogenesi
metastasi
subvert
immun
respons
alter
respons
hormon
mediat
suggest
factor
includ
reduc
apoptosi
alter
crypt
cell
metabol
chang
bile
acid
enterohepat
circul
also
suggest
bacteria
flora
specif
rodent
might
also
involv
tumor
develop
although
agent
biolog
activ
compound
nonmutagen
usual
shortterm
test
suggest
carrageenan
act
tumor
promot
shown
potenti
appear
carcinoma
rat
treat
standard
intestin
carcinogen
also
propos
agent
tumor
initi
base
develop
carcinoma
rat
treat
degrad
carrageenan
two
month
howev
despit
short
period
treatment
inflamm
regen
chang
squamou
metaplasia
persist
throughout
period
month
treatment
withdrawn
develop
cancer
rat
overal
consist
associ
carrageenan
dextran
sulfat
develop
carcinoma
rodent
chronic
inflamm
key
point
evalu
agent
produc
neoplasm
context
chronic
inflamm
larg
intestin
rodent
neoplasm
occur
absenc
sever
prolong
inflamm
similar
rang
neoplasm
defin
histolog
human
experiment
patholog
usual
appropri
use
classif
speci
domest
laboratori
anim
human
assess
neoplasia
difficult
context
chronic
inflamm
larg
zone
mucosa
may
develop
atyp
featur
field
chang
well
disrupt
inflamm
fibroblast
chang
fibrosi
invas
carcinoma
may
develop
context
small
flat
dysplast
chang
epithelium
context
grade
degre
atyp
cytolog
featur
use
sever
atypia
dysplasia
may
marker
precursor
carcinoma
may
malign
associ
direct
invas
underli
tissu
gener
agre
classif
rodent
intestin
tumor
summar
follow
adenoma
adenomat
polyp
repres
local
sessil
polypoid
neoplasm
compos
prolifer
tubular
gland
show
vari
degre
nuclear
hyperchromat
pseudostratif
cellular
pleomorph
figur
use
scheme
grade
carcinogen
potenti
hyperplast
mucosa
adenomat
polyp
human
base
degre
epitheli
pseudostratif
propos
kozuka
although
experiment
neoplasm
may
alway
show
full
spectrum
chang
report
human
grade
provid
use
baselin
concept
assess
noninvas
prolif
lesion
polyp
progress
show
increas
nuclear
pseudostratif
typic
branch
gland
neoplast
cell
gland
seen
stroma
stalk
base
diagnosi
carcinoma
made
villou
adenoma
form
adenoma
epitheli
prolifer
take
form
elong
villi
spars
fibrovascular
stroma
grade
similar
way
adenoma
glandular
neoplasm
variabl
differenti
sometim
origin
adenomat
polyp
villou
adenoma
show
infiltr
intestin
wall
ie
beyond
boundari
musculari
mucosa
squamou
carcinoma
also
occur
anorect
zone
similar
occur
squamou
epithelium
elsewher
similarli
mesenchym
neoplasm
also
found
small
larg
intestin
wall
see
integumentari
system
chapter
